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Abstract
Macrophages (Mc))) play a key role in renal inflammation and may be
cytotoxic to resident cells within tissues. I began this thesis by examining the effect
of M<j) upon the level of apoptosis and proliferation in tubular epithelial cells in vitro.
I used a microscopically quantifiable co-culture assay to determine whether
inflammatory M(j) modulated apoptosis and proliferation of (i) Madine-Darby canine
kidney (MDCK) cells and (ii) primary murine tubular epithelial cells. Bone marrow-
derived Mcj) and target tubular cells were differentially labeled with fluorochromes
and interacted for 24 hrs. Apoptosis and proliferation was quantified by fluorescent
microscopy after fixation and Hoechst staining. Quiescent non-activated Mcj) did not
induce significant apoptosis of tubular cells whilst cytokine activated (LPS/IFN-y)
Mcj) induced marked apoptosis of both MDKC and primary tubular cells.
Pharmacological inhibition of nitric oxide (NO) production with L-NAME or
inclusion of cytokine activated Mcj) derived from inducible nitric oxide synthase
(iNOS) knockout (KO) mice reduced apoptosis in both MDKC and primary tubular
cells. MDCK cell proliferation was significantly suppressed by both non-activated
and activated Mcj) from iNOS WT and iNOS KO mice indicating that it was an NO-
independent effect. In contrast, no effect upon primary tubular cell proliferation was
evident.
I then went on to examine the role of NO in vivo in the murine model of
unilateral ureteric obstruction (UUO) characterised by tubular cell apoptosis and
interstitial fibrosis. Initially UUO was performed in iNOS KO and wild-type mice
but iNOS KO mice exhibited significantly increased Mcj) infiltration. Therefore, the
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specific iNOS inhibitor L-NIL (control D-NIL) was administered between days 5 to
7 following UUO. Mice were sacrificed at day 7 and the obstructed kidney removed
for histological analysis. L-NIL treatment did not affect Mc|) infiltration but did
reduce both tubular and interstitial cell apoptosis. Proliferation of tubular cells and
interstitial cells was unaffected. Although myofibroblast accumulation was
unaffected, interstitial fibrosis was significantly increased by L-NIL treatment.
I also investigated the effect of conditional Mc() ablation in the UUO model.
The conditional M(|) ablation mice used in these studies are transgenic for the human
diphtheria toxin receptor (DTR) under the CDllb promoter (CDllb-DTR mice).
Intraperitoneal (i.p) administration of diphtheria toxin (DT) to DTR mice results in
the rapid and specific depletion ofmonocytes and M(J>. DTR mice underwent UUO at
day 0 and either DT or PBS was administered i.p on days 5, 6 and 7. Mice were
sacrificed at day 7 and the obstructed kidney removed for histological analysis.
Administration of DT resulted in a 3-fold reduction in interstitial Mc)) accumulation
in obstructed kidneys. However, Mcj) depletion had no effect upon proximal or distal
tubular cell proliferation or apoptosis. Interestingly, M(j) depletion had no effect upon
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The main functions of the kidneys are the production of urine, the secretion
of hormones, blood pressure control and the regulation ofwater, electrolyte and acid-
base balance. Two important functional regions of the kidney are the outer cortex
and the inner medulla (Figure 1-1). The functional units of the kidneys are the
nephrons (Figure 1-2) consisting of the glomerulus, an organised sieve-like structure
of capillary loops surrounded by the Bowman's capsule, and the associated tubules.
The major regions of the tubule are the proximal convoluted tube, the descending
and ascending limbs of the loops of Henle and the distal convoluted tube. The distal
convoluted tubule drains into the collecting duct, which serves many other nephrons.
The interstitium comprises the area between the tubules and contains the critically
important peritubular capillaries that provide the metabolically active tubules with
oxygen and nutrients. The interstitium also contains extracellular matrix that acts as a
supporting structure and a population of resident macrophages (M(J>), dendritic cells
(DC) and fibroblasts. Urine filtrate is produced in the glomerulus by filtration of the
plasma and the urine is modified by re-absorption and secretion as it passes along the
nephron tubules. The filtered urine continues in the collecting duct, drains into the
renal pelvis and subsequently via the ureter into the urinary bladder.
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Figure 1-1 Photomicrographs of normal mouse kidney after Periodic
acid Schiff (PAS) staining demonstrating cortex and medulla.
The cortex has glomeruli (big arrow heads) and tubules (small arrow heads)
(A). Medulla is shown in (B). (x100 magnification).
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Distal convoluted
Figure 1-2 Schematic diagram chart of a nephron within a kidney.
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1.2 TUBULAR EPITHELIAL CELLS
Tubular epithelial cells are the predominant cells in the renal
tubulointerstitium and are critically important resident renal cells. Proximal tubules
consist of cuboidal epithelial cells that are very metabolically active and have
microvilli that form an extensive brush border on their free apical surface. The
microvilli increase the surface area exposed to the glomerular filtrate and enhance
the reabsorprtion of substances such as filtered electrolytes as well as low molecular
proteins. The epithelial cells of the distal tubules are also cuboidal but lack
microvilli. Proximal tubular epithelial cells can easily be distinguished from distal
tubular epithelial cells by periodic acid Schiff (PAS) staining, as proximal tubular
cells exhibit a characteristic PAS-positive luminal brush border (Hughes et al., 1999)
(Figure 1-3). Proximal and distal tubular epithelial cells can further be characterised
by the differential expression of specific antigens, enzyme profiles, transport
function studies and hormonal responsiveness - these differences are summarised in
Table 1-1.
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Figure 1-3 Photomicrographs of normal mouse kidney after PAS
staining showing distal and proximal tubules.
Proximal tubules (A) are distinguished from the distal tubules (B) by their
characteristic pink brush border (x400 original magnification).
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Table 1-1 Surface antigens and characteristic features for
distinguishing proximal and distal tubular epithelial cells.
PROXIMAL DISTAL
TUBULAR EPITHELIAL CELL TUBULAR EPITHELIAL CELL
Surface antigens: Surface antigens:
N-cadherin E-cadherin
(Nouwen et al., 1993) (Nouwen et al., 1993)
Gamma-glytamyl transferase
(Briere et al., 1985)
Tamm Horsfall protein
(Baer et al., 2006)
Intestinal alkaline phosphatase
(Briere et al., 1985)
Alanine aminopeptidase
(Toutain et al., 1991)
Dipeptidyl peptidase IV
(Mentzel et al., 1996)
Leucine aminopeptidase
(Elliget and Trump, 1991)
Aquaporin-1
(Bedford et al., 2003)
Aquaporin-2
(Bedford et al., 2003)
Hormone responsiveness Hormone responsiveness







Transport studies Transport studies:
Sodium dependent a-methylglucoside
transport
(Chung et al., 1982)
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1.2.1 Primary tubular epithelial cell culture
In vitro cell culture of primary tubular epithelial (PTE) cells provides an
excellent means of studying specific cellular interactions in contrast to more
complicated in vivo experiments. A potential disadvantage of primary cell cultures is
that the cells have been directly removed from the in vivo condition and this may
induce a change in the phenotype of the cell from that which is evident in vivo.
Despite this potential confounding factor, much has been learned about the
function of various cell types in primary culture. Primary cell culture protocols have
been developed for the growth of tubular epithelial cells from various species
including human (Detrisac et al., 1984), mouse (Taub and Sato, 1980), rat (Elliget
and Trump, 1991) and rabbit (Chung et al., 1982). The culture method for PTE cells
(Harrison et al., 2006) that I used in this thesis is described in detail in Chapter 2.2.
Other methods are based on separation techniques such as differential sieving,
centrifugation using Percoll gradient (Gesek et al., 1987) or staining for specific
tubular epithelial cell markers surface makers followed by cell sorting using
magnetic beads (Baer et al., 1997) or FACS (Fluorescence-Activated Cell Sorter)
(Helbert et al., 2001).
1.2.2 Tubular epithelial cell lines
There are a number of well established immortalised (transformed) tubular
epithelial cell lines which can be used for in vitro studies. Commonly used tubular
epithelial cell lines include:
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(i) murine proximal PKSV-PR cells derived from the transgenic mouse
carrying the SV40 large T antigen (LTAg) gene under the control of the L-type
pyruvate kinase promoter (Lacave et al., 1993),
(ii) proximal MCT cells harvested from the cortex of SJL mice and then
transformed using the SV40 LTAg (Haverty et al., 1988),
(iii) distal MDCK (Madin Darby Canine Kidney) cells that were derived
from a female cocker spaniel in 1958 by S. H. Madin and N. B. Darby,
(iv) proximal porcine LLC-PKi cells harvested from juvenile male
Hamshire pig (Hull et al., 1976) and
(v) proximal HK-2 (Human Kidney-2) cell harvested from normal adult
human kidney and then transformed with the human papilloma E6/E7 gene (Ryan et
al., 1994).
1.3 INFLAMMATION
1.3.1 History of inflammation
Over 2000 years ago, the Greek physician Celsius (30BC-38AD)
documented the four cardinal signs of inflammation: rubor (redness), tumor
(swelling), calor (heat) and dolor (pain). Virchow (1799-1879) described the fifth
cardinal sign offunction laesa (loss of function) in 1871. Although Galen (129-201
AD) proposed that inflammation was an essential part of the response to injury,
inflammation was very much regarded as a 'disease' until the late 18(h century. John
Hunter (1728-1793) was the first to realise that inflammation was generally
beneficial to the host despite the fact that it was a response to tissue injury.
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Later Cohnheim (1839-1884), a former student of Virchow, described the
emigration of white blood cells though the walls of small blood vessels during
inflammation. Metchnikoff (1845-1916) described the process of phagocytosis in
1882. He inserted rose thorns into the larvae of starfish and demonstrated that
mesenchymal cells migrated and accumulated around the puncture site. He described
the phagocytic actions of these cells and named the big cells 'macrophagocytes' and
the smaller cells 'microphagocytes'. These cells are now known as M<j> and
neutrophils (PMN) (Segal, 2005).
Inflammation is now regarded as a protective response of the host to tissue
injury and infection. The prime purpose of inflammation is to localise, neutralise and
remove pathogens from the tissues whilst limiting tissue injury and setting the scene
for subsequent tissue repair (Henson, 2005). The inflammatory response results in
vasodilatation and an increased permeability of the microcirculation that facilitates
the emigration of leukocytes to the site of inflammation (Chapter 1.16).
1.3.2 The neutrophil (PMN)
PMN are the first cells to appear at the site of inflammation during acute
inflammation and are followed by monocytes which subsequently differentiate into
tissue M(j) (Serhan and Savill, 2005). The rapidly recruited PMN plays an important
role in host defense against bacterial infection as activated PMN generate
antimicrobial proteins and can undergo a 'respiratory burst', which produces large
amounts of reactive oxygen radicals and hydrogen peroxide. PMN generate proteases
that can degrade extracellular matrix that can damage host tissues (so-called 'friendly
fire'). Thus, the multiple effects of activated PMN during acute inflammation can
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result in significant tissue injury. The PMN has important phagocytic actions and
may also release cytokines and chemokines, which recruit more leukocytes to the site
of inflammation such that the inflammatory response is exacerbated.
1.3.3 The lymphocytes
PMN and Mc|) are the first line of defense and comprise key facets of the
innate immune system. The second line of defense is the adaptive immune system,
which is composed of DC and lymphocytes. DC are 'professional antigen presenting
cells' and play a crucial role in the initiation of immune responses against pathogens.
Activated DC migrate to lymphoid tissues and present antigens to naive lymphocytes
and initiate an immune response.
T and B lymphocytes are the main effector cells of the adaptive immune
system. B and T cells have antigen specific receptors such that an encounter with
specific antigen induces lymphocyte activation and clonal expansion.
T lymphocytes are divided into CD8+ cytotoxic T cells (Tc) and CD4+ T
helper (Th) cells and the Th cells are further dived into Thi and Th2 according to the
pattern of cytokines they produce (Mosmann et al., 1986) Tc lymphocytes recognise
antigens, which have been processed into peptides and are presented on major
histocompatibility complex (MHC) class I bearing cells. Th lymphocytes recognise
peptides presented by MHC class II on antigen presenting cells such as Mcj), DC and
B cells. The interaction with the MHC molecule/peptide complex is mediated by the
T cell receptor and associated co-stimulatory molecules such CD80 and CD86. T
cells become anergic or undergo apoptosis in the absence of the co-stimulatory
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signal. Tc lymphocytes use perforin and granzyme B to induce the lysis of target
cells.
B cells can recognise, process and present antigens in association with their
own MHC II molecules. Th lymphocytes can recognise B cells (CD40 on the B cell
and CD40 ligand [CD40L] on the Th cell) and support B cell proliferation via the
production of cytokines that may also influence antibody class switching. In
addition, cytokines released from Th lymphocytes are also important in modulating
M<() activation as discussed later (Chapter 1.5). Normal nai've T and B cells mainly
traffic within the lymphoid tissues but effector T cells migrate to the site of
inflammation where they are involved in tissue injury.
1.4 MONOCYTE DIFFERENTIATION
All normal non-inflamed tissues contain a population of resident M(|)
although these cells may exhibit different phenotypes in different organs e.g. Kupffer
cells in the liver, microglia in the central nervous system. During inflammation, it
was initially thought that infiltrating monocytes were recruited from a single pool of
circulating monocytes. However, recent work by Geismann and colleagues have
demonstrated the existence of two principal subsets of blood monocytes with distinct
migratory properties that may be distinguished by various surface markers including
CC chemokine receptor 2 (CCR2) (the receptor for CC chemokine ligand 2 [CCL2],
also known as monocyte chemoattractant protein 1 [MCP-1)), fractalkine receptor
(CX3CRI), Ly6C (subepitope for GR1) and CD62L (also known as L-selectin).
Monocytes with the profile CCR2+ CX3CR1IowCD62L+GR1+ were rapidly recruited
to injured tissues and developed into inflammatory M<j) - these monocytes represent
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the 'inflammatory monocyte subset'. In contrast, monocytes with the profile CCR2"
CX3CRlhlGRr were selectively recruited to normal, non-inflamed tissues and
differentiated into resident tissue M(() - these monocytes represent the 'resident
monocyte subset'. Both subsets were found to have the potential of differentiating
into DC (Geissmann et al., 2003).
It is currently unclear which developmental pathway and precursor cells are
involved in generating these two monocyte populations (Gordon and Taylor, 2005;
Taylor and Gordon, 2003). Interestingly, however, Fogg et al recently demonstrated
that M(|) and DC can arise from a common progenitor cell, which can give rise to
resident M(j) in the brain, resident splenic DC and inflammatory Mcj) and DC (Fogg et
al., 2006).
1.5 M<|) ACTIVATION
The Mc|) is a remarkably versatile cell and plays an important role in the
initiation, progression and resolution of inflammation (Cailhier et al., 2006; Duffield
et al., 2005b; Kluth et al., 2004). The outcome of inflammation is dependent upon
many factors but the nature of the M(() activating signals and the local
microenvironment at the inflamed tissue will be important modulating factors. M(j)
can adopt various phenotypes, with different effector functions. Although somewhat
simplistic, various Mc() activation states have been defined in vitro including:
(i) classical activation,
(ii) alternative activation,
(iii) type II activation and
(iv) activation following the phagocytosis of apoptotic cells.
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1.5.1 Classically activated M<|)
The classically activated M<|) phenotype can be induced by exposing M(|) to
interferon gamma (IFN-y), (provided in vivo by Th lymphocytes or natural killer
cells), followed by stimulation with microbial products that engage Toll like
receptors (e.g. lipopolysaccharide [LPS]). Classically activated M()) produce pro¬
inflammatory cytokines such as tumour necrosis factor alpha (TNF-a) and
interleukin (IL) 12 (IL-12) as well as nitric oxide (NO) and this phenotype is
associated with significant microbicidal activity. Classically activated M(j) express
high levels of MHC class II and CD86, (Mosser, 2003) but reduced mannose
receptor expression. They also have been reported to have a reduced capacity to
phagocytose apoptotic cells (Erwig et al., 1998).
1.5.2 Alternatively activated M<j>
Alternative activation follows M<() activation with IL-4, IL-13 or
glucocorticoids. Such treatment results in the expression of high levels of mannose
receptors, scavenger receptors and the IL-1 receptor antagonist. Alternatively
activated M([) do not generate significant amounts ofNO and are therefore relatively
ineffective at killing intracellular organisms. Alternatively activated M(f) are more
associated with tissue repair. Additional markers for alternatively activated M<J)
include FIZZI and YM1 (Edwards et al., 2006; Gordon, 2003).
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1.5.3 TYPE II activated M<j>
TYPE II activated M<J) were first described by Mosser and colleagues
(Anderson and Mosser, 2002). They exposed M(|) to CD40L in the presence of
immunoglobulin (Ig) G immune complexes and noted that these M(|) were anti¬
inflammatory as they produced enhanced levels of IL-10 and reduced levels of IL-
12. Type II activated M(|) promote the development of a Th2 adaptive immune
response with increased T cell IL-4 and IgG class switching in B cells (Mosser,
2003).
1.5.4 M<)) activation following the uptake of apoptotic cells
Cells may undergo apoptosis (Chapter 1.6) during normal tissue
homeostasis as well as during inflammation and the resultant apoptotic corpses must
be cleared. Apoptotic cells are avidly ingested by M(j) and may profoundly affect the
M(f) phenotype by inducing an anti-inflammatory M<j) phenotype characterised by
increased production of transforming growth factor-beta (TGF-ff) and prostaglandin
E2 as well as decreased production of IL-1, IL-6, TNF-a and M()>-inflammatory
protein 1 alpha (MlP-la) (Fadok et al., 1998; Voll et al., 1997). Apoptotic cells can
modulate the response of M()> to other stimuli. For example, the exposure of M(|) to
LPS after the uptake of apoptotic cells leads to an increased production of IL-10 and
a reduced production of IL-12. In addition, the simultaneous exposure of M(() to both
apoptotic cells and LPS modulates the M(|) response and results in increased early
production of TNF-a whilst increasing the later generation of TGF-|3 (Lucas et ah,
2003). It can therefore be appreciated that M(() ingestion of apoptotic cells may
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induce a switch in the phenotype from an injurious pro-inflammatory M(j) to a
reparative anti-inflammatory M(f) and it is highly likely that this M(j) phenotype is
very important during the resolution phase of inflammation (Savill et ah, 2002;
Serhan and Savill, 2005).
1.6 APOPTOSIS
Apoptosis, (programmed cell death) is an evolutionary conserved
physiological process and plays a central role in embryogenesis, the maintenance of
tissue homeostasis, host defense as well as the resolution phase of inflammation.
Apoptosis can be triggered a variety of stimuli such as growth factor deprivation, UV
damage or by the release of 'apoptosis inducing ligands' from cells of the immune
system. Regardless of the inducer of the apoptotic process, there are a series of
characteristic events that may occur that eventually leads to the demise of the cell.
In early seminal studies, apoptosis was described by morphological
alterations of the cell (Kerr et al., 1972) including cell shrinkage, cytoplasmic
condensation and vacuolation, chromatin condensation, cytoplasmic blebbing and
eventual fragmentation of the cell into membrane-bound apoptotic bodies. The
integrity of the plasma membrane and intracellular organelles remains intact during
apoptosis. Apoptotic cells represent a source of autoantigens (Casciola-Rosen et al.,
1994) and are therefore swiftly recognised and cleared by M(j) (Ren and Savill, 1998;
Savill, 1997; Savill et al., 2002; Savill and Fadok, 2000; Savill et al., 1989). It should
be noted, however, that apoptotic cell may also be phagocytosed by semi-
professional phagocytes such as mesangial cells and fibroblasts (Hall et al., 1994;
Hughes et al., 1997; Savill et al., 1992).
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In contrast to apoptosis, necrosis is characterised by widespread disruption
of cell integrity and the release of intracellular contents (Kanduc et al., 2002; Wyllie,
1980). Necrosis typically results from severe cellular injury such as severe ischemia,
sustained hyperthermia or high doses of toxic agents. Necrotic cell death mainly
affects groups or contiguous fields of adjacent cells, whereas apoptosis can affect
discrete cells within otherwise healthy and viable cell populations. Necrotic cells
display dramatic membrane dysfunction and disruption of organelles such that the
cell swells and eventually disintegrates. The internal homeostasis of the cell is lost
and cellular constituents are released into the microenvironment where they typically
evoke an inflammatory response.
1.7 DETECTION OF APOPTOTIC CELLS
The morphological criteria described by Kerr in 1972 still represent the
'gold standard' for identifying apoptotic cells in tissue sections. Additional methods
of identifying apoptotic cells in tissue sections include the terminal deoxynucleotidyl
transferase-mediated dUTP nick-end labeling (TUNEL) assay (Gavrieli et al., 1992)
for the identification of DNA fragmentation - a typical feature of the majority of
apoptotic cells. Other methods may be used for cells induced to undergo apoptosis in
vitro. For example, during apoptosis, the DNA is cleaved into discrete fragments of
multiples of 180 base pairs (bp) and a characteristic DNA ladder can be seen after
electrophoresis (Wyllie, 1980; Wyllie et al., 1980). The detection of apoptosis-
induced phosphatidylserine (PS) exposure (Fadok et al., 1992a; Fadok et al., 1992b)
by Annexin V binding is a common flow cytometric method for determining and
quantifying the level of apoptosis in cell populations (Koopman et al., 1994).
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Apoptotic cells are rapidly phagocytosed in vivo (Barres et al., 1992; Coles
et al., 1993; Parnaik et al., 2000) by neighbouring M(J) as well as other resident
parenchymal cells. The level of apoptosis is typically very low in normal tissues but
is increased during tissue injury and inflammation (Baker et al., 1994).
1.8 APOPTOTIC PATHWAYS AND EFFECTORS
1.8.1 Caspases
Caspases (cysteinyl aspartate proteases) are intracellular proteolytic
enzymes containing a cysteine at the active site and cleave substrates after an
aspartic acid residue. Caspases are highly conserved through evolution and are
common to multicellular organisms. The caspases can be divided into three families.
Caspases 1, 4, 5, 11 and 12 (in vertebrates) are involved in the proteolytic processing
of the precursors of the inflammatory cytokines such as IL-1 and IL-18 (Martinon
and Tschopp, 2004). The remaining caspases are mainly involved in apoptosis and
are divided into:
'Initiator caspases' such as caspase 2, 8, 9 and 10 (note, caspase-10 is not
present in the mouse) (Siegel, 2006), that are involved in the early events of the
apoptosis process. They further activate the caspase cascade leading to the activation
of the 'effector caspases'
The effector or 'executioner' caspase group includes caspase 3, 6 and 7 and
are involved in the final stages of the apoptosis process where they are responsible
for the proteolysis ofmany intracellular proteins.
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Two distinct pathways leading to the activation of initiator caspases can be
distinguished (Hengartner, 2000). The first pathway is triggered by ligands that
directly bind to death receptors expressed at the cell surface and this is called the
'extrinsic' apoptosis pathway (Walczak and Krammer, 2000). The second pathway
involves the mitochondria with caspase activation resulting from the release of
mitochondrial products (Green and Reed, 1998). This second pathway is called the'
intrinsic' apoptotic pathway (Green and Kroemer, 2004).
1.8.2 The extrinsic pathway of apoptosis
The extrinsic apoptotic pathway is triggered by ligand binding of death
receptors on the plasma membrane. The death receptors belong to the tumour
necrosis factor receptor (TNFR) superfamily and the best characterised are Fas (also
known as CD95) and TNFR1, for review see (Wallach et al., 1999). The death
receptors are activated after ligand-induced trimerisation. The extracellular domain
of the receptors contains one to five cysteine rich repeats whilst a death domain (DD)
is located in the cytoplasmic tail. Ligand binding of the death receptor results in
conformational changes. The resultant protein-protein interactions and resultant
caspase activation is based on close 'proximity induced activation' that is regulated
by DDs and death effector domains (DEDs) (Hengartner, 2000). Usually death
receptors activate caspase-8, which then leads to the activation of the caspase 3-
effector pathway. However, death receptor ligation can also activate caspase-2 and
10 (Jin and El-Deiry, 2005).
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1.8.2.1 Fas mediated apoptosis
The Fas death receptor is expressed by many cell types including T cells
(Krammer, 2000), and tubular epithelial cells (Du et al., 2004) Fas ligand (FasL) is
mainly expressed on leukocytes (especially T cells and M(j)) (Brown and Savill,
1999; Liles et al., 1996; Suda et al., 1995) but may also be expressed by parenchymal
cells such as tubular epithelial cells (Lorz et al., 2000).
Ligation of the Fas death receptor results in trimerisation of the receptor and
binding of the DD of the cytoplasmic portion of the trimerised Fas receptor to a
cytoplasmic adaptor protein called FADD (Fas associated death domain)
(Chinnaiyan et al., 1995) by DD-DD interactions. FADD recruits procaspase-8 by
homologous interaction of the DED domain of FADD and the DED of procaspase-8
and this generates a protein complex called the death-inducing signalling complex
(DISC) (Peter and Krammer, 2003). Caspase-8 is activated by autoproteolysis
(proximity induced activation) (Hengartner, 2000) and released from the DISC into
the cytoplasm. Active caspase-8 is able to activate various members of the caspase
family especially caspase-3, which completes the cell death programme and leads to
apoptosis of the cell. A simplified schema of the events involved in this process is
shown in Figure 1-4.
The activity of active caspase-8 can also be amplified via interactions with
the mitochondria ('a way for crosstalking between extrinsic and the intrinsic
pathway'). Activated caspase-8 can cleave cytosolic Bid (a pro-apoptotic member of
the Bcl-2 family). Truncated Bid is then translocated to the mitochondria and
stimulates the release of cytochrome c (Cyt c) (Luo et al., 1998) and other pro-
apoptotic factors (Figure 1-4). An additional level of regulation of the above events
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is represented by cellular FLICE inhibitor protein (c-FLIP) (Irmler et al., 1997). c-
FLIP is an inactive caspase homologue and binds to both FADD and pro-caspase-8
to inhibit the formation of active caspase-8 and inhibiting apoptosis (Tschopp et al.,
1998) (Figure 1-4).
1.8.3 The intrinsic pathway of apoptosis
The intrinsic pathway of apoptosis involves the mitochondria and can be
triggered by insults such as DNA damage (UV-induced) and cell 'stress' induced by
hypoxia, cytotoxic drugs, free radicals, growth factor withdrawal etc. A pivotal event
in the mitochondrial pathway is mitochondrial outer membrane permeabilisation
(MOMP). This leads to mitochondrial dysfunction characterised by a fall in the
mitochondrial membrane potential, swelling of the mitochondrial matrix and finally
rupture of the outer membrane resulting in the release of cyt c into the cytoplasm (the
mechanism of cyt c release is reviewed elsewhere (Garrido et al., 2006)). In the
presence of deoxyadenosine 5'-triphosphate (dATP), cyt C interacts with apoptosis
protease activating factor 1 (Apaf-1) which is activated via heptamerisation
following a conformational change. This complex then combines with pro-caspase 9
to form the apoptosome complex, which results in caspase-9 activation (Acehan et
al., 2002). Downstream activation of the 'effector' caspases follows which leads to
apoptosis (Figure 1-4). These events are regulated by several heat shock proteins and
by inhibitor of apoptosis proteins (IAPs). IAPs are potent intracellular inhibitors of
caspases (caspase 3 and 9) and can prevent cell death (Salvesen and Duckett, 2002).
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Figure 1-4 Diagram of the extrinsic and intrinsic apoptotic pathways.
The extrinsic pathway is exampled with Fas-induced apoptosis, see text for
details. (Modified from (Hengartner, 2000)).
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The activity of IAP can be neutralised by Smac/DIABLO (second
mitochondria-derived activator of caspases/direct inhibitor of apoptosis binding
protein with a low isoelectric point), or by HtrA2 (high temperature requirement
protein also know as Omi). Both Smac/DIABLO and HtrA2 are released from the
mitochondria during activation of the intrinsic pathway - an action that attempts to
ensure that apoptosis proceeds (Figure 1.4). Other pro-apoptotic proteins released
from the mitochondria include apoptosis inducing factor (AIF) and endoG (a
sequence unspecific DNase) These can translocate into the nucleus and mediate
caspase independent apoptotic cell death (Figure 1-4). The role of mitochondrial
released pro-apoptotic proteins in the apoptotic process is reviewed (Antonsson,
2004; van Loo et al., 2002).
1.8.4 Bcl-2 family
The Bcl-2 family consists of several members that may inhibit or induce
death. Many proteins of the Bcl-2 family are located in the outer mitochondrial
membrane and regulate MOMP and cyt c release from the mitochondria (Figure 1-
4). The Bcl-2 family members are divided into three main groups based on their
conserved Bcl-2 homology (BH) domains. Anti-apoptotic members such as Bcl-2
and Bc1-Xl contain four BH domains (BH1-BH4). Pro-apoptotic multidomain
members such as Bax and Bak possess three BH domains. Lastly, the pro-apoptotic
members of the third group share only homology in the BH3 domain and examples
are Bad, Bid and Bik (Hengartner, 2000). Bcl-2 can inhibit the recruitment of the
pro-apoptotic member Bax to the mitochondria and BcI-Xl inhibits the translocation
of truncated bid to the mitochondria (Figure 1-4).
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1.9 FasL/FAS IN THE KIDNEY
Although FasL may be expressed by mesangial cells, renal fibroblasts and
tubular epithelial cells it is mostly expressed by leukocytes such as lymphocytes, and
monocytes/Mcj) (Lorz et al., 2000; Ortiz et ah, 1997; Ortiz-Arduan et ah, 1996). In
vitro Fas ligation often induces apoptosis in various cells such as leukocytes,
fibroblasts and mesangial cells (Gonzalez-Cuadrado et ah, 1997; Ortiz et ah, 1997)
although it is of interest that tubular epithelial cells require cytokine priming (Ortiz-
Arduan et ah, 1996). Increased FasL expression has been noted in rat proliferative
glomerulonephritis (Lorz et ah, 2000) as well as human renal transplant patients with
chronic allograft nephropathy (Sharma et ah, 1996). Increased Fas expression is
evident in murine ischemia-reperfusion injury (Nogae et ah, 1998), murine LPS
endotoxaemia (Ortiz-Arduan et ah, 1996), the remnant kidney model in the rat
(Hattori et ah, 1998) and in human proliferative glomerulonephritis (Takemura et ah,
1995). Gonzalez-Cuadrado et al induced apoptosis of mesangial cells by treating
mice with an agonistic Fas antibody although there was little tubular cell apoptosis
evident in this study (Gonzalez-Cuadrado et ah, 1997).
1.9.1 Apoptosis of MDCK cells
The situation may be complicated in certain situations. For example, MDCK
cells undergo apoptosis following partial ATP (adenosine triphosphate) depletion
induced by 'chemical hypoxia', exhibit a marked increase in caspase-8 activity and
are rescued by treatment with caspase inhibitors (Feldenberg et ah, 1999). Activation
of caspase-3 is evident during ATP depletion or hypoxia and was accompanied by
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cyt c release from the mitochondria (Saikumar et al., 1998). However, although such
a stimulus would be predicted to act predominantly via the intrinsic or mitochondrial
pathway, the ATP-depleted cells upregulated the expression of Fas, FasL and FADD.
Thus, partial ATP depletion appears to induce Fas-mediated apoptosis that is
amplified by the mitochondrial pathway in MDCK cells. Treatment with exogenous
agonistic anti-Fas monoclonal antibodies also induces apoptosis of MDCK cells in
non-ischemic conditions indicating that MDCK cells retain a Fas-dependent pathway
of apoptosis.
1.9.2 Compartmentalisation of FasL/Fas in MDCK cells
An added level of complexity is that cells may exhibit compartmentalisation
of Fas and FasL which is believed to prevent auto-paracrine apoptosis in tubular
epithelial cells (Tan and Hunziker, 2003). Fas and FasL exist within different cellular
compartments and are thus segregated from each other. Fas is expressed at the
basolateral surface whilst FasL is expressed in the intracellular compartment (Tan
and Hunziker, 2003).
1.10 APOPTOSIS IS IMPORTANT IN THE RESOLUTION OF
INFLAMMATION
Apoptosis is very much a double-edged sword. The efficient deletion of
excessive, damaged or non-functioning renal cells as well as infiltrating
inflammatory cells by apoptosis is undoubtedly beneficial for the resolution of
glomerulonephritis (Savill, 1994). For example, the anti-thy 1.1 model of
glomerulonephritis in the rat is characterised by an initial wave of mesangial cell
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death followed by marked proliferation that results in glomerular hypercellularity
(Jefferson and Johnson, 1999). Over time, however, the glomeruli are remodelled
and normocellularity is restored. Elegant work by Baker et al demonstrated that the
hypercellular glomeruli exhibited high levels of mesangial cell apoptosis and a
careful kinetic analysis indicated that apoptosis could account for the loss of
mesangial cells during the remodelling phase (Baker et al., 1994). Thus, in this
context, apoptosis represents a beneficial cell clearance mechanism to
counterbalance excessive levels of cell proliferation. In contrast, the seminal work of
Gobe et al demonstrated that tubular epithelial cell apoptosis was a key factor in the
development of renal tubular atrophy in experimental hydronephrosis, induced by
unilateral ureteric obstruction (UUO), (Gobe and Axelsen, 1987).
1.11 CELL PROLIFERATION AND ITS REGULATION
1.11.1 The cell cycle
The cell cycle comprises a series of tightly controlled events that drive cell
proliferation. In response to mitotic signals, quiescent cells in Go enter the cell cycle
at early Gi. In the absence of mitogenic stimuli, the cells may undergo
differentiation, apoptosis or revert to Go. In late Gi there is a so-called 'restriction
point'. Once the cell has past this point, it becomes unresponsive to external stimuli
and the cell is committed to complete the cell cycle, regardless of the presence or
absence of mitogens. DNA is replicated and synthesised during the S phase and the
cell undergoes mitosis in the M phase, resulting in two daughter cells. There are two
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'checkpoints' where cell cycle progression can be arrested - one at the Gi/S
transition and one at the G2/M transition (Figure 1-5).
1.11.1.1 Positive cell cycle regulators
Cyclin-dependent kinases (CDKs) and cyclins act as positive regulators of
cell cycle progression. CKDs are serine-threonine protein kinases which are
constitutively expressed during the cell cycle. The activity of CKDs requires binding
to cyclins with the level of expression and activity of cyclins varying according to
the phase of the cell cycle. Formation of cyclin/CDK complexes results in
phosphorylation and activation of the CDKs and these complexes target substrates
that are involved in the transition between the cell cycle phases. The cell cycle starts
when cyclin D (there are three Dl, D2, D3) binds their catalytic partners CDK4/6.
This cyclin/CDK complex is essential for entry into Gi phase. The progression from
G]/S phase is regulated by the cyclin E/CDK2 complex whilst the cyclin A/CDK2
complex is required for DNA synthesis during S phase. The checkpoint at the G2/M
transition is controlled by the cyclin B/CDK1 complex with mitosis occurring
thereafter (Shankland and Wolf, 2000).
1.11.1.2 Negative cell cycle regulator
Cyclin kinase inhibitor (CKIs) inhibit the cell cycle at multiple checkpoints
via inactivation of the cyclin/CDK complexes. There are two families of CKIs - INK
and Cip/Kip (reviewed by (Sherr and Roberts, 1999)). Members of the INK family
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Figure 1- 5 The cell cycle.
Simple illustration of the cell cycle. Quiescent cells enter the cell cycle at
early G-i, followed by S phase (DNA synthesis), (G2) and finally mitosis (M).
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includes pl5INIC4b, pi6 INK4a? pi8 INK4c and pi9 INK4d which inhibit the
cyclin/CDK complexes in Gi. The second family includes p21Cip, p27Cip2 and p57 Kip
which inhibit cyclin-CDK complexes during both Gi and S phase of the cell cycle.
However, p21 can also inhibit DNA synthesis and repair by inhibiting the
proliferating cell nuclear antigen (PCNA) (Luo et al., 1995). In response to DNA
damage, p21 can be transcriptionally activated by p53 and acts to induce arrest in Gi
phase (Brugarolas et ah, 1995).
1.11.2 p53 and apoptosis
The cell cycle regulator p53 is a nuclear protein and has been called the
'guardian of the genome' as it is strongly upregulated following DNA damage
secondary to irradiation, genotoxic drugs, free radicals, etc. p53 induces cell cycle
arrest at Gi/S via upregulation of p21 as described earlier, thus allowing the cells to
undergo DNA repair and preventing the replication of cells which have damaged
DNA. If the DNA damage is severe and irreparable, then p53 induces apoptosis of
the cells (Figure 1-4), which may involve translocation of Fas to the cell surface
(Bennett et ah, 1998).
1.11.3 Cell cycle proteins and renal disease
The role of cell cycle and cell cycle regulatory proteins in renal disease has
been investigated by members of Stuart Shankland's group (reviewed in (Griffin et
ah, 2003a; Griffin et ah, 2003b; Marshall and Shankland, 2006; Shankland and Wolf,
2000). Work from this group investigated the role of the CKI p27 upon renal cell
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apoptosis in nephrotoxic nephritis (NTN) and UUO. Mice targeted for the deletion of
p27 exhibited increased tubular epithelial cell apoptosis in both models
(Ophascharoensuk et al., 1998). No role for p21 in tubular epithelial cell apoptosis
was found in UUO (Hughes and Shankland, 1999).
The level of p53 is increased in UUO (Morrissey et al., 1996). The absence
of p53 provides partial protection of tubular epithelial cells from apoptosis in UUO
as homozygous (p53 -/-) mice exhibited a 50% reduction in the level of tubular
epithelial cell and interstitital cell apoptosis compared to control (p53+/+) mice
(Choi et al., 2001). This suggest that renal cell apoptosis in obstructed kidneys
involves both p53-dependent and p53-independent pathways.
1.12 TUBULOINTERSTITIAL FIBROSIS
Tubulointerstitial fibrosis is characterised by the excessive accumulation
and deposition of ECM components, which eventually leads to tissue damage and
scarring and associated renal impairment. Fibroblasts and myofibroblasts are the
major ECM producing cells in the diseased tubulointerstitium and produce excess
ECM such as collagens (type I, III, IV). The pathogenesis and mechanism of
tubulointerstitial fibrosis has been reviewed in detail elsewhere (Eddy, 2000; Iwano
and Neilson, 2004; Liu, 2006; Okada and Kalluri, 2005; Zeisberg et al., 2001).
30
1.12.1 Description of fibroblasts and myofibroblasts
Cortical fibroblasts and associated ECM provide structural support for the
normal kidney interstitium. Normal renal fibroblasts typically display a spindle
shaped elongated 'fusiform' phenotype and are quiescent (low
proliferation/turnover). They may, however, proliferate in response to a variety of
stimuli. Cultured 'normal' fibroblasts can be phenotyped according to their
expression of fibroblast-specific protein 1 (FSP-1, also known as S100A4), vimentin
and CD90 and lack of expression of desmin and cytokeratin (Grupp and Muller,
1999; Strutz et al., 1995). During renal inflammation, activated fibroblasts
proliferate, adopt a myofibroblasts phenotype and produce abundant ECM.
Myofibroblasts express alpha smooth muscle actin (a-SMA) and the presence and
abundance of a-SMA positive cells is associated with the progression of renal
disease (Badid et al., 2001; Roberts et al., 1997).
The origin of fibroblasts and myofibroblasts in diseased kidneys remains
controversial. Fibroblasts may originate from the resident fibroblast population or by
recruitment from bone marrow-derived stem cells (Abe et al., 2001). Also,
myofibroblasts may be derived from these sources as well as from tubular epithelial
cells by a process known as epithelial mesenchymal transition (EMT) (Iwano et al.,
2002).
1.12.2 Epithelial to mesenchymal transition
EMT in renal fibrosis was first described by Strutz et al, when they showed
that tubular epithelial cells could express the fibroblast marker FSP-1 in a mouse
31
model of anti-tubular basement membrane disease (Strutz et al., 1995). Currently,
EMT is generally recognised as providing a significant contribution to the generation
of interstitial myofibroblasts in renal fibrosis (reviewed by (Kalluri and Neilson,
2003; Lee et al., 2006)). Yang et al has suggested 4 key steps in the process of EMT:
(1) loss of epithelial cell adhesion; (2) de novo a-SMA expression and actin re¬
organisation; (3) disruption of the tubular basement membrane (TBM) and (4)
enhanced cell migration and invasion (Yang and Liu, 2001).
EMT has been observed in human renal biopsies (Rastaldi et al., 2002),
human kidney transplants (Vongwiwatana et al., 2005) and in various animal models
of renal fibrosis (reviewed in (Liu, 2004)).
1.13 DESCRIPTION OF MEDIATORS INVOLVED IN
TUBULOINTERSTITAL FIBROSIS
The accumulation of ECM during tubulointerstitial fibrosis may be a
consequence of excessive synthesis coupled with impaired ECM degradation.
Proteolytic enzymes involved in ECM degradation are matrix metalloproteinases
(MMPs), connective tissue proteases and components of the plasminogen system
(plasminogen, plasminogen activators, and plasmin). MMP activity is regulated by
tissue inhibitors of MMPs (TIMPs) and the plasminogen system is regulated by
plasminogen activator inhibitor (PAI-1).
Various inflammatory mediators such as cytokines, NO and different
growth factors are also involved in the regulation and accumulation of ECM in the
tubulointerstitium. Examples of pro-fibrotic factors are TGF-[3, connective tissue
growth factor, angiotensin II and platelet-derived growth factor. In contrast,
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hepatocyte growth factor (HGF) and bone morphogenic protein 7 (BMP-7) are anti-
fibrotic.
1.13.1 Matrix metalloproteinases
Most MMPs are initially secreted as pro-enzymes that are proteolytically
activated. MMP expression can be induced by various factors (inflammatory
cytokines, growth factors and cell-ECM interactions), while their activity is inhibited
by TIMPs (Nagase and Woessner, 1999). MMPs are subdivided into groups
according to their domain structure and substrate preference: collagenases (MMP-1,
8 and 13), gelatinases (MMP-2 and 9), stromelysins (MMP-3, 10 and 11), matrilysins
(MMP-7 and 26), membrane type (MT)-MMPs (MT-MMP 14, 15, 16, 17, 24 and 25)
etc. (reviewed by (Nagase et al., 2006)).
During renal inflammation and scarring MMPs can be produced by
infiltrating inflammatory M(|), fibroblasts, myofibroblasts and tubular epithelial cells
and undoubtedly play a role in disease (reviewed by (Catania et ah, 2007)). For
example, MMP-2 can be involved in degradation of TBM, as transgenic mice
overexpressing MMP-2 in proximal tubular epithelial cells developed spontaneous
EMT and peritubular fibrosis (Cheng et ah, 2006).
Metalloelastase (MMP-12) is expressed mainly by Mcf) and digests elastin
and other ECM molecules. It allows Mcj) to invade tissue and degrade ECM (Shipley
et ah, 1996). M(j) can also release collagenases (MMP-1 and 13) and regulate the
activity of gelatinases (MMP-2 and 9) (Gibbs et ah, 1999) and matrilysin (MMP-7)
(Song et ah, 2000). Human monocytes can also express matrilysins (Busiek et ah,
1995). It can therefore be appreciated that M<J> are capable of modulating the fibrotic
process.
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1.13.2 Tissue inhibitors of matrix metalloproteinases (TIMP)
There are four TIMPs (TIMP-1, 2, 3 and 4) and they inhibit MMP activity.
TIMP-2 and 3 are normally expressed in the kidney while the expression of TIMP-1
has been shown to increase in human and animal models of renal fibrosis (Catania et
al., 2007; Duymelinck et al., 2000).
Genetic deficiency of TIMP-1 fails to attenuate tissue fibrosis in the UUO
model or in mice with overload proteinuria (Eddy et al., 2000; Kim et al., 2001a)
indicating that TIMP-1 dependent inhibition of MMP is not critical in interstitial
fibrosis and this may represent compensation by other TIMPs.
1.13.3 Plasminogen system
Plasmin is a serine protease and is generated from its pro-enzyme
plasminogen by either urokinase-type plasminogen activator (uPA) or tissue-type
plasminogen activator (tPA). Plasmin can degrade various components of ECM and
is also involved in activating pro-MMPs .
Edgtton et al demonstrated that plasminogen is not protective in the UUO
model since the obstructed kidneys of plasminogen deficient mice exhibited less
fibrosis than wild-type (WT) control mice (Edgtton et al., 2004). Plasminogen
deficient mice exhibited reduced M(j) infiltration but comparable myofibroblast
accumulation. Expression of TGF-|3 and MMP-2 was lower in the plasminogen
deficient mice while MMP-9 activity was unchanged.
When UUO was induced in uPA receptor (uPAR) knockout (KO) mice, the
activity of uPA, and tPA was reduced and these mice had more fibrosis compared to
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WT control mice. The uPAR KO mice also had reduced HGF expression compared
to WT controls (Zhang et al., 2003).
Yang et al induced UUO in mice lacking tPA and found reduced fibrosis,
reduced TBM damage and reduced EMT in these mice compared to WT controls
(Yang et al., 2002).
PAI-1 inhibits the plasminogen activators and is therefore likely to promote
fibrosis. Indeed, the obstructed kidneys of transgenic mice overexpressing PAI-1
exhibit increased fibrosis compared to control mice (Matsuo et al., 2005). The
transgenic mice exhibited increased M(() infiltration, increased myofibroblast
accumulation and reduced uPA activity. The pro-fibrotic effect of PAI-1 was also
demonstrated by Oda et al as PAI-1 KO mice were protected from fibrosis following
UUO (Oda et al., 2001). PAI-1 KO mice exhibited reduced M(j) infiltration and
myofibroblast accumulation, but the activity of plasminogen activators and plasmin
were unaffected. These two studies suggest that the pro-fibrotic action of PAI-1 is
via an increase in M<J) infiltration and that its effect as an inhibitor of serine proteases
is less important.
1.13.4 TGF-p
In mammals there are three TGF-(3 isoforms (TGF-|31, TGF-(32, and TGF-
(33). TGF-(3 plays important role in tissue development, inflammation, immune
responses, wound healing, tissue repair and the progression of fibrosis. TGF-|3 is
both an inhibitor and a stimulator of cell proliferation in a variety of cells.
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The role of TGF-p in renal fibrosis has been thoroughly investigated
including the various signaling pathways involved (reviewed in (Bottinger and
Bitzer, 2002; Wang et al., 2005).
TGF-|3 promotes ECM accumulation in tubulointerstitial fibrosis by
stimulating the production of interstitial proteins from both fibroblasts and
myofibroblasts. In addition TGF-P can reduce the expression ofMMPs and stimulate
the production of TIMPs and PAI-1 thereby inhibiting the degradation of ECM and
promoting fibrosis. TGF-P has also been shown to play an important role in the
induction ofEMT.
Strutz et al demonstrated that TGF-|31 induced proliferation of human renal
fibroblasts - a process dependent on the action of basic fibroblast growth factor -2
(FGF-2) (Strutz et al., 2001). Interestingly, tubular epithelial cells can produce TFG-
(3 and are able to stimulate fibroblast proliferation (Johnson et al., 1998). TGF-P also
stimulates tubular epithelial cells to undergo EMT in vitro (Forino et al., 2006).
TGF-P expression is increased in experimental models of renal fibrosis
(Downer et al., 1988; Fukuda et al., 2001; Wright et al., 1996). The key role of TGF-
P in the induction of renal scarring was demonstrated by study of transgenic mice
expressing TGF-P under the control of the murine albumin promoter. These mice
exhibited increased levels of circulating TGF-P and marked tubulointerstitial fibrosis
and glomerulosclerosis (Kopp et al., 1996). Several studies have demonstrated that
inhibition of the expression or action of TGF-P is protective in experimental models
of renal scarring (Hwang et al., 2006; Isaka et al., 2000; Lan et al., 2003; Miyajima et
al., 2000; Moon et al., 2006).
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1.13.5 HGF and BMP-7
HGF and BMP-7 are anti-fibrotic growth factors that can inhibit the
development of fibrosis. Studies have demonstrated that HGF gene therapy or the
administration of recombinant HGF, ameliorates fibrosis in the UUO model (Gao et
al., 2002; Mizuno et al., 2001; Yang and Liu, 2003). The administration of either
HGF or BMP-7 can prevent TGF-(3 induced EMT of tubular epithelial cells (Yang et
ah, 2005; Zeisberg et ah, 2003), whilst the administration of BMP-7 to mice with
UUO or NTN reversed EMT, repaired damaged tubular epithelial cells and improved
renal function (Morrissey et ah, 2002; Zeisberg et ah, 2003). BMP-7 can also induce
mesenchymal to epithelial transition (MET) in adult renal fibroblasts and facilitates
regeneration of the injured kidney (Zeisberg et ah, 2005).
1.14 M<|> INDUCTION OF TUBULOINTERSTIAL FIBROSIS
A significant body of data suggests that M(j) may play an important role in
the development of tubulointerstitial fibrosis. The degree of M(j> infiltration correlates
with the severity of the renal fibrosis, whilst blocking chemokines or adhesion
molecules involved in Mc)) infiltration reduces fibrosis in experimental models
(Anders et ah, 2002; Cheng et ah, 2000; Kitagawa et ah, 2004; Lloyd et ah, 1997;
Panzer et ah, 1999; Wada et ah, 2004). Also experiments using animals deficient in
genes encoding proteins involved in M<|) recruitment to inflamed sites have
demonstrated protection from scarring (Kitagawa et ah, 2004; Lange-Sperandio et
ah, 2002; Lange-Sperandio et ah, 2006).
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M((> generate many pro-inflammatory mediators at inflamed sites such as
cytokines, reactive oxygen species, and NO but may also produce pro-fibrotic
mediators such as TGF-|3, epidermal growth factor (EGF) and FGF-2 (Eddy, 2000).
These pro-fibrotic mediators stimulate the proliferation of fibroblasts and
myofibroblasts and these cells may produce chemokines, that amplifies the
inflammatory response. The fibroblasts and myofibroblasts produce increased
amounts of interstitial collagens and ECM accumulation occurs. M(j) production of
these pro-fibrotic mediators may also induce EMT of tubular epithelial cells (Strutz
et al., 2002). M(|> can also affect the activation and production MMPs that degrade
ECM and the expression of TIMPS. Thus, the M(j) is likely to play a key role in renal
fibrosis and scarring.
1.15 THE MODEL OF EXPERIMENTAL HYDRONEPHROSIS
The model of experimental hydronephrosis is induced by ligation of one of
the ureters and is also known as unilateral ureteric obstruction (UUO). UUO results
in tubulointerstitial fibrosis and the model was pioneered by Klahr and colleagues
(Klahr, 1991). UUO in rodents is a useful model of renal inflammation and scarring
as it a robust, reliable and reproducible model that induces disease in all murine
strains (Diamond et al., 1998). UUO is regarded as a non-immune model of renal
inflammation as disease is lymphocyte independent (Shappell et al., 1998).
Obstructed kidneys do not exhibit PMN infiltration but develop a prominent
tubulointerstitial M(f> infiltrate and this model therefore facilitates the study of M(j)
function during tubulointerstitial inflammation.
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Mc() infiltrate the cortical tubulointerstitium just hours after the induction of
UUO and continue to accumulate with time (Diamond, 1995). Interstitial
myofibroblasts and tubular epithelial cells proliferate early in the course of the
disease (Diamond et ah, 1995). Over time, however, continued ongoing apoptosis of
tubular epithelial cells and myofibroblast accumulation results in progressive renal
tubular atrophy and hypocellular interstitial scarring (Bascands and Schanstra, 2005;
Gobe and Axelsen, 1987; Truong et al., 1998). There are similarities between UUO
in rodents and the features of human obstructive uropathy although the rodent
disease has a markedly accelerated course (Klahr, 1998).
I have used the experimental model ofUUO model to study the mechanism
underlying M(j) induction of tubular epithelial cell apoptosis and the role of in
tubulointerstitial inflammation.
1.16 DESCRIPTION OF FACTORS INVOLVED IN M(|> LOCALISATION IN
TUBULOINTERSTITIAL INFLAMMATION
Mc|) within an inflamed kidney may either be directly derived from the
circulation or result from M(j) proliferation in situ. Work by Tesch et al suggested that
significant M(() proliferation may occur within inflamed kidneys with the M(() growth
factor CSF-1 (colony stimulating factor-1) being a key driver of this process (Le
Meur et al., 2002). In contrast, recent studies in murine NTN suggest that M(j)
infiltration is predominantly the result of monocyte recruitment from the circulation
(Duffield et al., 2005a).
Recruitment of leukocytes to inflamed sites involves a series of
interdependent and closely regulated adhesive interactions between leukocytes and
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the endothelium (reviewed by (Luster et ah, 2005; Sean Eardley and Cockwell, 2005;
Springer, 1994)).The circulating monocyte localises to sites of inflammation in
response to a gradient of released chemoattractants or chemokines with all intrinsic
renal cells being capable of secreting chemokines in response to injury (Segerer,
2003). The monocytes adhere to the activated endothelium and subsequently
transmigrate via a typical leukocyte cascade involving rolling, firm adhesion and
transendothelial migration. Selectins and their ligands mediate the initial contact
between circulating leukocytes and the endothelium resulting in capture and rolling
of the leukocytes along the vessel wall. The leukocyte becomes exposed to
chemoattractants/chemokines and activating stimuli expressed on the endothelial
surface and this leads to firm adhesion mediated by integrins and their ligands. The
last step involves transendothelial migration of the leukocyte by diapedesis which is
mediated by interactions between the integrins, PECAM-1 (platelet endothelial cell
adhesion molecule 1) and members of the junctional adhesion molecule family.
1.16.1 Selectins
Selectins are carbohydrate-binding transmembrane proteins and there are
three closely related members within the selectin family: E-selectin, L-selectin and
P-selectin, which are named according to the cell type on which they were originally
identified (i.e. endothelium, leukocytes and platelets respectively). E- and P-selectin
are expressed on activated endothelial cells and bind to carbohydrate ligands, which
are constitutively expressed on monocytes. L-selectin is constitutively expressed on
most leukocytes and plays an important role in capturing leukocytes to the
endothelial cell surface.
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Lange-Sperandio et al performed UUO in neonatal triple selecting deficient
(EPL-/-) and WT mice and demonstrated reduced M((> infiltration in EPL-/- mice
compared to WT control mice thereby indicating a role for selectins in M<j>
recruitment to the tubulointerstium (Lange-Sperandio et al., 2002).
1.16.2 Integrins and adhesion molecules
Integrins are heterodimeric receptors consisting of non-covalently
associated a and p subunits. The integrins on the rolling leukocytes must be activated
and undergo a conformational change before they can bind to their specific
endothelial ligands to establish firm adhesion to the endothelial surface.
The major integrins expressed on monocytes are the |3i integrin very late
activation antigen 4 (VLA-4, also known as CD49d/CD29 or cmPi) and the two P2
integrins, leukocyte functional antigen 1 (LFA-1, also known as CDlla/CD18 or
aLPi) and Mac-1 (also known as CDllb/CD18 or aMP2) (Lange-Sperandio et al.,
2006). Firm adhesion of monocytes involves the adhesive interaction between
integrins and members of the immunoglobulin superfamily on endothelial cells e.g.
intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule 1
(VCAM-1). Finally, the transendothelial migration and diapedesis of monocytes is
mediated by interactions between PECAM-1 ((Muller and Randolph, 1999) and
members of the junctional adhesion molecule family (Aurrand-Lions et al., 2002).
Recent work by Lange-Sperandio et al investigated the role of P2 integrins
in M(|) recruitment in experimental hydronephrosis performed in neonatal mice. UUO
was induced in 2 day old neonatal mice targeted for the deletion of either Mac-1 or
LFA-1. Mac-1 KO mice displayed reduced M(j> infiltration at days 1, 5 and 12 after
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UUO while LFA-1 KO mice exhibited reduced levels at days 1 and 5 but at day 12
the M(j) infiltration was comparable to WT control mice. Tubular epithelial cell
apoptosis, tubular atrophy and tubulointerstitial fibrosis was reduced in Mac-1 KO
mice but not in LFA-1 KO mice (Hughes, 2006; Lange-Sperandio et al., 2006).
The role of ICAM-1 in the murine UUO model was studied by Cheng et al
by the administration of antisense oligonucleotides against ICAM-1. This resultant
reduction in tubular epithelial cell expression of ICAM-1 was associated with
diminished M<|) infiltration and reduced extracellular matrix deposition (Cheng et al.,
2000).
1.16.3 Chemokines
Chemokines (an abbreviation of 'chemotactic cytokines') are proteins that
both stimulate leukocyte movement (chemokinesis) and direct movement
(chemotaxis). Chemokines generate chemokine gradients that provide directional
cues for the migration of leukocytes. Chemokines are important in leukocyte
maturation in the bone marrow, lymphocyte trafficking and the replenishment of
circulating leukocytes. Chemokines play an essential role during inflammation in the
multi-step adhesion cascade as they activate integrins and thereby induce firm
adhesion of leukocytes to endothelial cells (Luster, 1998; Moser et al., 2004). In
addition chemokines exert other functions such as modulation of angiogenesis and
involvement in lymphoid organ development. Some chemokines can also activate
leukocytes and stimulate degranulation or the release of pro-inflammatory mediators.
(Mackay, 2001; Rossi and Zlotnik, 2000).
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Chemokines are structurally divided into four families (C, CC, CXC and
CX3C) according to the position of conserved cysteine residues in their primary
sequence. Individual chemokines are named using the acronyms of the structural
class they belong to, followed by an L (for ligand) and their gene number (Zlotnik
and Yoshie, 2000). The nomenclature of the chemokine receptors is analogous to
that of chemokines, using the family acronym followed by an R (for receptor) (CR,
CCR, CXCR and CX3CR) and a number that corresponds to the order of its
discovery (Murphy et al., 2000). Many chemokines can bind to several different
receptors within a subfamily and some chemokine receptors bind multiple
chemokines (Rossi and Zlotnik, 2000; Zlotnik and Yoshie, 2000).
The largest family is the CC chemokines in which the cysteine residues lie
next to each other. CC chemokines play important roles in recruiting mononuclear
cells to sites of inflammation. CCL2 (MCP-1) belongs to this family. CCL2 mainly
attracts monocytes but is also a chemoattractant for PMN, DC and T cells. CCL2
binds to the receptor CCR2 and CCL2 plays an important role in the recruitment of
M(|) to the inflamed tubulointerstitium (Sean Eardley and Cockwell, 2005). Other CC
chemokines include CCL3 (MlP-la), CCL4 (M(() inflammatory protein-(3, MI P-1 (3)
and CCL5 (also called RANTES [regulated upon activation normal T cell expressed
and secreted]). CCL5, CCL4 and CCL3 bind to the chemokine receptor CCR1.
The role of CCL2 and its receptor CCR2 in tubulointerstitial inflammation
has been extensively studied by using CCL2 or CCR2 deficient mice or function
blocking antibodies (Sean Eardley and Cockwell, 2005). Tesch et al induced NTN in
CCL2 KO mice and demonstrated that these mice exhibited comparable glomerular
M(j) infiltration injury but significantly less tubulointerstitial M(|) infiltration, thereby
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suggesting that CCL2 mainly directed M<|) recruitment to the interstitium in this
model (Tesch et al., 1999). Wada et al used anti-CCL2 gene therapy in the UUO
model and demonstrated reduced numbers of infiltrating CCR2 positive M(f>
associated with diminished tubulointerstitial fibrosis (Wada et al., 2004).
CCR2 blockade during UUO or the use of CCR2 KO mice has demonstrated
that the absence of CCR2 ameliorates tubulointerstitial fibrosis (Kitagawa et al.,
2004). In contrast, NTN induced in CCR2 KO mice resulted in more severe disease
compared to WT control mice despite the reduction in M<() infiltration (Bird et al.,
2000).
Eis et al demonstrated that CCR1 but not CCR5 mediates leukocyte
recruitment and tubulointerstitial fibrosis in the UUO model (Eis et al., 2004).
Blockade of CCR1 with the CCR1 antagonist BX471 during UUO also resulted in
diminished M<f) recruitment and reduced tubulointerstitial fibrosis (Anders et al.,
2002). In contrast, Topham et al, induced NTN in CCR1 deficient mice and
demonstrated that absence of CCR1 resulted in increased M(j) and T cell infiltration,
an enhanced Thi response and more severe glomerulonephritis (Topham et al., 1999).
Lloyd et al administered neutralising antibodies against CCL5 or CCL2 in
mice with NTN (Lloyd et al., 1997). Although both antibodies reduced glomerular
M(j> infiltration, only neutralisation of CCL2 reduced glomerular crescent formation
and collagen I deposition (Lloyd et al., 1997). The effect of the CCL5 antagonist
amino-oxypentane RANTES (AOP-RANTES) in the rat model of anti-Thy 1.1
model of glomerulonephritis was studied by Panzer et al (Panzer et al., 1999).
Administration of AOP-RANTES attenuated M(() infiltration and reduced collagen IV
deposition. In contrast, administration of the RANTES antagonists (AOP-RANTES
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or Met-RANTES) in murine immune complex glomerulonephritis resulted in more
severe glomerulonephritis despite the diminished glomerular M<j) infiltration (Anders
et al., 2003).
Other monocyte chemoattractants are CXCL8 (IL-8) and CX3CLI
(fractalkine). Fractalkine is attached directly to the cell membrane via a mucin stalk
and the membrane bound protein must be cleaved before it can function as a soluble
chemoattractant. In addition, membrane bound fractalkine can function as an
adhesion molecule and arrest leukocytes directly upon the endothelial cell surface.
1.16.4 Cytokines
Cytokines are secreted proteins and they exert their actions by both
autocrine and paracrine mechanisms. They are a multifunctional proteins involved in
activation, immunity, inflammation, cell differentiation and cell growth (Feldmann et
al., 1996). Cytokines can either increase or inhibit production of cytokines or other
proteins such as chemokines (Gouwy et al., 2005). The main M(j)-derived cytokines
involved in tubulointerstitial inflammation are listed in Table 1-2.
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1.17 M<|> AND TUBOLINTERSTITIAL INFLAMMATION
M(|) play a critical role in renal inflammation (Duffield et al., 2005a; Lange-
Sperandio et al., 2002; Lange-Sperandio et al., 2006; Sean Eardley and Cockwell,
2005; Tesch et al., 1999) and infiltrate both the glomerular and tubulointerstitial
compartments. The tubulointerstitium of the kidney, however, plays an important
role in the progression of renal disease in humans irrespective of the initial trigger or
site of injury (Bohle et al., 1994; Risdon et al., 1968). The degree of leukocyte
infiltration and the severity of tubulointerstitial inflammation correlates with loss of
renal function and predicts the risk for progression to end stage renal failure (Bohle
et al., 1996; Bohle et al., 1992). Tubulointerstitial disease is characterised by all of
the hallmarks of inflammation including leukocyte infiltration, cellular apoptosis and
proliferation and the deposition of extracellular matrix. Although renal inflammation
may resolve successfully, human disease as well as a number of animal models of
renal disease may be characterised by ongoing unchecked apoptosis. This may lead
to the excessive loss of key resident renal cells and the eventual development of
hypocellular fibrotic scarring characterised by renal tubular atrophy and interstitial
fibrosis (Diamond, 1995; Diamond et al., 1998; Gobe and Axelsen, 1987).
A small number of resident M(J) are present within the normal kidney and
prominent Mc() infiltration is a striking feature of all forms of inflammatory renal
disease. Examples of animal models of renal disease characterised by M<j) infiltration
include both immune mediated such as nephrotoxic nephritis (NTN) (Schreiner et al.,
1978) and Thy 1 nephritis (Bagchus et al., 1990) and non-immune models such as
UUO and renal ablation (Van Goor et al., 1994). Similarly, M(f> infiltration is a
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feature of a range of human diseases including lupus glomerulonephritis, IgA
nephropathy and diabetic nephropathy (Schreiner, 1991).
Previous work has examined the role of M(j) in NTN. Huang et al used
micro-encapsulated clodronate to deplete infiltrating renal M(j) and significantly
diminished proteinuria (Huang et al., 1997). Also, clodronate-mediated M(f) depletion
in Thy 1 glomerulonephritis was associated with diminished production of mesangial
cell matrix (Westerhuis et al., 2000). These studies indicate that infiltrating Mcj) play
a key role in mediating renal inflammation and scarring.
1.18 M«j) EFFECTORS AND TUBULAR EPITHELIAL CELL
INJURY/APOPTOSIS
Mcj) are armed with multiple potentials mechanism to injure and kill
pathogens and these are important during infection. In addition, M(j) may also induce
apoptosis of tumour cells (Cui et al., 1994) and various host cells. Elegant studies by
Professor Richard Lang's group demonstrated that M<{) can trigger microvascular
endothelial cell apoptosis during the developmental deletion of intraocular vessels in
the rodent eye (Diez-Roux et al., 1999; Lang et al., 1994; Lang and Bishop, 1993).
Previous work from Duffield et al indicates that M(|) may induce mesangial cell
apoptosis in vitro (Duffield et al., 2000; Duffield et al., 2001). In addition, M(j) may
induce apoptosis of vascular smooth muscle cells in vitro and this is believed to be
potentially important in atheromatous disease (Boyle et al., 2001; Boyle et al., 2002;
Boyle et al., 2003).
The mechanism by which M<j) induce apoptosis in various cell types has
been investigated. Inflammatory M(|) produce myriad pro-apoptotic mediators such as
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NO, TNF-a as well as FasL. NO and TNF-a play a role in the induction of apoptosis
in both mesangial cells and vascular smooth muscle (Boyle et ah, 2002; Boyle et al.,
2003; Duffield et al., 2000; Duffield et al., 2001). In addition, M(j) can produce
MMPs capable of degrading ECM and this may disrupt key survival signals imparted
to renal cells by ECM (Mooney et al., 1999). Indeed, the degradation of ECM by
M(j)-derived MMPs may indirectly influence the fate of renal cells since tubular cell
apoptosis may result from the ECM disruption evident in a murine model of Alport's
syndrome (Rodgers et al., 2003).
An accumulating body of data indicate that M(j) may induce tubular cell
apoptosis in both immunological and non-immunological tubulointerstitial
inflammation (Duffield et al., 2005a; Lange-Sperandio et al., 2002; Lenda et al.,
2003; Tesch et al., 1999). As indicated previously, Tesch et al (Tesch et al., 1999)
induced NTN in CCL2 KO mice and demonstrated a significantly reduced
tubulointerstitial M<|) infiltrate that was associated with reduced tubular cell
apoptosis. This suggested that CCL2 promoted M(|)-mediated tubular injury in this
model. Although Tesch et al examined the interaction between M(j) and tubular
epithelial cells in vitro, they were unable to determine the mechanism underlying the
cytotoxic effect of M(j) but thought that a soluble factor was involved.
The concept that M(j) may induce renal cell death in vivo was additionally
supported by recent work in the Centre for Inflammation Research, University of
Edinburgh. Duffield et al employed conditional Mcj) ablation to deplete M(j> numbers
in a model of progressive murine NTN (Duffield et al., 2005a). Mcj) ablation was
associated with a significant reduction in the level of tubular cell apoptosis. In
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addition, M<(> ablation resulted in diminished proteinuria, improved renal function
and diminished tubulointerstitial scarring.
Other researchers have studied the role of M<j) in the 'non-immunological'
model of UUO. Lenda et al induced UUO in CSF-1 deficient mice that exhibit
reduced levels of M(j) infiltration and activation (Lenda et al., 2003). Analysis of the
obstructed kidneys of the CSF-1 deficient mice demonstrated a reduced interstitial
M(|) infiltrate that was associated with a reduced level of tubular cell apoptosis.
Lange-Sperandio et al obstructed the kidneys of triple E-, P- and L-selectin KO mice
and WT control mice within the first 48 hours after birth (Lange-Sperandio et al.,
2002). As predicted, triple selectin KO mice exhibited a diminished level of
tubulointerstitial M(J> infiltration and this was associated with reduced levels of
tubular cell apoptosis compared to control mice. These combined data strongly
suggest that M({) play a role in modulating the level of tubular cell apoptosis in the
inflamed tubulointerstitium of the kidney (Duffield et al., 2005a; Lange-Sperandio et
al., 2002; Lenda et al., 2003). In addition, a striking correlation was found between
the severity of the tubulointerstitial Mc|) infiltration and the level of tubular epithelial
cell apoptosis (Duffield et al., 2005a; Lange-Sperandio et al., 2002; Lenda et al.,
2003).
When I was undertaking the studies described in this thesis, there was very
little data available regarding the mechanism involved in M())-directed tubular cell
death. Although in vitro studies attempting to dissect these mechanisms had been
performed there was no clear Mcj)-derived death effector. Lange-Sperandio et al co-
cultured cytokine activated J774 Mc|) (a murine M(|) cell line) with PKSV-PR cells (a
murine proximal tubular cell line) and demonstrated that cytokine activated M(j)
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induced significant tubular cell apoptosis (Lange-Sperandio et al., 2003). This study,
however, and the previous more limited work by Tesch et al (Tesch et al., 1999) was
unable to determine the nature of the M(j) death effector which remained an
undefined soluble mediator. It is pertinent, however, that Lange-Sperandio was
unable to demonstrate a role for TNF-a, FasL or TGF-|3 (Lange-Sperandio et al.,
2003).
1.19 CONDITIONAL M<|> ABLATION MODEL
Identification of the human receptor for diphtheria toxin (DT) (also known
as heparin-binding epidermal growth factor (hbEGF) (Naglich et al., 1992), or
referred to as DTR for diphtheria toxin receptor) created an opportunity for a unique
ablation strategy. The murine form of hbEGF binds DT poorly, but murine cells can
be rendered sensitive through transgenic expression of human hbEGF or DTR.
Richard Lang's group generated transgenic mice expressing human hbEGF lineage
specifically under the CD lib promoter (CDllb-DTR) and demonstrated that cell
ablation results from toxin injection (Cailhier et al., 2005). In addition, since DT is a
protein synthesis inhibitor this strategy results in the induction of death in both
mitotic and terminally differentiated cells. The death mechanism is apoptosis as
65% of the F4/80 positive peritoneal Mtj) are Annexin-V positive 6 hours after DT
administration (Cailhier et al., 2005) The generation of CD1 lb-DTR transgenic mice
used in this study have also been used to demonstrate the importance of M(j) in
progressive renal inflammation (Duffield et al., 2005a) and the progression of liver
injury and subsequent resolution of fibrosis (Duffield et al., 2005b). This strategy has
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also been used to generate transgenic mice in which hepatocytes (Saito et ah, 2001)
or DC (Jung et al., 2002) may be conditionally ablated.
1.20 NITRIC OXIDE
NO was first discovered as an endogenous vasodilator released from the
endothelium to regulate vascular tone (Furchgott and Zawadzki, 1980). Since then
knowledge of the biology of NO has increased enormously. NO plays an important
role in the regulation of a wide range of physiological processes including
angiogenesis, neurotransmission, platelet aggregation, host defense and immunity
and modulation of inflammatory responses (Clancy et al., 1998; Moncada and Higgs,
2006; Quinn et al., 1995).
NO is enzymatically generated by NO synthases (NOS), which catalyse the
oxidation of the amino acid L-arginine to NO and L-citrulline (Moncada et al., 1989;
Palmer et al., 1988). This reaction is dependent on nicotinamide adenine dinucleotide
phosphate (NADPH) as co-substrate, calmodulin, flavin mononucleotide (FMN),
flavin adenine dinucleotide (FAD) and tetrahydrobiopterine (BFI4) as co-factors.
Three different isoforms of NOS in mammals have been isolated. The
neuronal NOS (nNOS also called NOS I) is expressed predominantly in neurons in
the brain and peripheral nervous system. Endothelial NOS (eNOS, also called NOS
III) is mainly expressed by endothelial cells. Both nNOS and eNOS are
constitutively expressed and their activity is triggered by calcium binding to
calmodulin. The constitutive NOS isoforms generate NO at physiological
concentrations. The third isoform of the NOS family is inducible NOS (iNOS, also
called NOS II). The iNOS isoform is not detectable in resting quiescent cells but
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expression of iNOS can be induced by pro-inflammatory mediators such as cytokines
and microbial products. iNOS is expressed in various cell types including M(J)
hepatocytes, chondrocytes, epithelial cells, mesangial cells and smooth muscle cells.
Following the induction of iNOS expression, large amounts ofNO may be generated
over a prolonged period of time. iNOS binds tightly to calmodulin and its enzyme
activity is independent of intracellular calcium concentrations. All NOS isoforms
contain binding sites for FAD, FMN, calmodulin, heme and BH4.
1.21 Reactive nitrogen oxide species (RNOS)
High concentrations of NO generated by iNOS, can rapidly be oxidised to
reactive nitrogen oxide species (RNOS) such as nitrogen dioxide (NO2), dinitrogen
trioxide (N2O3) and dinitrogen tetraoxide (N2O4). N2O3 is the active species in
biological systems. N2O3 can nitrosate (add an NO+ group to) thiols (S-nitrosation)
or amines (N-nitrosation) and N2O3 can also be excreted as nitrite (NO2") after
hydrolysis (Brown and Borutaite, 2006). Under conditions of high NO and oxidative
stress, superoxide anion (O2") rapidly reacts with NO to produce the potent
peroxynitrite (ONOO), which is a powerful oxidant. The most severe cytotoxic
effects ofNO are thought to be mediated by peroxynitrite. Peroxynitrite can trigger
DNA breakage, inhibit DNA repair enzymes, cause protein oxidation and nitration
and initiate lipid peroxidation (Pacher et al., 2007).
The major thiol in the cells is the reduced form of the cysteine-containing
tripepetide gluthathione, and it plays an important role in protecting cells against
oxidative stress (Meister and Anderson, 1983). The formation of peroxynitrite can be
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inhibited by the removal of superoxide by scavenging enzymes called superoxide
dismutases (SOD).
1.22 INHIBITION OF NO AND INOS KO MICE
iNOS mediated NO production can be inhibited by arginine analogues such
as NG-mono-methyl-L-arginine (L-NMMA) and NG-nitro-L-arginine-methyl ester
(L-NAME). These compounds act as competitive non-specific inhibitors of iNOS.
Selective inhibitors of iNOS include L-N-imino-ethyl lysine (L-NIL), 1400W,
GW5140 and aminoguanidine.
Protective effects of iNOS inhibition by these compounds upon injury and
inflammation have been shown in various models of disease: collagen induced
arthritis (Cuzzocrea et al., 2002), experimental ischemia-reperfusion injury (I/R) in
rats and mice (Chatterjee et al., 2002; Chatterjee et al., 2003; Mark et al., 2005).
There is controversy in the literature regarding the participation of iNOS derived NO
in experimental glomerulonephritis (reviewed (Cattell, 2002; Trachtman, 2004),
where renoprotective effects were demonstrated in some studies (Narita et al., 1995;
Ogawa et al., 2002; Satriano et al., 2005), whereas other studies showed increased
injury following iNOS inhibition (Weinberg et al., 1994; Westenfeld et al., 2002).
Chronic iNOS inhibition by L-NIL and aminoguanidine has been shown to attenuate
renal injury in 5/6 nephrectomised rats (Bautista-Garcia et al., 2006), whereas
chronic NOS inhibition by L-NAME resulted in aggravated glomerular injury in rats
with subtotal nephrectomy (Fujihara et al., 1995). NO production plays an important
role in the pathogenesis of adriamycin nephropathy as administration of the iNOS
inhibitor aminoguanidine suppressed proteinuria, interstitial cell infiltration and
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apoptosis in animals with adriamycin nephropathy (Ozen et al., 2001). Furthermore
studies have shown that systemic inhibition of iNOS reduces acute tubulointerstitial
injury in rat renal allograft rejection (Vos et al., 2000).
To study the role of iNOS derived NO, mice targeted for the deletion of the
iNOS gene has been generated (Wei et al., 1995). Work by Wei et al demonstrated
that iNOS KO mice were more susceptible to the parasite infection Leishmania
major than control iNOS WT mice. Further studies have demonstrated that iNOS KO
mice are resistant to to LPS induced septic shock (Wei et al., 1995) , have impaired
wound healing (Shi et al., 2001; Yamasaki et al., 1998), and exhibit resistance to
bleomycin induce lung injury (Genovese et al., 2005). Flochberg et al induced UUO
in iNOS KO mice and demonstrated that these mice developed increased
tubulointerstitial fibrosis compared with iNOS WT control mice (Hochberg et al.,
2000). In addition a later study from the same group demonstrated that the obstructed
kidneys of iNOS KO mice at 7 day exhibited significantly more apoptotic tubular
epithelial cells than compared withWT control mice (Miyajima et al., 2001).
1.23 NO DONORS
NO releasing compounds (NO-donors) can be used to study the effects of
NO upon apoptosis. Sodium nitroprusside (SNP) is a stable NO-donor, and does not
release NO spontaneously (unless exposed to light). SNP requires complex
metabolism to generate intracellular NO and membrane-bound proteins are thought
to have a role in NO generation (Butler and Megson, 2002). Diazeniumdiolates (also
known as 'NONOates') are a group of NO donors, which have an NO dimer linked
to a nucleophilic molecule via a nitrogen atom (Maragos et al., 1991). The
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NONOates release NO spontaneously in aqueous solutions and examples of these are
diethylamine NONOate (DEA/NO) and spermine NONOate (spermine/NO). These
NO-donors have clearly defined rates of NO release and range over prolonged
periods (first-order kinetics): DEA/NO (half-life [ti/2]= 9 minutes) and Spermine/NO
(ti/2= 39min).
1.24 NITRIC OXIDE AND APOPTOSIS
The generation of high levels ofNO can trigger both necrotic and apoptotic
cell death. As is often the case for key biological mediators, NO represents a 'double
edged sword' and NO has been described as a "Jekyll and Hyde" molecule as
evidence indicates that NO possesses both pro and anti-apoptotic properties
(reviewed by (Brune, 2003; Choi et al., 2002; Chung et ah, 2001; Dimmeler and
Zeiher, 1997; Kim et ah, 2001b; Liu and Stamler, 1999).
NO generated at low concentrations (picomolar to nanoomolar) by the
constitutive isoforms have beneficial and protective effects. However, at high
concentrations of NO produced when iNOS is activated and during condition of
oxidative stress, NO reacts with superoxide anion to produce peroxynitrite. NO may
be highly cytotoxic under these conditions and drive cell death.
The pro-apoptotic signalling cascade of NO is attuned with the apoptotic
pathway involving mitochondria (Bosca and Hortelano, 1999; Brown, 1999; Pacher
et ah, 2007). The RNOS formed from NO can damage DNA directly, and inhibit
DNA repair enzymes (Wink et ah, 1996). NO evoked upregulation of the tumour
suppressor protein p53 has also been described (Messmer et ah, 1994).
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1.25 AIMS OF THIS WORK
Ihe aim of my studies was to identify the mechanism whereby
inflammatory M(|) modulate renal inflammation by regulating the level of
proliferation and apoptosis of tubular epithelial cells. This project therefore involved
examining the effect of inflammatory Mc|) upon tubular epithelial cell apoptosis and
proliferation in vitro and in vivo. The main aim was to determine the nature of the
M(()-derived mediators. My aims were as follows:
1) To use a co-culture strategy to determine whether inflammatory M(j)
modulate renal tubular epithelial cell proliferation and apoptosis in vitro.
2) To define the mechanism by which inflammatory M<|) induced renal
tubular epithelial cells apoptosis in vitro and to test the in vivo relevance of the
findings in the model of UUO.
3) To investigate the effect of conditional M<|> ablation on tubulointerstitial






The tissue culture reagents were from Life Technologies and tissue culture
plastics were obtained from Costar Ltd or from BD Falcon. All other reagents used
in this thesis were from Sigma-Aldrich Company Ltd (unless otherwise stated).
2.1.1 MDCK cells
MDCK cells are a distal tubular epithelial cell line originally derived from
canine renal cortex. The MDCK cells were a gift from Jamie Davies (Dept of
Physiology, University of Edinburgh, UK).
2.1.1.1 Thawing and passaging cells
A cryovial of frozen cells (MDCK cells or L929 cells, Chapter 2.1.2), which
had been stored at liquid nitrogen (-196°C), was placed on dry ice and transported to
the tissue-culture laboratory. Cells were thawed by agitating the vial by hand in a
37°C water bath after which the contents were transferred by pipette to a 15ml
Falcon tube (BD Falcon, UK) containing 10ml of pre-warmed hanks balanced salt
solution (HBSS) in a pre-cleaned tissue culture hood (10% Decon Neutracon with
water, Decon Laboratories Ltd, UK), followed by 70% ethanol [EtOH] with water).
All work carried out in the tissue-culture hood employed general sterile tissue-
culture techniques. The cells were mixed by aspirating and releasing the cells by a
pipette and the suspension was centrifuged at 21Og for 5 minutes (min) at room
temperature (RT). Without disturbing the cell pellet, the supernatant was gently
aspirated in order to remove the storage solution from the thawed cells. The cells
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were then resuspended in 5-10ml of Eagle's minimum essential medium (MEM)
containing 1% non-essential amino acids, lOOU/ml penicillin, 100pg/ml
streptomycin and 10% heat-inactivated foetal calf serum (FCS). The cell suspension
was added by pipette to a Costar culture flask containing the above pre-warmed
medium (5ml medium for T25cm2 flask, 10ml for T75cm2, or 30ml for T 162cm2)
and placed inside a 37°C incubator with humidified atmosphere of 5% carbon
dioxide (CO2). The growing cells were maintained in culture by passaging the cells
when they were 80-90% confluent. The MDCK cells adopted a cobble stone
appearance when confluent and this is a typical morphological pattern for tubular
epithelial cells. To passage the MDCK cells, the old media was removed from the
culture flask with a sterile pipette and the cells were washed twice with 5-10ml of
sterile phosphate buffered saline (PBS) without calcium and magnesium (PBS-/-), to
remove divalent cations and serum. The cells were enzymatically digested by adding
sterile lx trypsin- Ethylene-diamine-tetra acetic acid (EDTA) [50 units/ml trypsin
and 5mM EDTA] solution (0.5ml for T25cm2, 1ml for T75 cm2 and 2ml for
T 162cm2 culture flask). The flask was placed in the 37°C incubator for 2-5min, until
the cells were detached. Detachment of cells was carefully monitored under the light
microscope. Sometimes the flask was gently tapped in order to loosen all the cells.
Trypsin was inactivated by adding fresh medium containing 10% FCS (4.5ml for
T25cm2, 9ml for T75cm2 and 18ml for T162cm2 flask) and the cell suspension was
resuspended. The cells were then split 1:5 or 1:10 by adding an aliquot of the cell
suspension to a new culture flask containing fresh pre-warmed medium. The flask
was placed in the 37°C incubator so that the cells could adhere. The media was
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changed every 2-3 days by aspirating and discharging the old media and replacing
with fresh pre-warmed media.
2.1.1.2 Freezing and storage of cells
For long-time storage, 80-95% confluent MDCK cells (or L929 cells,
Chapter 2.1.2) were detached with trypsin/EDTA and cell number was determined
by microscopical counting using a haemocytometer after the trypsin inactivation
step. The cells were then centrifuged at 210g for 5min at RT and the pellet was
resuspended at 2x106 cells/ml in freezing medium, which consisted of 20%
dimethylsulphoxide (DMSO) in FCS. The cell suspension was transferred to a
cryovial and immediately positioned inside a 'cell-freezing container', which
contained iso-propanol, and then placed inside the -80°C freezer. After couple of
days the vials were transferred to liquid nitrogen for long-term storage. This freezing
procedure ensured gradual freezing of the cells.
2.1.2 L929 cells
L929 cells are a murine malignant fibrosarcoma cell line, which
spontaneously secrete Mcf) colony stimulating factor (M-CSF), into the culture
supernatant. The L929 conditioned supernatant is used for culturing bone-marrow
derived M(|) (BMDM) (Chapter 2.3). These L-929 cells were maintained in
Dulbecco's modified Eagle medium with F12 (DMEM/12) containing glutamax (a
stable replacement for L-glutamine) supplemented with 10% FCS, penicillin
(100U/ml) and streptomycin (100pg/ml). Cells were grown in Costar T162cm flasks
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in 25ml medium and were split 1:30 as described for MDCK cells (Chapter 2.1.1.1)
when confluent. The supernatant was harvested, filtered through a 0.45 pm filter,
aliquoted into 15ml Falcon tubes and stored at -80°C.
2.2 PREPARATION OF PTE CELLS
PTE cells were derived from kidneys of several strains of mice including
C57BL/6 and FVB/N mice. The mouse was killed by cervical dislocation (Schedule
1 killing). The animal's coat was washed with 70% EtOH to limit contamination by
fur and dander. Using autoclaved instruments, a lateral incision was made in the skin
about midway down the abdomen and the skin was removed. The peritoneum was
opened carefully and the left and right kidneys were removed and immediately
placed in ice cold HBSS containing ABAM (antibiotic antimycotic solution;
lOOU/ml penicillin, 1OOpg/ml streptomycin and 250ng/ml amphotericin B). The
kidneys could be stored on ice for up to 5 hours, but higher yields of PTE cells were
obtained if the kidneys were processed immediately in a sterile pre-cleaned tissue
culture hood. The kidneys were decapsulated, bisected and the medulla was removed
using autoclaved scalpel and forceps on a sterile petri dish containing fresh pre-
warmed FIBSS. The kidneys were then transferred to a fresh petri dish containing
fresh HBSS and the cortices were finely chopped into pieces that were approximately
1mm3 in size. Excess HBSS was gently removed with a sterile pasteur pipette. The
chopped tissue was transferred to a Universal tube containing 9ml of sterile filtered
digestion mixture, which contained 0.5mg/ml Collagenase type IV and lOpg/ml
DNase I (Roche Molecular Biochemicals, UK) in HBSS. The mixture was incubated
in a 37°C water bath and every 5-10min the mixture was resuspended, in order to
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assist the digestion of the kidney pieces. After 20min incubation at 37°C, the mixture
was resuspended and then allowed to settle. A 0.5ml sample of the supernatant was
removed and transferred to a petri dish. The presence of tubules was observed under
the light microscope if the enzymic digestion was adequate. If no tubules were
present (or only short stumpy pieces) the kidneys were returned to the water bath for
further digestion. Once dispersed long tubular segments pieces were present (Figure
2.1a), the supernatant was transferred to a new Universal tube and the digestion
mixture and 10ml of HBSS was added and the tube was placed on ice. After 20min
the tubules had settled to the bottom of the Universal tube. The HBSS was gently
removed and the tubules were washed with 20ml of fresh HBSS and returned to ice
for a further 20min to allow the tubules to settle again. After gentle aspiration of
HBSS, the tubules were resuspended in pre-warmed PTE cell medium. This
consisted of serum-free DMEM/12 containing lOOU/ml penicillin, lOOpg/ml
streptomycin, 1 Opg/ml insulin, 5.5pg/ml transferrin, 5ng/ml selenium, 36ng/ml
dexamethasone and 25ng/ml EGF. Two digested kidneys were resuspended in a total
volume of 12ml PTE cell medium and plated in four Falcon T25cm2 flasks (3ml cell
suspension/flask). The cells were incubated in a humidified atmosphere of 5% CO2
at 37°C and the media was changed every 2-3 days. After 2 days of culture, a cobble
stone morphology characteristic of tubular epithelial cells started to appear (Figure
2.1 b). This typical cobble stone morphology was more apparent in confluent
monolayers (after 7-10 days of culture) without evidence of fibroblast contamination
(Figure 2.1c).
There was a potential for other cells to grow in the PTE cell cultures since
the tubules were digested from whole kidney cortex. However, the selection of PTE
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cell growth is favoured by the serum-free conditions and the specific media
supplements used. To ensure that the cells maintained their primary cell phenotype
and to minimise the risk of EMT (Chapter 1.12.2) the PTE cells were only
trypsinised once. After the trypsin inactivation step, the cells were pelleted by
centrifugation at 210g for 5min at RT. The supernatant was carefully aspirated and
cells were washed with 10ml HBSS to ensure that excess FCS was removed. This
was repeated once more and the cells were finally resuspended in serum-free PTE
medium. Instead of passaging them to new flasks, they were directly seeded into the
wells of Costar tissue-culture plates. If the PTE cells were trypsinised beyond the
second passage they began to adopt a fibroblast like appearance and this may have
been caused by growth factors present in FCS (especially TGF-P) since serum




Figure 2-1 Light photomicrographs showing PTE cell cultures at day
0, day 2 and day 10.
Tubules are visible at day 0 of culture (A) and islands of PTE cells start to
form after 2 days of culture (B). A confluent monolayer of PTE cells is evident
after 10 days of culture and exhibits a characteristic cobble stoned
morphology, typical of tubular epithelial cells (C). (x400 magnification).
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2.2.1 Characterisation of PTE cells
The PTE cells were characterised for a tubular epithelial cell phenotype
morphologically by inspection under the light microscope, as confluent PTE cells
exhibited a cobble stone appearance (Figure 2.2c). They were also characterised
immunohistochemically after staining for cytokeratin, vimentin and a-SMA. Tubular
epithelial cells should stain positively for cytokeratin, since this is a specific
epithelial cell surface marker, while no staining should be observed for vimentin
(fibroblast marker) or a-SMA (myofibroblast marker) (Chapter 1.121). Sterile
autoclaved glass-cover slips were placed inside the wells of a Costar 24-well plate
and 0.5ml of PTE medium added per well. The PTE cells were trypsinised and lxlO5
cells/ml were seeded onto the glass-cover slips. The cells were left to grow until they
were 70-80% confluent. Unbound cells were washed off with HBSS and the cultures
were fixed by adding a mixture of ice-cold methanol (MeOEl) and acetone (50:50)
solution. After lOmin of fixation, the fixative was removed and the coverslips were
left to air-dry. Non-specific binding was blocked by incubating the coverslips in a
blocking solution consisting of PBS -/- with 2% normal goat serum and 0.1% Triton
xlOO for 30min at RT. This was achieved by placing a small amount of blocking
solution onto a sheet of parafilm and the cover-slips were then inverted, so their cell-
containing surface was in contact with the blocking solution. All subsequent
incubations steps were performed in this manner. Primary antibodies included
monoclonal anti-pan cytokeratin (IgGl and IgG2a), monoclonal anti-vimentin (clone
VIM 13.2, IgM) and monoclonal anti-a-SMA (IgG) or their respective isotype
controls. Antibodies were diluted in the above blocking solution (cytokeratin 1/50,
vimentin 1/100 and anti-a SMA 1/1000) and incubated overnight at 4°C. The next
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day cells were washed x3 with blocking solution and incubated with their appropriate
secondary antibodies: FITC conjugated goat-anti-mouse (IgM, 1/100) or Rhodamine
red-conjugated goat-anti-mouse (IgGl, 1/100; Jackson ImmunoResearch Europe Ltd,
UK). Following 45min incubation at RT the cells were washed x3 with PBS. Finally
the coverslips were mounted onto glass-slides with Vectashield containing DAPI
(Vector Laboratories, UK). Positive control cells included primary renal fibroblasts
(kindly prepared by my colleague Madeleine Vernon). The cells were characterised
by fluorescent microscopy. PTE cells did not express a-SMA (data not shown).
However the cells stained positive for the tubular epithelial cell marker cytokeratin,
(Figure 2-3a) and were negative for the fibroblast marker vimentin (Figure 2-3b). It
is likely that the PTE cells were of a mixed tubular origin, since the cells were
prepared by digestion of the whole kidney cortex. The tubular segment of the
nephron consists of different parts (proximal, distal and collecting duct) and the PTE
preparation method that I used did not allow the separation of these different cell
types. For the purposes of this thesis, the PTE cells were not characterised for the
different tubular origins. Proximal and distal tubular epithelial cell markers are
discussed in the introduction (Chapter 1.2).
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Figure 2- 2 Fluorescent photomicrographs of cytokeratin positive and
vimentin negative PTE cells.
PTE cells were prepared and labeled according to Chapter 2.2.1. PTE cells
stained positive for the specific epithelial cell marker cytokeratin (A) and were
negative for the fibroblast marker vimentin (B). The specificity of the staining
was checked by staining murine primary renal fibroblasts (cytokeratin C,
vimentin D). Isotype control antibodies were negative (data not shown).
(x1000 magnification).
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2.3 PREPARATION OF BMDM
BMDM were prepared from the femurs of FVB/N or C57BL/6 mice. A 20-
25g mouse was killed by cervical dislocation (Schedule 1 killing). The animal's coat
was washed with 70% EtOH to limit contamination by fur and dander. Using
autoclaved instruments, a lateral incision was made in the skin about midway down
the abdomen and the skin was removed from the lower abdomen and legs. The femur
was then revealed by dividing the muscles surrounding the bone and removing the
tissue surrounding the hip joint. Finally the limb was excised by cutting through the
knee joint and the hip joint. The limbs were rinsed with 70% EtOFI and placed on ice
in a container with HBSS containing lOOU/ml penicillin, lOOpg/ml streptomycin and
transported to a sterile pre-cleaned tissue culture hood. The femurs were placed in a
petri-dish containing 70% EtOH and tissue from the bones was removed with a
sterile scalpel. Any remaining connective tissue was removed with disinfectant
wipes. The femurs were washed in 70% EtOH and transferred to a fresh petri-dish
containing 1ml of DMEM/F12. 10ml of DMEM/F12 supplemented with 20%
conditioned L929 medium was drawn into a 10ml syringe and connected to a green
25 gauge needle. Using the scalpel blade and holding the femur close to the proximal
end, the proximal 2mm of bone was removed. The bone was now held using sterile
forceps over a clean Universal container and the needle inserted into the shaft of the
bone from its proximal end. By applying gentle pressure medium was passed into the
marrow cavity to flush out the marrow cells and the process was repeated for the
other bone. The bone became translucent as the red bone marrow was flushed out.
The cells were resuspended through a wide 19 gauge needle and cell number was
assessed by microscopical counting using a haemocytometer. Typically one mouse
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yielded 30-50xl06 BMDM. The cells from one femur were placed into one 60ml
'non-adherent' Teflon pot (RVetter, Germany) and matured for seven days in a total
volume of 40ml of DMEM/F12 medium with 20% conditioned L929 medium, to
stimulate differentiation and maturation of M(J>. 10ml of the medium was replenished
every second day with fresh medium.
2.3.1 Characterisation of BMDM
2.3.1.1 Cytospin followed by Diff-quik staining
The maturation and purity of day 7 BMDM was assessed by examination of
a cytospin following Diff-quik staining. 100-200pl of a suspension of BMDM (lxlO6
BMDM/ml) was added to the well of a 'cytospin holder' and the cells were
cytocentrifuged at 300g for 3min in a Shandon Cytospin II (Shandon, UK). The cells
were then fixed with 100% MeOH for 2min, followed by staining in the Diff-quik
Red solution for lmin and Diff-quik Blue solution (both from Gamidor Ltd, UK) for
lmin. All steps were performed at RT. The slides were rinsed with distilled water,








Figure 2- 3 Phenotyping day 7 BMDM morphologically after Diff Quik
staining.
Maturation of day 7 BMDM was checked by cytopsin followed by Diff Quik
staining. The cells were stained as described in Chapter 2.3.1.1. A low power
view (x100 magnification) of many mature BMDM, without any contaminating
cells such as PMN (A) and a high power view (x1000 magnification)
indicating the features of BMDM (B).
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2.3.1.2 Flow cytometry
Mature BMDM were also characterised by flow-cytometric analysis for
their expression of F4/80 (a murine M(J> restricted cell surface glycoprotein)
(McKnight et al., 1996). BMDM were also analysed for CDllb, which is expressed
by both monocytes and M(|). Double labelling with F4/80 and CDllb enables the
identification of mature M(|), which are F4/80hl8h/Cdl lbhlgh, in contrast to monocytes
which should only express CD1 lb.
Day 7 Mcj) were harvested from the Teflon pots into chilled polystyrene
FACS tubes (BD Falcon, UK) and centrifuged at 300g x 5min at 4°C. The
supernatant was carefully discarded and the cells were washed by adding 2ml of cold
PBS -/-, followed by centrifugation at 300g x 5min at 4°C. After discarding the
supernatant, cells were resuspended (2xl05cells/ml per FACS tube) in 100pi
blocking solution (PBS -/- containing 10% mouse serum) and incubated for 30min
on ice. Allophycocyanin (APC) conjugated monoclonal rat-anti-mouse F4/80
(IgG2aic, Caltag Laboratories,UK) and fluorescein isothiocyanate (FITC) conjugated
rat-anti-mouse CDllb (IgG2bic, eBiosciences, UK), both diluted 1/100 in blocking
solution, or their respective isotype controls were then added. The cells were mixed
gently and incubated on ice for 30min in the dark. Before undergoing flow
cytometric analysis, the cells were washed with cold PBS -/- and resuspended in 200-
300pl of PBS -/-. Analyses were performed using a FACScan instrument (Becton
Dickinson, UK) and the results were analysed with Cell Quest software (Becton
Dickinson, UK) or FlowJo software (Treestar, USA). Flow cytometric analysis of
day 7 BMDM after staining for F4/80 and CD1 lb is shown in Figure 2-4.
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BMDM derived from iNOS WT and iNOS KO mice were also characterised
by flow cytometry for their expression of iNOS. Mature BMDM were placed inside
small 5ml Teflon pots (5xl05/pot) and cultured for 24h in the presence or absence of
LPS (lpg/ml) and murine IFN-y (100 U/ml, Peprotech, UK). The BMDM were then
harvested and stained for flow cytometry as described in the previous sections with
the following modifications. Non-specific binding and permeabilistaion of the cells
was achieved by incubating with blocking solution (10% goat serum, 1% Triton X-
100, diluted in PBS) for 30min. Primary antibody (polyclonal rabbit-anti-human
iNOS which also detects murine iNOS, Transduction Laboratories, UK) or isotype
control (rabbit IgG) was diluted 1/100 in 2% goat serum (in PBS-/-) and incubated
overnight at 4°C. Following two washes with cold in PBS -/-, the cells were
incubated for 30min at RT with secondary antibody (Alexa Fluor®-488 conjugated
goat-anti-rabbit IgG (H+L, Molecular Probes, USA, 1/100 dilution in 2% goat serum
































Figure 2- 4 Phenotyping day 7 BMDM by flow cytometric analysis for
the expression of F4/80 and CD11b.
Maturation of day 7 BMDM was assessed by staining for the specific M<(>
marker F4/80 together with CD11b and the level of expression was analysed
by flow cytometry. FACS dot blot showing the gating in forward scatter (FSC)
and side scatter (SSC) (A). A pure M(j> population (94.6%) expressing both
F4/80 and CD11b is seen in the upper right quadrant of the FACS dot blot
(B). Histograms for F4/80 staining (C) and CD11b staining (D). The cells
were stained as described in Chapter 2.3.1.2.
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2.4 CO-CULTURE EXPERIMENTS
The interaction BMDM with MDCK cells and PTE cells was studied by
using a robust microscopically quantifiable co-culture assay which was previously
developed by Jeremy Duffield in our Department (Duffield et ah, 2000). A schematic
diagram for the co-culture experiment is illustrated in Figure 2-5.
2.4.1 Direct co-culture of BMDM with tubular epithelial cells
MDCK or PTE cells were pre-labelled with fluorescent CellTracker Green
whilst in some experiments mature BMDM (7-10 day) were pre-labelled with
fluorescent CellTracker Orange (both CellTracker dyes obtained from Molecular
Probes, USA). The CellTracker dyes are thiol-reactive fluorescent dyes that are
retained by live cells following cell division and do not have any deleterious
biological effects on the cells. The dyes are lipid soluble and interact with cellular
and serum proteins. 70-80% confluent T25 or T75 flasks of tubular epithelial cells
(MDCK or PTE cells) were washed twice with 5ml serum-free medium. This was
aspirated and replaced with serum-free medium containing 5pi of CellTracker green
stock solution (lmg/ml in DMSO) in 5ml for a T25 flask (lOpl of CellTracker green
in 10ml for a T75 flask). The cells were incubated for lh at 37°C. After this the
medium was aspirated and replaced with 5-10ml of medium containing 10% FCS to
remove any unbound CellTracker dye. The cells were further incubated for 15min to
make sure that all free dye was removed.
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Figure 2- 5 Schematic diagram of the in vitro co-culture assay that
was used to study the interaction between BMDM and tubular epithelial
cells.
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The tubular epithelial cells were then trypsinised and cell number was
determined after counting with the haemocytometer. Tubular epithelial cells were
seeded into the wells of Costar 48-well plates, to cover 60-70% of the well surface:
this typically required 1x104MDCK cells/well and 1.5xl04 PTE cells/well. The outer
wells of the 48-well plates were not used for experiments since they tended to dry
out. To maintain moisture, the outer wells were overlaid with PBS. The MDCK cells
were left to adhere for 4h whilst PTE cells were left to adhere overnight. After this
the wells were washed twice with HBSS to remove non-adherent cells prior to
addition of BMDM.
In some experiments the BMDM were pre-labelled with fluorescent
CellTracker orange. BMDM were harvested from the Teflon pots and centrifuged at
300g for 5min at RT. The medium was carefully aspirated and the cells from one
Teflon pot (i.e. derived from one femur) were resuspended in 5ml of serum-free
medium and 5pl of CellTracker orange stock solution (lmg/ml in DMSO) was
added. The cell suspension was transferred into a 15 ml Teflon pot and incubated for
30min at RT. After this 10ml of medium containing 10% FCS was added and
incubated for further 15min in order to remove any free dye. The cells were then
centrifuged at 300g for 5min and the medium was carefully aspirated.
For MDCK co-cultures the BMDM were resuspended in DMEM/F12
medium containing 10% FCS but for co-cultures involving PTE cells, the BMDM
were washed twice with PTE medium prior to final resuspension in PTE medium
containing 1% FCS. BMDM were added to epithelial cells at a ratio of 2 BMDM : 1
epithelial cell. Pilot experiments were undertaken, where the number of BMDM
were titrated against a constant number of epithelial cells and various BMDM:
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epithelial cell ratios were tested (10:1, 5:1, 4:1, 3:1, 2:1, 1:1 and 0.5:1). Higher
BMDM:epithelial cell ratios (ratio 4:1 upwards) exhibited a reduction in total cell
number, whilst the level of free apoptotic cells remained low. It was felt that this
may reflect Mc(> phagocytosis of apoptotic cells. The highest level of epithelial cell
apoptosis was observed at a ratio of 2 BMDM:1 epithelial cell and therefore this ratio
was chosen for experiments. Control wells with tubular epithelial cells alone
(without BMDM) and wells with BMDM alone were also prepared. MDCK
experiments were conducted in DMEM/F12 medium containing 10% FCS and PTE
cell experiments were conducted in PTE cell medium containing 1% FCS. In later
MDCK co-culture experiments, the BMDM were plated prior to the MDCK cells but
this had no effect on the results. However, the PTE cells were always plated prior to
the BMDM since the PTE cells proliferated slowly. The BMDM were left to adhere
for 3-4h, and non-adherent cells were removed by washing the wells twice with
HBSS.
Selected co-cultures were then activated (in a total volume of 300pl/well)
with lpg/ml LPS and lOOU/ml of IFN-y, whilst non-activated co-cultures were
exposed to medium alone. After 24h incubation, the undisturbed co-cultures
underwent in situ fixation with formaldehyde (approximately 4% final concentration)
by adding 33pi of 38% formaldehyde solution (BDH, UK) to each well in the fume
hood. The plates were fixed for 48h at 4°C to ensure firm retention of the apoptotic
target cells before being processed for fluorescent microscopy analysis.
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2.5 PREPARATION OF CONDITIONED SUPERNATANTS FROM BMDM
I undertook experiments involving the transfer of conditioned supernatants
from LPS/IFN-y activated BMDM, in order to determine whether soluble mediators
present in the supernatants from activated BMDM could induce apoptosis of tubular
epithelial cells. 2.5x10s mature BMDM were cultured in 0.5ml of BMDM media
(with 10% FCS for experiments involving MDCK cells) and in PTE media (with 1%
FCS for experiments involving PTE cells), in the presence or absence of LPS
(lpg/ml) and IFN-y (lOOU/ml). After 24h incubation, the BMDM supematants were
harvested and clarified at RT by centrifugation at 300g x 5min, followed by
centrifugation at 10,000g x 5min. Cell-free supernatants from either activated or non-
activated BMDM or media with or without LPS/IFN-y was then added directly to 24-
well plates containing tubular epithelial cells (1.25x10s tubular epithelial cells/well;
i.e. a ratio of BMDM conditioned supernatant : tubular epithelial cell ratio of 2:1)
and incubated for 24h. The cultures were fixed with 4% formaldehyde and processed
for fluorescent microscopy after 48h of pro-longed fixation.
2.5.1 CO-CULTURE USING TISSUE CULTURE INSERTS
In order to study whether direct cell-to-cell contact is important during the
co-culture, I used tissue-culture inserts (TCI) to separate the target tubular epithelial
cells from the BMDM. The TCI (BD Falcon, UK) have a 0.4gM semi-permeable
membrane (1.6xl06 pores/cm2, effective growth area 0.3cm2), which allows the
sharing of the same culture medium whilst preventing direct cell contact between
cells above and below the insert.
79
Tubular epithelial cells were cultured on the tissue-culture membrane with
BMDM being present in the bottom of 24-well tissue-culture insert companion plates
(BD Falcon, UK). This arrangement represents the spatial relationship present in
vivo. Confluent tubular epithelial cells grown on TCI become polarised with apical
and basolateral domains. In vivo interstitial infiltrating M(|) will be adjacent to the
basal aspect of tubular epithelial cells. In order to reproduce this spatial arrangement
in vitro, the M<j> were placed in the bottom of the wells of the companion plates. Thus
the basal aspect of the overlying tubular epithelial cells would be directly exposed to
secreted products from the M(J). The distance from the cell culture membrane and the
bottom of the companion plate well was 0.8mm.
0.9 ml of pre-warmed tubular epithelial cell medium was added to the wells
of the companion plate and the tissue-culture insets were gently placed inside the
wells. 0.3ml of tubular epithelial cell medium was then added to the insert
compartment and the inserts were secured so that the 'flanges' were resting in the
notches of each well. The tubular epithelial cells were trypsinised and 5x104 cells/per
insert were seeded and incubated until the cultures became confluent. Mature
BMDM (1.25xl05/well) were seeded to the bottom of the wells of a fresh companion
plate and left to adhere for 3-4 hours. Non-adherent BMDM were removed after
washing with HBSS. The confluent tubular epithelial cells growing on the TCI
(inside a different companion plate) were also washed with HBSS. Co-culture was
established by transferring the TCI to the companion plates containing the BMDM.
Tubular cells cultured alone on the inserts (without BMDM) were also set up as
controls. Both compartments shared the same medium and selected cultures were
activated with lgg/ml of LPS and lOOU/ml of IFN-y. After 24h incubation the
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cultures were terminated by adding 4% formaldehyde solution (final concentration)
to both compartments. The cultures were fixed for 48h at 4°C and processed for
fluorescent microscopy. A schematic diagram for the steps involved in this
experiment is shown in Figure 3-8 (Chapter 3).
2.6 ASSESMEMT OF TUBULAR EPITHELIAL CELL APOPTOSIS AND
PROLIFERATION BY INVERTED FLUORESCENT MICROSCOPY
Bisbenzimide Hoechst 33342 is a dye that fluoresces blue at 365nm and this
dye is a specific stain for AT-rich regions of double-stranded DNA. Hoechst 33342
labels both apoptotic and necrotic cells whilst live cells are able to 'pump it out'.
Fixation with formaldehyde permeabilises all cells thereby allowing the entry of the
dye into all cells. After fixation and Hoechst 33342 staining, apoptotic cells are
easily discernible from healthy cells as they fluoresce extremely brightly.
Identification of cells undergoing mitosis is also possible due to their characteristic
chromatin pattern. This staining method of formaldehyde fixed co-cultures was
chosen since it allowed the simultaneous detection of apoptotic and mitotic cells as
well as the total number of target tubular epithelial cells.
2.6.1 Collection of'floaters'
Prolonged formaldehyde fixation of the co-culture plates allowed firm
fixation and retention of the apoptotic cells. However, there was a possibility that
this fixation process could be incomplete and allow a partial loss in cell number since
late apoptotic and necrotic cells tend to 'de-adhere' and float in the culture medium.
Therefore, after 48h of fixation the formaldehyde solution (containing any
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unattached cells termed 'floaters') was collected into FACS tubes. The monolayer
was washed with PBS and the washing fraction was also collected to the same tube.
To remove the formaldehyde, the FACS tubes were centrifuged at 300g x 5min at
4°C and the supernatant was carefully removed inside the fume hood. The floaters
were finally resuspended in 200pl of PBS and analysed by flow cytometry. Flow
check counting beads were also added to determine the total cell number. Results
from FACS analysis showed that only a very minor proportion of the cells were lost.
The floaters represented less than 1% of tubular epithelial cells and I decided not to
collect the floaters routinely in experiments.
2.6.2 Hoechst 33342 staining of fixed co-cultures
After fixation with formaldehyde, the co-culture was stained with 1 pg/ml of
Hoechst 333342 and incubated for 15min at RT. The stain was removed and the
fixed cells were overlaid with a fluorescent-quenching mounting medium containing
90% glycerol, 10% PBS pH 8.6 and 1-4-diazabicyclo-2-2-2-octane (DABCO) at
5mg/ml. Target tubular epithelial cell apoptosis and proliferation was then assessed
by inverted fluorescent microscopy. The advantage of this method was that the co-
culture plates could be stored and analysed later.
2.6.3 Inverted fluorescence microscopy
The co-culture plates were analysed by inverted fluorescent microscopy on
a Zeiss Axiovert microscope equipped with FITC/GFP, DAPI and Rhodamine filters.
(Carl Zeiss Ltd, UK). Target tubular epithelial cells undergoing apoptosis were
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identified by their green condensed nuclei when viewed under the FITC filter and
their bright pyknotic nuclei when viewed under the DAPI filter (Figure 2-6d).
Healthy cells exhibit much larger nuclei which were not condensed and did not
exhibit bright fluorescence (Figure 2-6b). Mitotic epithelial cells were discernible by
their characteristic chromatin pattern (Figure 2-6e-j). Orange BMDM were visualised
under the Rhodamine filter. BMDM phagocytosis of green apoptotic epithelial cells
was also identified after inspection under all 3 filters (Figure 2-7).
The following routine was undertaken to ensure that each well was assessed
in an unbiased way. After Hoechst 33342 staining, the experimental plates were
coded and the lids were removed prior to analysis by fluorescent microscopy. Using
inverted fluorescent microscopy (x32 objective), 5 to 8 non-overlapping high power
fields (hpf) from each well were randomly and blindly chosen so that at least 200
epithelial cells were counted per well. For each hpf, the number of apoptotic, mitotic
and total number of tubular epithelial cells was counted. The number ofBMDM that
had phagocytosed apoptotic tubular epithelial cells was also recorded. The records
were maintained by the 'well code' stamped on the plate (B2, B3 etc) and once all
the wells were counted, the lids were matched with the plates to reveal the
experimental conditions.
The results were expressed as the number of apoptotic or mitotic tubular
epithelial cells per hpf or as a percentage of the total number of epithelial cells (%
apoptosis and % mitosis).
Each experimental condition was in triplicate wells and the experiments
were performed on at least three separate occasions (unless otherwise stated).
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BMDM and primary tubular epithelial cell cultures were derived from at least three
different mice (unless otherwise stated).
Sometimes the fluorescent images were captured using a Coolsnap camera
(24-bit colour, Princeton Instruments/Acton, UK) connected to the inverted
fluorescent microscope. For each hpf, 3 photos were captured under each filter set
(red, blue and green), using Open Lab version 3.0 software (Improvision, UK). The
images were saved in a TIFF format (Tagged Image File Format) for later analysis
with Adobe Photoshop (version 7.0, Adobe Systems, USA). A single image was
created in Adobe Photoshop by merging the 3 separate images using automated
'plugins'. The merged images were then scored for apoptosis, mitosis, phagocytosis
and total cell number. The advantage of performing image analysis on captured
photos allowed the use of a tool called 'opacity'. This facilitated the graded transfer







Figure 2- 6 Fluorescent micrographs of healthy, apoptotic and mitotic
MDCK cells after Hoechst 33342 staining.
MDCK cell apoptosis and mitosis was analysed by fluorescent microscopy
after counterstaining with Hoechst 33342. (A) Healthy CellTracker Green
labeled MDCK cell. (B) Same cell after Hoechst 33342 staining (C) Apoptotic
green MDCK cell, exhibiting cytoplasmic condensation. (D) Same cell after
Hoechst 33342 staining. Note the nucleus of the apoptotic cells is much
smaller than the healthy MDCK cell. (E-K) MDCK cells in different stages of
mitosis. (x320 original magnification).
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Opacity
Figure 2- 7 Fluorescent micrographs of activated co-culture of PTE
cells with BMDM at 24h.
CellTracker green labeled PTE cells were cultured in the presence of
cytokine activated CellTracker orange labeled BMDM. The culture was fixed
after 24h incubation followed by Hoechst 33342 staining. Photomicrograph
indicating 3 phagocytosed apoptotic PTE cells (examples arrowed) (A). The
use of the opacity tool is demonstrated (B). (x320 original magnification).
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2.7 ASSESMEMT OF TUBULAR EPITHELIAL CELL APOPTOSIS BY
FACS
The microscopical method for quantifying apoptosis was very time
consuming and therefore it was decided to try to develop a rapid and sensitive flow
cytometric based assay for quantifying tubular epithelial cell apoptosis after co-
culture with BMDM. 1 decided to use the method of Annexin V staining. I first tested
this method on PTE cells alone in the presence or absence of NO-donors before I
went on to try to optimise a 4-colour FACS for the co-culture experiments.
2.7.1 Annexin V-PE/7AAD staining
In normal cells, PS residues are found in the inner leaflet of the cytoplasmic
membrane. During the onset of apoptosis, PS residues flip to the outer leaflet of the
membrane. Annexin V is a calcium dependent phospholipid-binding protein with a
high affinity for PS. Translocation of PS is not unique to apoptosis but occurs also
during cell necrosis. The difference between these two forms of cell death is that
during the initial stages of apoptosis the cell membrane remains intact while the cell
membrane of necrotic cells loses its integrity and becomes leaky. Therefore the
measurement of Annexin V binding has to be performed in conjunction with a dye
exclusion to test to establish the integrity of the cell membrane. The dye 7AAD can
be used to indicate membrane disruption. Thus, apoptosis and necrosis can be
determined by labelling cells with Annexin V conjugated phycoerythrin (PE) and
7AAD and then analysing by flow cytometry.
2.5x105 PTE cells were seeded in the wells of 24-well Costar plates
containing 500pi of PTE cell medium and left to adhere over-night. The next day,
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unbound cells were washed off with HBSS. The cells were then treated with the
following NO donors SNP (3mM), DEA/NO (1.5mM) and Spermine-NO (0.1 p.M),
(both NONOates were obtained from Axxora Ltd, UK) for 24h at 37°C. NO-induced
apoptosis of PTE cells was assessed by flow cytometric analysis after staining with
the Annexin V-PE and 7AAD apoptosis detection kit (Becton Dickinson, UK).
Cell supernatants containing any detached cells were harvested from the
wells, placed in FACS tubes and stored on ice. The adherent PTE cells were
trypsinised and combined with the detached cells. Cells were pelleted by
centrifugation at 300g for 5min at 4°C and the cell pellet was washed twice with lx
Annexin V binding buffer (Becton Dickinson, UK), followed by centrifugation at
300g for 5min at 4°C. The supernatant was carefully aspirated and the cells were
resuspended in lOOpl of Annexin V binding buffer. Subsequently 2pi of Annexin V-
PE and 2pl of 7ADD (Both from Becton Dickinson, UK) were added per tube and
allowed to bind for lOmin at RT in the dark. Detection of viable cells (Annexin V-PE
negative 7-AAD negative), early apoptotic (Annexin V-PE positive, 7AAD
negative), late apoptotic cells that had undergone secondary necrosis (Annexin V-PE
positive, 7AAD positive) and necrotic cells (Annexin V-PE negative, 7AAD
positive) was performed by flow cytometric analysis. The effect of the inclusion of
3mM of SNP upon PTE cell apoptosis is shown in Figure 2-8. Note that control PTE
cells have a high level of cell death.
I also tried to optimise a four-colour FACS assay for assessing PTE cell
apoptosis in co-culture experiments with BMDM with the following labelling
combinations:
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(1) CellTracker green labeled PTE cells (detected in the FL1 channel)
(2) BMDM labeled with F4/80-APC (detected in the FL4 channel)
(3) Annexin V-PE (detected in the FL2 channel)
(4) 7AAD (detected in the FL3 channel)
The 4-colour FACS experiments were problematic. Control non-apoptotic
PTE cells bound Annexin V non-specifically and the level of apoptosis in these
control cultures was high in comparison to the results obtained with microscopical
assessment of apoptosis following Hoechst 33342 staining (data not shown). In
addition control BMDM cultured alone also bound Annexin V non-specifically (data
not shown) and not all the BMDM were released after the trypsinisation process.
BMDM adhere avidly to tissue-culture plastics and I did not want to scrape off the
cells as this might affect their membrane function and integrity. The Annexin V-
PE/7AAD staining kit is usually employed for cells in suspension and not adherent
cell cultures and there is a possibility that the trypsinisation process facilitates the
non-specific binding of Annexin V.
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Figure 2- 8 FACS analysis of PTE cell apoptosis after treatment with
3mM SNP.
PTE cells were incubated with PTE medium (control), or in the presence of
3mM SNP for 24h and the percentages of Annexin V-positive (apoptotic)
cells were analysed by flow cytometry after double staining with Annexin NA¬
PE and 7AAD (Chapter 2.11). Cells were distinguished as being viable
(Annexin V-PEneg/7-AADne9) bottom left quadrant, early apoptotic (Annexin V-
PEpos/7-AADneg) bottom right quadrant, late apoptotic cells that had
undergone secondary necrosis (Annexin V-PEpos/7-AADpos), top right
quadrant and necrotic cells (Annexin V-PEne9/7-AADpos), top left quadrant.
Note that the level of cell death was high (13% early apoptotic and 24% late
apoptotic) in control PTE cells (A). Treatment with PTE cells with 3mM SNP




The following experimental animals were used:
(1) C57BL/6 mice were bred in-house at the University ofEdinburgh.
(2) iNOS KO and WT control mice (on the 129/sv background) were
obtained from B and K Universal, UK.
(3) Homozygous CD1 lb-DTR mice (on the FVB/N background) were bred
at the University ofEdinburgh.
(4) FVB/N mice were obtained from Harland, UK.
All experiments were performed in accordance with the UK Government
Home Office regulations. The mice were housed in cages with free access to food
and drinking water in a constant temperature room with a 12-hour dark/12-hour light
cycle.
2.9 THE MODEL OF EXPERIMENTAL HYDRONEPHROSIS
Experimental hydronephrosis was induced by performing unilateral ligation
of the left ureter to induce unilateral ureteric obstruction (UUO). The left ureter of
mice was ligated at the ureteropelvic junction under inhalational anaesthesia. (All
surgery was kindly performed by Dr. Jeremy Hughes and Experimental Surgeon
Spike Clay).
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2.9.1 Effect of genetic ablation of iNOS in UUO
The effect of genetic ablation of iNOS in the UUO model was studied by
inducing UUO in iNOS KO mice and control iNOS WT mice. The mice underwent
surgery at day 0 and were sacrificed on day 7 (n=7 per group) (Figure 2-9a).
2.9.2 Effect of pharmacological blockade of iNOS in UUO
In order to pharmacologically inhibit iNOS activity in the model of
experimental hydronephrosis, the specific, irreversible iNOS inhibitor L-NIL was
administered in the drinking water. FVB/N mice underwent surgery at day 0 and
were treated with either L-NIL or the control inactive isomer D-N6-(l-iminoethyl)-
lysine (D-NIL) (n=7-8 per group) in the drinking water (lmg/ml) for 48 hours prior
to sacrifice at day 7 (Figure 2-9b). L-NIL and D-NIL were obtained from
Fluorochem Ltd (Old Glossop, UK) and were made up fresh in nitrite free water. The
dose used in this study has previously been reported to significantly inhibit iNOS
activity in murine models of inflammation (Reilly et al., 2002; Westenfeld et ah,
2002). Mice were examined daily and the volume of drinking water drinking
consumed and body weight were monitored. The mean water consumption of mice
from preliminary metabolic cage tests was 3ml/day.
2.9.3 Effect of conditional M<|) ablation in UUO
UUO was induced in CD1 lb-DTR mice at day 0 and DT was administered
on day 5 after induction of UUO when there is a prominent M(|) infiltration. In the
first M(j) ablation experiment, DT was administered i.p on day 5 (20ng/gBW) and on
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day 6 (lOng/g BW) whilst an equal volume of PBS was administered to control
animals (n=5 per group, Figure 2-9c). The mice were culled at day 7. In the second
M(() ablation experiment, DT (25ng/g BW) or an equal volume of PBS was
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Figure 2- 9 Experimental designs for the UUO studies.
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2.9.3.1 Removal of tissue for histological analysis
The obstructed hydronephrotic kidneys were removed at day 7 following
ureteric ligation and normal non-obstructed kidneys were used as controls. The
kidneys were decapsulated, divided sagitally sections and processed in the following
order:
1/6 of the kidney was immediately removed for mRNA analysis and placed
inside 500pl of RNAlater (Ambion, UK),
1/6 of the kidney was embedded in OCT compound (Bright Instrument Ltd,
UK) and snap frozen in liquid nitrogen,
1/3 of the kidney was placed inside a clear glass bottle containing 3ml
Methyl Carnoys solution (a fixative comprising MeOH:Chloroform:Glacial Acetic
acid in the ratio 60:30:10),
1/3 of the kidney was placed in a plastic vial containing 3ml of 10% neutral
buffered formalin solution (4% formaldehyde, 1.5% (MeOH), pH 7.0, Costar,
Fischer Scientific, UK).
The RNAlater samples were incubated at 4°C overnight and then transferred
to -80°C. The OCT snap frozen tissues were transferred to -80°C. The formalin and
Methyl Carnoys biopsies were fixed overnight at 4°C and the fixative was carefully
removed and discarded into special containers in the fume hood the next day. Methyl
Carnoys was replaced with 3ml of 100% (MeOH) and the formalin was replaced
with 3ml PBS. The biopsies were processed by the Department of Pathology
(University of Edinburgh), embedded in paraffin and tissue sections cut as required.
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2.10 IMMUNOHISTOCHEMISTRY
Methyl Carnoys fixed tissue was routinely used for the majority of
immunostaining. Methyl Carnoys fixed kidney tissue sections of 4jam thickness were
deparaffinised by dewaxing in Histoclear solution (Raymond A Lamb Ltd, UK) for
5x3min and rehydrated in decreasing grades of EtOH, 100% EtOH (3x3min), 95%
EtOH (2x2min) and 70% EtOH (lxlmin).
Endogenous peroxidase activity was blocked by incubating the slides in 3%
hydrogen peroxide (H2O2) (20ml of H2O2 +180ml MeOH, freshly prepared) for
20min. The tissue sections were then washed in PBS (3x2.5min) and the tissue
section carefully encircled with a Pap pen (Vector Laboratories, UK). To perform
single immunoperoxidase staining, the tissue sections were incubated with the
primary and secondary antibodies as indicated below. Antibody dilutions were made
in 1% BSA or in ChemMate Antibody diluent (DakoCytomation, UK). The sections
underwent three washes in PBS (3x2.5min) between the application of each
antibody. Negative controls for immunostaining comprised the substitution of an
irrelevant isotype control for the primary antibody. Positive control tissue included
sections from diseased mice that were known to express the antigens. All antibodies
were titrated so that optimal specific staining with minimal background staining was
obtained. The following antibodies were used:
- Rat monoclonal antibody (IgG2b) directed against mouse F4/80, a murine
M(|) marker, (1/500 dilution; Caltag Laboratories, UK) was incubated at 4°C
overnight, followed by a mouse-adsorbed biotinylated rabbit-anti-rat IgG (1/1000
dilution; Vector Laboratories, UK) at RT for 30min.
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- A monoclonal mouse anti-human-a-SMA (clone 1A4, IgG2a) directed
against a-SMA (1/1000 dilution) at 4°C overnight, followed by a biotinylated rat-
anti-mouse IgG2a (Zymed Laboratories, USA) at RT for 30min.
- A goat-anti-human type I collagen antibody which also detects murine
type I collagen (1/250 dilution; Cambridge Bioscience Ltd,UK) at 4°C overnight,
followed by a biotinylated rabbit-anti-goat IgG (1/100 dilution, Vector Laboratories)
at RT for 30min.
- A goat-anti-human type III collagen antibody which also detects murine
type III collagen (1/50 dilution; Cambridge Bioscience Ltd, UK) at 4°C overnight,
followed by a biotinylated rabbit-anti-goat IgG (1/100 dilution, Vector Laboratories)
at RT for 30 min.
- A rabbit-anti-human iNOS antibody which also detects murine iNOS
(1/150 dilution, Abeam, UK) at 4°C overnight, followed by a biotinylated goat-anti-
rabbit (1/300 dilution, Dako Cytomation, UK) at RT for 30 min.
- A chicken polyclonal TGF-|3 antibody which also detects murine TGF-|3
(1/100 dilution, R&D, UK) at 4°C overnight, followed by a biotinylated hamster-
anti-chicken IgG (1/300 dilution, Vector Laboratories, UK) at RT for 30 min.
Following washing in PBS (3x2.5min), tissue sections were incubated in
horseradish peroxidase (HRP) conjugated avidin D (1/2000 dilution in distilled
water; Vector Laboratories, UK) at RT for 20min. Sections were washed in PBS
(3x2.5min) and then colour was developed using diaminobenzidine (DAB) without
nickel as the chromogen. The developing reaction was terminated by placing the
slides in distilled water for 5min and sections were then counterstained with methyl
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green (Raymond A Lamb Ltd, UK) for 5min. Sometimes slides were counterstained
with hematoxylin for 10s followed by a dip in Scott's tap water (0.1% sodium
bicarbonate diluted in distilled water) and rinsing the slides in running tap water for
2-5 min (counterstaining appears blue). Tissue sections were then dehydrated in
increasing grades of EtOH: two quick 'dips' in 95% EtOH (following
counterstaining with Methyl green), 3x2min in 100% EtOH, followed by clearing in
Histoclear 3x3min. The slides were then mounted by adding few drops of histomount
(Raymond A Lamb Ltd, UK) and then coverslipped. Air bubbles were removed by
gently pressing on the top of the glass cover slip with the wooden end of a cotton
bud. The slides were left to dry before analysis.
2.10.1 Double immunofluorescent staining for iNOS and F4/80
Methyl carnoys fixed tissue sections were deparaffinised and rehydrated.
All washing steps between antibody incubations consisted of 3x 5min rinses in Tris-
buffered Saline (TBS) buffer pH 7.6, and the tissue-sections were protected from
light. The sections were first stained with primary iNOS antibody as described for
flow cytometric analysis of iNOS expression (Chapter 2.3.1.2) with the following
modifications: the secondary Alexa Fluor®-488 conjugated goat-anti rabbit antibody,
used to detect iNOS was diluted in TBS. Subsequent staining for F4/80 was carried
out as described in Chapter 2.10, but instead of using HRP-conjugated strepavidin
the sections were incubated with Alexa Fluor®-568-conjugated strepavidin (1/300
dilution in TBS, Molcecuar Probes, USA) for 30min at RT. Finally the sections were
mounted with Vectashield Hard-set mounting medium (Vector Laboratories, UK)
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and coverslipped. The sections were left to dry overnight in the dark before analysis
by fluorescent microscopy.
2.10.2 Picrosirius red staining
Picrosirius red staining is commonly used for the assessment of tissue
fibrosis as the Sirius Red stain is specific for polymeric and monomeric collagen
matrix (Junqueira et al., 1979). Picrosirius red staining for collagen was kindly
performed on 10pm formalin fixed tissue sections by Susan Harvey (Department of
Pathology, University of Edinburgh). The tissue sections were deparaffinised,
rehydrated and stained with 0.1% Sirius red F3B solution for lh at RT. The sections
were then washed twice (2x5min) with acidified water (0.5% acetic acid diluted in
distilled water). Excess water from the slides was removed with a damp filter paper
and the sections were then dehydrated, mounted and coverslipped.
2.11 DETECTION OF APOPTOSIS AND CELL PROLIFERATION
2.11.1 TUNEL staining
Apoptotic cells were detected by the terminal deoxynucleotidyl transferase
(TdT)-mediated dUTP biotin nick end labeling (TUNEL) assay (Gavrieli et al.,
1992). 4pm formalin fixed tissue sections were deparaffinised, rehydrated in EtOH
and endogenous peroxidase activity was blocked as described previously. Antigen
retrieval was performed by boiling the slides in sodium citrate (lOmM, pH 6.0) for
3min in a 750W microwave. The slides were cooled for 15min in an ice-slurry and
rinsed in 2 changes of PBS (2x3min). Excess fluid from the slides was removed by
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wiping the periphery of the slide with absorbent paper and the tissue section was
carefully encircled with a pap pen. Sections were then incubated with 6.2 pg/ml of
proteinase K (2\x\ of Proteinase K stock [Roche Molecular Biochemicals, UK] in 6ml
of sterile water) to strip nuclear protein for a maximum 20min followed by washing
in PBS (2x3min). Slides were then pre-incubated in lx One-Phor-All buffer (diluted
with sterile water from the lOx stock, Amersham Pharmacia Biotech, UK) for 5min
at RT. The buffer was removed and slides were incubated with TdT reaction mixture
[300 enzyme units/ml TdT; (Amersham Pharmacia Biotech, UK) and 0.94mM Bio-
14-dATP, Gibco BRL, Life Technologies, UK)] for lh at RT. The TdT reaction was
terminated by washing the slides in PBS (2x3min). The sections were then blocked
in 2% BSA in water for lOmin at RT followed by washes in PBS (2x3min).
Biotinylated ATP was detected after incubating the slides with R.T.U Vectastain
Elite ABC Reagent (Vector Laboratories, UK) for 30min at RT. Following washes in
PBS (2x3min), the slides were incubated in Tris buffer (0.05M, pH 7.6) for 5min at
RT. Colour was developed using DAB with nickel as the chromogen. The reaction
was terminated by placing the slides in distilled water for 5min. The sections were
counterstained by 'dipping' once in 25% eosin diluted in distilled water (Raymond A
Lamb Ltd, UK) and were then dehydrated, mounted and coverslipped. The positive
control tissue section was pre-treated with DNase I buffer (lOmM Tris-HCl pH 7.4;
ImM MgCl2 and lmg/ml BSA) for 5min at RT. The buffer was removed and 20
Kunitz units/ml of DNAse I (Roche Molecular Biochemicals, UK, 1:100 dilution in
DNase I buffer) was added and incubated for 1Omin at RT followed by two washes
in distilled water (2x3min). The positive control slide was thereafter incubated with
the TdT reaction mixture as described above but incubated separately since DNase
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contamination may result in false positive staining. As a negative control the TdT
was omitted. Kidney tissue sections from day 14 obstructed mice were used as
positive tissue control since these kidneys showed increased number of apoptotic
cells, whereas non-obstructed kidneys served as a negative tissue control as minimal
number of apoptotic cells were present.
The TUNEL technique may result in 'false positive' staining if cells are
necrotic or proliferating. I therefore regarded cells as 'apoptotic' if their nuclei were
TUNEL positive and exhibited an apoptotic morphology characterised by typical
nuclear pyknosis and chromatin condensation. The number of TUNEL positive cells
in each biopsy was quantified in a blinded fashion by counting the number of
TUNEL positive tubular in 20 sequentially selected non-overlapping fields of renal
cortex at 1 OOx magnification and expressed as the mean number per hpf.
2.11.2 PAS staining
PAS stained tissue sections were used to quantify proximal and distal
tubular epithelial cell apoptosis and proliferation as proximal tubular cells exhibit a
characteristic PAS-positive luminal brush border (Hughes et al., 1999). Tissue
sections (4pm thickness) of Methyl Carnoys or formalin fixed tissue sections were
deparaffinised and rehydrated to distilled water as described previously. Slides were
then immersed in PAS solution for 5min at RT followed by three washes with
distilled water (3x2min). Slides were then immersed in Schiff s solution for lOmin at
RT. The reaction was terminated by washing the slides in running tap water for
lOmin. Slides were counterstained with hematoxylin solution for lmin, rinsed under
tap water, dehydrated, cleared and mounted.
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Apoptotic proximal and distal tubular epithelial cells were characterised by
their pyknotic condensed nuclei whilst mitotic cells were readily identifiable.
Proximal and distal cell apoptosis and proliferation was calculated in a blinded
fashion by counting the number of apoptotic or mitotic proximal and distal tubular
epithelial cells in 20-30 sequentially selected non-overlapping fields of renal cortex
at 400x magnification and expressed as the mean number per hpf.
2.12 MORPHOMETRIC ANALYSIS USING COMPUTER ASSISTED IMAGE
ANALYSIS
Assessment of immunohistochemical staining can be performed using
computerised image analysis (Hunter et ah, 2005; Johansson et ah, 2001).
Computerised image analysis can calculate the number of 'immunostained objects'
per section as well as the area of the immunostained objects expressed as a
percentage of the total area examined. Interstitial M<j) infiltration was quantified in a
blinded fashion by analysing 10 sequentially selected non-overlapping fields of renal
cortex of F4/80 stained tissue sections at lOOx magnification using computer assisted
image analysis (ImageJ 1.30h National Institutes of Health, USA,
http://rsb.info.nih.gov/ii/Javal,3.1 03). Images were digitally captured using the
Open Lab version 3.0 software (Improvision, UK). The original colour image was
converted to a red, green and blue (RGB) stack and split into 3 separate grey-scale
images, each representing red, green and blue, using the ImageJ software. The grey-
scale has 256 shades of grey, where 0=is pure black and 255=pure white. The green-
grey images were used for analysis. Lower and upper grey-scale thresholds were set
to highlight the pixels specific for the detection ofF4/80 positive stained area (Figure
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2.10b) and for intratubular luminal space (tubular dilatation) (Figure 2.10c).
Automated Plug-ins were recorded for the thresholds with the ImageJ software so
that the number of thresholded pixels in each image was automatically measured. M<f>
infiltration is expressed as the percentage of tissue surface area positive for F4/80
immunostaining. Interstitial myofibroblast accumulation and interstitial fibrosis were
quantified in a similar fashion using tissue sections immunostained for a-SMA and
collagens type I, III and IV as well as picrosirius red staining. In addition, I
quantified the degree of tubular dilatation (as a percentage of total cortical area) in
order to exclude differences between groups as this would result in variation in the
amount of interstitial tissue examined.
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Figure 2-10 Morphometric analysis of F4/80 stained sections.
The original light bright field image stained for F4/80 is shown in (A). F4/80
positive pixels are highlighted in (B) whilst pixels detecting tubular space are
highlighted in (C) (x100 original magnification).
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2.13 GRIESS ASSAY
NO is rapidly converted into the stable end products nitrite and nitrate and
these may be used as indirect measures of the amount of NO produced. I used the
Modified Griess reagent from Sigma to measure nitrite. This assay is based on the
reaction between nitrites and the Griess reagent containing sulfanilic acid and N-(l-
naphtyl) ethylendiamine, which produces a deep purple chromophoric azo-derivative
molecule that absorbs light at 540 nm (Green et al., 1982). Nitrite accumulation in
cell-free supernatants from non-activated or cytokine activated BMDM was analysed
by the Griess assay. 2.5x105 day 7 mature BMDM were plated in the wells of 24-
well Costar tissue-culture plates and left to adhere overnight. The next day, unbound
cells were washed off with PBS -/- and the BMDM were incubated in control
medium alone or medium containing activating cytokines (LPS [lpg/ml] and IFN-y
[lOOU/ml] in a total volume of 500pl medium per well. After 24h incubation the
supernatants were harvested and clarified by centrifugation. lOOpl of cell-free
BMDM supernatant was incubated with an equal volume of the Griess reagent in a
96-well flat-bottom Costar assay plate. After 15min incubation at RT, the absorbance
(A) was read at 560nm in an automated plate reader. The nitrite concentrations were
calculated from a standard curve using 9 standard samples of sodium nitrite (serial
dilutions :75, 50, 25, 12.5, 6.25, 3.12, 1.56, 0.78, 0.39pM). The Griess reagent is a
sensitive assay between concentrations of 0.5 pM to 65 pM nitrite. A representative












Figure 2-11 Nitrite standard curve used in the Griess assay.
Standard curve of sodium nitrite against absorbance at 560nm.
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2.14 GENOTYPING CD11b-DTR MICE
The genotype of CDllb-DTR mice was determined by PCR using genomic
DNA derived from an ear punch. The genotyping primers amplify a 970bp fragment
from the DTR-eGFP fusion protein sequence (1.4 Kb total).
2.14.1 Genomic DNA extraction
Ear samples were placed inside 1.5ml eppendorf tubes and incubated in
200pl of lysis buffer (0.2 % SDS, 0.1M Tris-buffer pH 8.5, 5 mM EDTA, 200 mM
NaCl and 50pg/ml of proteinase K) overnight at 55°C in a 'shaking incubator'. The
next day the samples were centrifuged at 13,000g for lOmin at RT. The supernatant
was thereafter gently transferred to a fresh 1.5ml eppendorf tube and an equal
volume of 100% isopropanol was added. The solution was gently mixed by inversion
(no vortex) and left undisturbed for lh at RT in order to give clean DNA). Following
centrifugation at 13,000g for lOmin at RT, the supernatant was carefully removed
and 200pl of ice-cold 70% EtOH was added. The samples were then centrifuged at
13,000g for 5min at RT and all of the supernatant was carefully removed and left to
air-dry until no liquid could be visualised. The DNA was finally resuspended in 50pi
of 10 mM TE (Tris-EDTA) buffer and incubated at 50°C for 20min.
The DNA was diluted 1/100 with milli-q-water and the yield and quality of
DNA was determined by spectrophotometric analysis at A260 and A280-
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2.14.2 PCR
lOOng of genomic DNA per PCR reaction was used to amplify the 970bp
segment of with primers specific for the DTR-eGFP fusion protein and in a separate
tube lOOng of DNA/PCR reaction was used to amplify the 450bp segment with
primers specific for the human house keeping gene GAPDH which also detect
murine GAPDH. All primers were obtained from TAGN (TAGN, UK) and the
primer sequences are shown below:
Forward Primer (5'DTR): 5'-TTCCACTGGATCTACGGACC-3'
Reverse Primer (3'eGFP): 5 '-TGTCGGCCATGATATAGACG-3'
Forward Primer (GAPDH) 5'-TGCCTCCTGCACCACCAACTGC-3'
Forward Primer (GAPDH) 5AATGCCAGCCCCAGCGTCAAAG -3'
The PCR reagents obtained from Qiagen (Qiagen, UK) and each PCR
reaction consisted of: 40.2pl milli-q-water, 5pi of lOx PCR reaction buffer, 1 pi
MgCh (2mM final concentration), 0.4pl dNTPs (0.2mM of each), lpl forward
primer (lOOpmoles), lpl reverse primer (lOOpmoles), lpl of genomic DNA
(lOOng/reacion) and 0.4pl of Taq polymerase (lUnits/reaction). The PCR conditions
were as follows: hot start at 110°, initial denaturation (96°C, 2min), 3 step cycling -
denaturation (96°C, 30s), primer annealing 56°C and primer extension (72°C,
1.5min) repeated for 35 cycles. The last condition was for final extension at 72°C for
9min.
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2.14.3 Preparation of agarose gels and DNA electrophoresis
1% agarose gel was prepared in lx Tris-acetate-EDTA (TAE) and agarose
was dissolved by boiling inside the mirowave. Inside a fume-hood cabinet, ethidium
bromide (lOpg/ml final concentration) was added once the agarose had cooled to a
hand held temperature and then poured into gel electrophoresis plates. Finally a
'well-comb' was inserted and the gel was allowed to set.
lOpl of final PCR reaction product was mixed with 5pi of loading buffer
dye and in order to estimate the size of the DNA products, 5pi of lkb ladder
(Promega, UK) was diluted with 5ul loading buffer dye. The samples were then
loaded into the wells of the 1% agarose gel, which had been placed inside a gel
electrophoresis tank containing lxTAE. Electrophoresis was carried out at 90 volts
for lh and the DNA bands were later visualised after inspection under UV-light. A
typical result from PCR of ear genomic DNA from CDllb-DTR mice run on 1%





Figure 2-12 Genotyping CD11b-DTR mice by PCR of genomic DNA run
on 1% agarose gel containing ethidium bromide.
Lane 1 shows 1kB ladder and genomic ear DNA from CD11b-DTR mice




Results are presented as mean ± standard error. Statistical analysis was
based on a series of independent experiments, where each value contains a
pooled/averaged intra-assay replicate data (applied to n=/>3 independent
experiments. Statistical analysis was performed using GraphPad Prism 4.0
(GraphPad software, USA). The Student's t-test was employed for comparisons
involving two groups and statistical differences among multiple groups of data were
assessed by one-way ANOVA followed by Student Newman Keuls post-hoc test.
Correlation between data sets was analysed with Pearsons correlation coefficient. All








Although previous studies have shown that inflammatory M(|) induce
apoptosis of tubular epithelial cells in vitro (Lange-Sperandio et al., 2003; Tesch et
al., 1999), there is no data regarding the pro-apoptotic mechanism employed by the
Mcj). Lange-Sperandio et al used a co-culture assay involving the murine J774 M(j)
cell line with murine PKSV-PR proximal tubular cells (an immortalised cell line) and
although cytokine activated M(j> induced tubular cell apoptosis in vitro the death
effector mechanism remained unclear (Lange-Sperandio et ah, 2003). This work,
however, did not demonstrate any role for TNF-a, FasL, TRAIL or TGF-J3. Tesch et
al co-cultured murine primary tubular epithelial (PTE) cells with activated murine
BMDM but was unable to define the mechanism although the pro-apoptotic mediator
was soluble and was present in medium conditioned by activated BMDM (Tesch et
ah, 1999).
In the studies outlined in this chapter I used a well established
microscopically quantifiable in vitro co-culture assay previously developed by Dr.
Jeremy Duffield in our group to study the cytotoxic interaction between murine
BMDM and both MDCK cells (a canine distal tubular cell line) and murine primary
tubular epithelial (PTE) cells. In this chapter I will describe the results of these




3.2.1 Cytokine activated M<|) induce apoptosis of MDCK cells and
inhibit MDCK cell proliferation
To determine whether Mcj) could induce apoptosis of MDCK cells, BMDM
and MDCK cells were co-cultured for 24 hours. The MDCK cells were pre-labeled
with fluorescent CellTracker Green whilst in some experiments mature (7-10 day)
BMDM derived from FVB/N mice were pre-labeled with CellTracker Orange.
Target MDCK cells were trypsinised and added to 48-well plates such that the
adherent cells covered 60-70% of the well surface area. Wells were washed after 4
hours to remove any non-adherent MDCK cells. Mature BMDM were then added to
wells containing MDCK cells at a ratio of 2 BMDM to 1 MDCK cell. Control
cultures comprising MDCK cells cultured in the absence of BMDM were also
prepared. Once the BMDM were adherent (3-4h), the wells were washed and
DMEM/F12 medium containing 10% FCS was added. Some wells were activated
with LPS (lpg/ml) and IFN-y (lOOU/ml); a stimulus previously shown to be optimal
for classical M(|) activation (Duffield et al., 2000). After 24 hours incubation the
undisturbed co-cultures underwent in situ fixation with formaldehyde for 48 hours in
order to ensure retention of all cells including any 'free' apoptotic cells. Fixed co-
cultures were then stained with the blue fluorescent DNA binding dye Hoechst
33342, thereby allowing the identification of healthy, apoptotic and mitotic MDCK
cells. Using inverted fluorescent microscopy, the number of apoptotic or mitotic
MDCK cells was counted and expressed as either the number of apoptotic or mitotic
cells per high power field (hpf) or as a percentage of the total number ofMDCK cells
(% apoptosis and % mitosis respectively).
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The first finding was that co-culture of MDCK cells with non-activated
BMDM did not induce significant levels of MDCK cell apoptosis (Figure 3-la)
indicating that non-activated BMDM are not inherently cytotoxic. Also, the presence
of non-activated BMDM did not significantly affect the level of MDCK cell
proliferation (Figure 3-lb) although there was a trend to reduced levels of MDCK
cell proliferation. In addition, MDCK cells cultured alone in the presence of the
activating cytokines (LPS and IFN-y) did not exhibit an increased level of apoptosis
(Figure 3-la) or a reduced level of proliferation (Figure 3-lb). However, when
MDCK cells were co-cultured with cytokine activated BMDM, there was a
significant increase in the level ofMDCK cell apoptosis after 24 hours (Figure 3-la).
Apoptotic MDCK cells exhibited characteristic cytoplasmic condensation (Figure 3-
2a and 3-2b) and nuclear pyknosis (Figure 3-2c). Cytokine activated BMDM also
inhibited MDCK cell proliferation (Figure 3-lb) but there was no difference in target
cell number (Table 3-1). The results of experiments depicted in Figure 3-1 are also
presented in Table 3-1 but the levels of target MDCK cell apoptosis and mitosis have
been expressed as a percentage of total cell number rather than the number of
apoptotic cells or mitotic cells per hpf since this is how other investigators have
presented their data (Bergin et al., 2000; Tanaka et al., 2005). It should be noted that
the level of target cell death in my studies was comparable to previously published
work examining Mcj) induction of mesangial and tubular cell death (Duffield et al.,
2000; Lange-Sperandio et al., 2003). However, I have expressed the remaining
results of the in vitro co-culture experiments described in this chapter as the 'number
of apoptotic cells or mitotic cells per high power field'. This readout is more robust
as it is not confounded by any effect ofBMDM upon the total cell number: total cell
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number would be reduced by inhibition of cell proliferation and/or the induction of




Figure 3-1 Cytokine activated BMDM induce MDCK cell apoptosis and
inhibit MDCK cell proliferation.
MDCK cells were cultured alone or in the presence of mature BMDM from
FVB/N mice (BMDM : MDCK cell ratio= 2 : 1) in the presence or absence of
LPS (1pg/ml) and IFN-y (100U/ml). After 24h of incubation the co-culture was
fixed with formaldehyde solution. Following counterstaining with Hoechst
33342, the level of MDCK cell apoptosis and mitosis was scored by
fluorescence microscopy. Cytokine activated BMDM induce significant




Figure 3- 2 Fluorescent photomicrographs of activated co-culture of
BMDM and MDCK cells.
CellTracker green labeled MDCK cells were cultured in the presence of
cytokine activated mature unlabeled BMDM from FVB/N mice. After 24h
incubation the co-culture was fixed with formaldehyde solution and
counterstained with Hoechst 33342. (A) Low power view (x100
magnification) of bright green apoptotic MDCK cells exhibiting cytoplasmic
condensation. (B) High power view (x320 magnification) of one green
apoptotic MDCK cell. (C) The nucleus of a rounded apoptotic MDCK cell is
pyknotic (green arrow). The nucleus of an adjacent unlabelled BMDM is also
evident (red arrow). (D) The merged image demonstrates the close proximity
of the BMDM to the MDCK cell.
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Table 3-1 The effect of cytokine-activated BMDM upon MDCK cell
apoptosis, proliferation and cell number at 24h.
Non-activated Activated
% Apoptosis
MDCK cells alone 0.96 ± 0.3% 1.4 ±0.3%
Co-culture 1.5 ±0.3% 12.3 ±4.1%*
% Mitosis
MDCK cells alone 7.2 ± 3.0% 4.6 ± 1.1%
Co-culture 4.5 ± 0.6% 0.90 ± 0.5%*
Cell number per 5 hpf
MDCK cells alone 148 ±44 168 ±50
Co-culture 113 ± 19 94 ±26
*p<0.05 vs non-activated co-culture (n=4)
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3.2.2 BMDM-derived NO is an important mediator of MDCK ceil
apoptosis, but does not modulate MDCK cell proliferation
Previous work in the Centre for Inflammation Research indicated the
involvement of NO in the induction of mesangial cell apoptosis (Duffield et al.,
2000). I employed two approaches to determine whether M(j)-derived NO also
induced apoptosis ofMDCK cells. First, I used potent pharmacological inhibitors of
NO production in co-culture experiments with MDCK cells. In addition, I
determined the cytotoxic effect of BMDM derived from either iNOS KO mice or
iNOS WT mice in co-culture experiments with MDCK cells.
3.2.2.1 Cytokine-activated BMDM produce NO
I initially determined the level of NO production from cytokine stimulated
BMDM derived from different strains of mice. BMDM from FVB/N, C57BL/6,
iNOS WT and iNOS KO mice were plated onto 24 well-plates (2.5x105 mature
BMDM/well) and left to adhere overnight. The cells were washed and cultured in
0.5ml of DMEM/F12 media containing 10% FCS and some wells were activated
with LPS (1 pg/ml) and IFN-y (lOOU/ml). After 24h incubation, the BMDM
supernatants were harvested and clarified by centrifugation. The generation of NO
was determined by the Griess assay which measures nitrite; a stable product of NO
release. Non-activated BMDM do not produce significant amounts of NO. In
contrast, cytokine-activated BMDM of all strains of mice with the predictable
exception of iNOS KO mice produced significant amounts ofNO (Table 3-2). It is of
interest, however, that activated iNOS KO M<|) did produce NO (Table 3-2). The
reasons underlying this are unclear but there is a possibility that other NOS isoforms
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such as eNOS could be upregulated, which generate NO less efficiently (Wei et al.,
1995). It should be noted that previous work by Jeremy Duffield also demonstrated
that cytokine activated BMDM from commercially obtained iNOS KO mice (also
from B and K Universal, Hull) generate NO. Indeed, cytokine activated iNOS KO
BMDM exhibited a 13-fold increase in the level ofNO production compared to non-
activated control iNOS KO M(j) (Duffield et ah, 2000).
I also cultured cytokine activated FVB/N BMDM in the presence or absence
of the non-competitive NOS inhibitor Nitro-L-arginine methyl ester hydrochloride
(L-NAME), (concentration range 100pM-2mM). Nitrite generation by activated
FVB/N BMDM was significantly reduced by the inclusion of the non-competitive
NOS inhibitor L-NAME (Table 3-3).
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Table 3- 2 Nitrite produced by BMDM after 24h.
Non-activated Activated (LPS+IFN-
Y)
FVB/N BMDM 54.5 ± 5 2038±130*
C57BL/6 BMDM 61 ± 12 1811 ±42*
iNOS WT (129/sv) BMDM 50 ± 10 2093 ± 99*
iNOS KO BMDM 29 ±8 588 ±115*
Nitrite accumulation pM/10e cells *p<0.05 (n=5) vs non-activated.
Table 3- 3 The effect of L-NAME on nitrite production by activated
FVB/N BMDM at 24h.
pM nitrite/106 cells
Non-activated 41 ±9*
Activated (LPS+IFN-y) 1672 ±113
2 mM L-NAME 356 ±17*
1 mM L-NAME 607 ±19*
0.5 mM L-NAME 656±17*
0.2 mM L-NAME 774 ± 18*
0.1 mM L-NAME 1036±19*
*p<0.05 (n=3) vs activated.
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Since the Griess analysis demonstrated that cytokine activated iNOS KO
BMDM were able to produce nitrite, I assessed the level of iNOS expression by flow
cytometry and immunofluorescence. Flow cytometric analysis for iNOS expression
demonstrated that non-activated iNOS WT BMDM (Figure 3-3a) and iNOS KO
BMDM (Figure 3-3c) did not express iNOS. However, following cytokine activation
(LPS+IFN-y) for 24h, the level of iNOS expression was markedly increased in
activated iNOS WT BMDM (Figure 3-3b). Cytokine activated iNOS KO BMDM
also expressed iNOS (Figure 3-3d) although the flow cytometric profile suggested
that the expression of iNOS was limited to a sub-set of BMDM derived from iNOS
KO mice. Furthermore, immunofluorescent staining for iNOS indicated that the level
of iNOS expression in activated iNOS KO BMDM was significantly less (Figure 3-
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Figure 3- 3 Phenotyping iNOS WT BMDM and iNOS KO BMDM by flow
cytometric analysis of iNOS expression.
Mature BMDM from iNOS WT and iNOS KO mice were cultured for 24 h in
the presence or absence of LPS+IFN-y. The BMDM were stained with rabbit-
anti-human iNOS antibody or an isotype control, followed by an Alexa-488
conjugated secondary antibody. Flow cytometric analysis of iNOS expression
showed that non-activated iNOS WT BMDM (A) and iNOS KO BMDM (C) do
not express iNOS. There was a marked increase in the level of iNOS
expression in activated iNOS WT BMDM (B). Note that activated iNOS KO
BMDM also expressed iNOS although the level of expression was




Figure 3- 4 Phenotyping iNOS WT BMDM and iNOS KO BMDM by
immunofluorescence staining for iNOS.
Mature BMDM from iNOS WT and iNOS KO mice were cultured for 24h in
the presence of LPS+IFN-y. The BMDM were stained with rabbit-anti-human
iNOS antibody (A) and (C) or an isotype control (B) and (D), followed by an
Alexa-488 conjugated secondary antibody. The level of iNOS expression was
evaluated by immunofluorescence microscopy after counterstaining with
Hoechst 33342. Cytokine activated iNOS WT BMDM strongly express iNOS
(examples arrowed) (A), compared to isotype control antibody (B).
Occasional expression of iNOS is evident in some cytokine activated iNOS
KO BMDM (examples arrowed) (C), whereas no immunofluorescent staining
is evident in iNOS WT or iNOS KO BMDM stained with an isotype control
antibody (B, D). (x320 original magnification).
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These experiments establish that cytokine (LPS+IFN-y) activated BMDM
produce significant levels of NO and that activated iNOS KO BMDM produce
significantly less NO. My data does, however, indicate that a sub-set of activated
iNOS KO BMDM can express iNOS protein and generate NO in response to
stimulation with LPS and IFN-y. I then wished to determine whether BMDM-derived
NO was involved in the induction ofMDCK cell apoptosis. I therefore performed co-
culture experiments with MDCK cells and BMDM derived from either iNOS KO
mice or control iNOS WT mice. In addition, pharmacological inhibition of NO was
achieved by the addition of the non-competitive NOS inhibitor L-NAME to the
culture medium. The co-cultures were established as previously described.
Co-cultures of activated iNOS WT BMDM and MDCK cells exhibited a 3.5
fold higher level of MDCK cell apoptosis compared to co-cultures of MDCK cells
with activated iNOS KO BMDM (Figure 3-5). In addition, cytokine activated iNOS
KO BMDM did not induce apoptosis above the background level evident in cytokine
treated MDCK cells alone, thereby suggesting a key role for BMDM-derived NO in
the induction of MDCK death (Figure 3-5). Furthermore, the cytotoxic effect of
activated iNOS WT BMDM was completely abrogated by the inclusion of the non¬
competitive NOS inhibitor L-NAME (final concentration 200pM), thereby
reinforcing the importance ofNO as a death effector in these cytokine activated co-
cultures (Figure 3-5). Importantly, inclusion of the control isomer D-NAME (final
concentration 200pM) did not prevent the cytotoxic action of cytokine activated
iNOS WT BMDM (Figure 3-5).
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MDCK cell proliferation was significantly inhibited by co-culture with
BMDM with the anti-proliferative effect being independent of cytokine activation of
BMDM with LPS/IFN-y (Figure 3-6). Furthermore, this anti-proliferative effect was
unaffected by the inclusion of the NOS inhibitor L-NAME in the co-culture or the
use of iNOS WT or KO BMDM (Figure 3-6). This indicates, in contrast to previous
work examining the effect of cytokine activated BMDM upon mesangial cells
(Duffield et al., 2000) that NO was not involved in the modulation of MDCK cell
proliferation. It is interesting, however, that my previous experiments demonstrated
no significant reduction in MDCK cell mitosis in non-activated co-cultures (Figure
3-lb). It should be noted that these experiments still demonstrated a trend towards a
reduced level of MDCK cell mitosis in non-activated co-cultures. Previous work
suggest that MDCK cell proliferation may be modulated by TGF-|3 (Nicolas et al.,
2003; Yang et al., 1998) and it is possible that non-activated iNOS WT and KO
BMDM secrete more TGF-(3 than non-activated BMDM derived from FVB/N mice.
I did not pursue this observation as the main focus of these studies was the
investigation of BMDM-mediated tubular cell apoptosis. Lastly, no difference was
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Figure 3- 5 BMDM-derived NO is an important mediator of MDCK cell
apoptosis.
CellTracker-green labeled MDCK cells were cultured alone or in the
presence of CellTracker-orange labeled BMDM derived from either iNOS WT
or iNOS KO mice. Co-culture was established (BMDM : MDCK cell ratio of 2 :
1). Cultures were activated with LPS (1pg/ml) and IFN-y (100U/ml) in the
presence or absence of the NOS inhibitor L-NAME or control D-NAME (final
concentration 200pM for both reagents). iNOS KO BMDM are not cytotoxic
under any conditions, whilst the cytotoxicity of iNOS WT BMDM is abrogated
by pharmacological inhibition of NO production,*p<0.05 vs non-activated
iNOS WT BMDM co-cultures (n=3).
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Figure 3- 6 BMDM-derived NO does not modulate MDCK cell
proliferation.
CellTracker-greeri labeled MDCK cells were cultured alone or in the
presence of CellTracker-orange labeled BMDM derived from either iNOS WT
or iNOS KO mice. Co-culture was established (BMDM : MDCK cell ratio of 2 :
1). Cultures were activated with LPS (1pg/ml) and IFN-y (100U/ml) in the
presence of the NOS inhibitor L-NAME (final concentration 200pM). BMDM
inhibition of MDCK cell proliferation is independent of cytokine activation,
BMDM genotype or pharmacological inhibition of NO production * p<0.05 vs
MDCK cells alone (n=3).
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Table 3-4 The effect of cytokine-activated BMDM from iNOS WT or
iNOS KO mice in the presence or absence of L-NAME or D-NAME, upon





MDCK cells alone 309 ± 82 254 ± 61 257 ± 67
iNOS WT BMDM 231 ±37 215 ± 31 193 ±45
iNOS KO BMDM 211 ±58 216 ±27 184 ±25
(n=3) Cell number per 8 hpf.
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3.2.3 Conditioned supernatant transfer from activated BMDM does
not induce apoptosis of MDCK cells
Previous work by Tesch et al (Tesch et al., 1999) suggested that activated
BMDM generated soluble mediators that played a role in the induction of tubular cell
apoptosis. In order to determine whether soluble mediators, present in the
supernatants from activated BMDM could induce apoptosis of MDCK cells, I
undertook experiments involving the transfer of conditioned supernatants from
LPS/IFN-y activated BMDM to MDCK cells. 2.5x105 mature BMDM were cultured
in 0.5ml of BMDM media with 10% FCS in the presence or absence of LPS
(lpg/ml) and IFN-y (lOOU/ml). After 24h incubation, the BMDM supernatants were
harvested and clarified by centrifugation. Cell-free supernatants from either activated
or non-activated BMDM or media with or without LPS/IFN-y was then added
directly to 24-well plates containing MDCK cells (1.25xl05 MDCK cells/well; i.e. a
ratio ofBMDM conditioned supernatant: MDCK cell ratio of 2:1). The MDCK cells
were fixed after 24 hours of incubation and the level of apoptosis and mitosis was
analysed by fluorescent microscopy following Hoechst 33342 staining.
Conditioned supernatants from cytokine-activated BMDM failed to induce
MDCK cell apoptosis (Figure 3-7a). This suggested that the death effector of
cytokine-activated BMDM could be a short-lived molecule that was rapidly degraded
or inactivated during the conditioned supernatant transfer process or it might be
bound to the cell surface. Neither MDCK cell proliferation nor total cell number was
affected by incubation with conditioned supernatants from non-activated or activated
BMDM (Figure 3-7b, c). These experiments were performed with BMDM derived
from two separate mice. Statistical analysis was not performed since n is <2 for
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independent experimental data. It should be noted that this was the result of time
constraints and work was prioritised. However, I would have liked further time to
























Figure 3- 7 Conditioned supernatants from activated BMDM fail to
induce MDCK cell apoptosis.
Mature BMDM (2.5x10 /well) were cultured in the presence or absence of
LPS (Vg/ml) and IFN-y (100U/ml). After 24h incubation, the conditioned
BMDM supernatants were harvested, clarified by centrifugation and added to
MDCK cells (1.25x105/well). Cells were cultured with either BMDM
conditioned supernatants, media alone or media supplemented with
cytokines. After 24h wells were fixed with formaldehyde and counterstained
with Hoechst 33342. The level of MDCK cell apoptosis and proliferation was
scored by fluorescent microscopy. Conditioned supernatants from activated
BMDM failed to induce MDCK cell apoptosis (A) and had no effect upon
MDCK proliferation (B) or total cell number (C) (n=2, error bars are standard
deviations of the mean).
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3.2.4 Direct cell contact or 'close proximity' may be required for the
induction of MDCK cell apoptosis by activated BMDM
Since the transfer of conditioned supernatant from activated BMDM failed
to induce MDCK cell apoptosis, I wanted to determine whether direct cell contact
between BMDM and the target cell was required. Co-cultures were set up as
previously described but the target MDCK cells were separated from the BMDM by
a tissue culture insert (TCI). A schematic diagram for this experiment is illustrated in
Figure 3-8. The inserts have a semi-permeable membrane with a pore size of 0.4pM
and the distance between the insert and the well inside TCI companion plate is 8mm.
This allows the sharing of the same culture medium, but prevents the cells from
being in direct contact with each other. MDCK cells were trypsinised and 5x104
MDCK cells were plated onto each TCI. The cells were left to grow until confluent.
Meanwhile, mature BMDM (1.25xl05/well) were plated to the bottom of the wells of
a TCI companion plate. The inserts containing the MDCK cells were then placed
above the Mcj). This arrangement represents the spatial relationship present in vivo.
Confluent tubular epithelial cells grown on TCI become polarised with apical and
basolateral domains. In vivo interstitial infiltrating M<j) will be adjacent to the basal
aspect of tubular epithelial cells. In order to reproduce this spatial arrangement in
vitro, the M(|) were placed in the bottom of the wells of the companion plates. Thus
the basal aspect of the overlying tubular epithelial cells would be directly exposed to
secreted products from the M(|). Control wells had MDCK cells on the inserts but no
BMDM in the bottom of the wells. The cultures were then activated with lpg/ml of
LPS and lOOU/ml of IFN-y. The medium was placed in both the upper and lower
compartments. After 24h incubation the cultures were fixed with formaldehyde and
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target cell apoptosis and mitosis was analysed by fluorescence microscopy following
Hoechst 33342 staining.
Cytokine activated BMDM failed to induce MDCK cell apoptosis when the
MDCK cells were separated from the BMDM by tissue-culture inserts (Figure 3-9a),
thereby indicating that cell-to-cell contact or 'close proximity' between BMDM and
the target cell was likely to be important. This experiments was performed with 3
replicates but the BMDM were derived from the same mouse. Statistical analysis
was not performed since n is <2 for independent experimental data. It should be
noted that this was the result of time constraints and work was prioritised. However,
I would have liked further time to ensure that these data were not statistically
significant even after 3 or 4 independent experiments.
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culture inserts (TCI).
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Figure 3-8 A schematic diagram illustrating the steps involved in co-
culture experiments using tissue culture inserts.
5x104 MDCK are seeded onto each tissue-culture insert (TCI) and left to
grow until confluent (A). Meanwhile BMDM are seeded into the bottom of TCI
companion plates (B). Co-culture without contact is facilitated by transferring
the TCI containing the MDCK cells above the BMDM (2.5x105/well) inside the
TCI companion plate (C,i). Control MDCK cells on TCI (C,ii) do not have
BMDM in the bottom of the companion plate. The cultures were activated
with cytokines and incubated for 24h. The cultures were fixed with
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Figure 3- 9 Cell contact or 'close proximity' is required for BMDM to
induce MDCK cell apoptosis
5x104 CellTracker green labeled MDCK cells were plated onto the semi¬
permeable membranes of TCI and left to grow until confluent. 1.25x105
mature BMDM were plated in the wells of the TCI companion plates. Some
inserts containing the MDCK cells were then placed above the BMDM. LPS
(Vg/ml) and IFN-y (100U/ml) was added to all cultures and incubated for
24h. The wells were fixed with formaldehyde and counterstained with
Hoechst 33342. The level of MDCK cell apoptosis and proliferation was
analysed by fluorescent microscopy. Activated BMDM separated from target
MDCK cells failed to induce MDCK cell apoptosis, (A). No effect was evident
upon MDCK proliferation (B) or total cell number (cells/insert) (C). (n=1, error
bars are standard deviations of the mean).
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3.2.5 Cytokine activated BMDM induce apoptosis of murine primary
tubular epithelial (PTE) cells but do not modulate PTE cell
proliferation
The data presented so far indicates that cytokine-activated murine BMDM
are capable of inducing significant apoptosis of MDCK cells and that BMDM-
derived NO is an important key mediator of this cytotoxic effect. Even though the
MDCK cells are a well-established tubular cell line, they are of canine origin and
may therefore not be susceptible to other putative murine BMDM-derived death
effectors such as FasL and TNF-a. I therefore undertook a similar series of
experiments using murine primary tubular epithelial (PTE) cells.
The PTE cells were cultured and characterised as described previously
(Harrison et al., 2006). Since PTE cells were of primary origin, the handling of these
cells differed from that of MDCK cells. PTE cells had to be grown in specified
media supplemented with EGF, dexamethasone etc, and the PTE could only be
passaged once as they lost their characteristic epithelial cell phenotype on subsequent
culture/passage.
The co-cultures were set up in a similar manner as for MDCK cells, but the
CellTracker green labeled PTE cells were left to adhere overnight before co-cultures
with CellTracker orange labeled mature murine BMDM were established (Chapter 2-
4.1). A ratio of 2 M(j) : 1 PTE cell was used in experiments. Control cultures were
also established comprising of PTE cells alone. Some wells were activated with
lpg/ml of LPS and lOOU/ml of IFN-y and following 24 hours incubation the co-
cultures were fixed with formaldehyde. Apoptotic and mitotic PTE cells were
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quantified by inverted fluorescence microscopy after staining with Hoechst 33342.
Although I made several attempts to assess the level of PTE cell apoptosis by flow
cytometric based assays of apoptosis, they were not successful (data not shown).
Non-activated BMDM did not induce significant PTE cell apoptosis in co-
culture studies, thereby indicating that BMDM are not inherently cytotoxic (Figure
3-10a). In addition, treatment of PTE cells alone with LPS and IFN-y had no
significant effect upon the level of PTE cell apoptosis (Figure 3-10a). However, co-
cultures with cytokine activated BMDM induced a significant 3-fold increase in PTE
cell apoptosis compared to non-activated co-cultures (Figure 3-10a) and apoptotic
PTE cells exhibited characteristic cytoplasmic condensation (Figure 3-11).
Furthermore, inclusion of the NOS inhibitor L-NAME reduced PTE cell death to
baseline levels (Figure 3-10a). In contrast to MDCK cells, incubation of PTE cells
with non-activated BMDM or activated BMDM had no effect upon the level of PTE
cell proliferation (Figure 3-10b). It should, however, be noted that PTE cells were of
primary origin and therefore exhibited a much lower level of proliferation compared




















<9 A (N XX V
, V A , V A / CPNAs A xG 0-° xG o'°
















A A A A A AA A
G A A; A xG<y c< <y o' -c
<T G <? G <? GP
Figure 3-10 Cytokine activated BMDM induce apoptosis of murine PTE
cells but do not affect PTE cell proliferation.
CellTracker green labeled PTE cells were cultured alone or in the presence
of mature Cell-Tracker orange labeled BMDM derived from FVB/N mice. Co-
culture was established (BMDM : PTE cell ratio = 2 : 1). Selected cultures
were activated with LPS/IFN-y in the presence or absence of L-NAME (final
concentration 200pM). After 24h, the co-culture was fixed with formaldehyde,
counterstained with Floechst 33342 and PTE cell apoptosis and mitosis was
scored by fluorescence microscopy. Co-culture with activated BMDM induce
significant levels of PTE cell apoptosis (A). *p<0.05 vs activated co-cultures
in the presence or absence of L-NAME. No significant difference in the level
of PTE cell proliferation was seen (B). (n=3).
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Figure 3-11 Fluorescent photomicrograph of cytokine activated co-
culture of BMDM and murine PTE cells.
CellTracker green labeled PTE cells were cultured in the presence of
cytokine activated mature Cell-Tracker orange labeled BMDM from FVB/N
mice. Co-culture was established (BMDM : PTE cell ratio = 2:1). After 24h
incubation the co-culture was fixed with formaldehyde solution and
counterstained with Hoechst 33342. Fluorescent photomicrograph showing
apoptotic green PTE cells exhibiting cytoplasmic condensation (examples
arrowed). (x320 original magnification).
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Table 3- 5 The effect of cytokine-activated BMDM in the presence or





PTE cells alone 199 ±57 206 ± 50 224 ± 27
FVB/N BMDM 177 ±45 187 ±34 219 ±39
(n=3), PTE cell number per 8 hpf.
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3.2.6 iNOS KO BMDM fail to induce apoptosis of murine PTE cells
Next, I went on to determine whether BMDM-derived NO was the key
mediator for BMDM-directed apoptosis of murine PTE cells by performing co-
cultures of PTE cells with BMDM derived from either iNOS KO mice or iNOS WT
mice.
The results from these experiments demonstrated that co-cultures with non-
activated BMDM did not induce significant levels of PTE cell apoptosis (Figure 3-
12). However activated iNOS WT BMDM, induced significant levels of PTE cell
apoptosis (Figure 3-12), whilst co-cultures involving activated iNOS KO BMDM did
not exhibit significant PTE cell apoptosis compared to control non-activated iNOS
KO BMDM co-cultures (Figure 3-12).
In contrast to co-cultures ofBMDM with MDCK cells, I noted phagocytosis
of apoptotic PTE cells by BMDM in this primary cell co-culture system (Figure 13-a
and b). The effect of phagocytosis and subsequent rapid degradation of the ingested
cell would be predicted to reduce the level of 'free' apoptotic cells evident and this
may explain why a lower number of apoptotic PTE cells were detected in these
experiments compared to experiments using MDCK cells. Interestingly, in
accordance with the increased level of PTE cell apoptosis in activated co-cultures of
iNOS WT BMDM compared to iNOS KO BMDM, an increased number of
M(j) containing phagocytosed apoptotic PTE cells was also seen (Figure 3-13b)
although this did not reach statistical significance.
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I—I Non-activated
Figure 3-12 BMDM-derived NO is an important mediator of murine PTE
ceil apoptosis.
CellTracker green labeled PTE cells were cultured in the presence of Cell-
Tracker orange labeled mature BMDM derived from either iNOS WT or iNOS
KO mice. Co-culture was established (BMDM : PTE cell ratio = 2:1) and
selected cultures were activated with LPS (1 jig/ml) and IFN-y (100U/ml).
After 24h incubation the co-culture was fixed with formaldehyde solution and
counterstained with Hoechst 33342. The level of PTE cell apoptosis was
scored by fluorescence microscopy. Cytokine activation of iNOS WT BMDM
induced significant PTE cell apoptosis whilst activated iNOS KO BMDM were
not cytotoxic. *p<0.05 vs non-activated co-culture (n=5).
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Green Orange Hoechst Merged
Figure 3-13 Activated co-cultures of BMDM and murine PTE cells
exhibit phagocytosis of apoptotic PTE cells.
CellTracker green labeled PTE cells were cultured in the presence of Cell-
Tracker orange labeled mature BMDM derived from either iNOS WT or iNOS
KO mice. Co-culture was established (BMDM : PTE cell ratio = 2:1) and
selected cultures were activated with LPS (1 jag/ml) and IFN-y (100U/ml).
After 24h, the co-culture was fixed with formaldehyde, counterstained with
Hoechst 33342 and phagocytosis of apoptotic PTE cells was scored by
fluorescence microscopy. (A) Photomicrographs from an activated co-culture
demonstrating evidence of BMDM recognition and phagocytosis of apoptotic
tubular cells. The merged image demonstrates a condensed apoptotic
CellTracker green labeled PTE cell with a pyknotic nucleus that has been
ingested by a CellTracker orange labeled BMDM. (x320 original
magnification). (B) A trend towards increased phagocytosis of apoptotic PTE
cells by activated iNOS WT Mcj> was observed. (n=5).
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I also attempted to perform some co-culture experiments with PTE cells
derived from either iNOS WT and iNOS KO mice but unfortunately these
experiments were unsuccessful as the PTE cells did not adhere well in the 48-well
plates and the level of basal apoptosis was high in the non-activated control wells.
This may have been secondary to the age of the mice, which were 9 months old.
In addition, I also performed experiments involving the addition of NO
donors to iNOS WT and iNOS KO PTE cells to determine whether the presence or
absence of iNOS might modulate the level of apoptosis in response to NO.
Unfortunately I used a flow cytometry based assay (Chapter 2.7) and high levels of
apoptosis were evident in control non-treated (medium alone) PTE cells. However,
the level of apoptosis between the iNOS WT and KO PTE cells after treatment with
NO donors was comparable (Table 3-6). These experiments were performed with
PTE cells derived from two separate mice. Statistical analysis was not performed
since n is <2 for independent experimental data. It should be noted that this was the
result of time constraints and work was prioritised. However, I would have liked
further time to ensure that these data were not statistically significant even after 3 or
4 independent experiments.
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Table 3- 6 The effect of NO donors upon tubular epithelial cell
apoptosis on PTE cells derived from either iNOS WT or iNOS KO mice.
iNOS WT PTE cells
% Apoptosis*
iNOS KO PTE cells
% Apoptosis*
Medium alone 15.8 ±4.2 18.4 ±4.5
0.1 pM Spermine/NO 31.5 ± 10.7 26.6 ± 1.4
1.5mM DEA/NO 25.9 ±1.8 26.0 ±8.3
Tubular epithelial cell apoptosis was analysed by flow cytometry after double
staining with Annexin V and 7AAD. '(Annexin Vpositive and 7AADnegative)
n=2 mice and standard deviations of the mean.
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3.2.7 Activated BMDM from syngeneic and allogeneic BMDM induce
similar levels of murine PTE cell apoptosis
The PTE cells used in these experiments were always derived from
C57BL/6 mice since these mice were readily available. The data from the PTE cell
co-culture experiments presented thus far has involved the use of allogeneic BMDM
derived from FVB/N mice. In order to rule out the confounding issue of MHC
mismatch between the target cell and the BMDM, co-culture of C57BL/6 PTE cells
was performed with either allogeneic FVB/N BMDM or syngeneic C57BL/6
BMDM. In these experiments there was no significant difference in the level of
C57BL/6 PTE cell apoptosis between activated co-cultures comprising either
allogeneic FVB/N BMDM or syngeneic C57BL/6 BMDM (0.58±0.1 versus (vs)
0.42±0.06 apoptotic cells per hpf; FVB/N derived BMDM vs C57BL/6 derived
BMDM, p>0.05).
3.2.8 Direct cell contact or 'close proximity' is required for BMDM
induction of murine PTE cell apoptosis
The effect of BMDM conditioned supernatant transfer was tested as
described previously for MDCK cells. Conditioned supernatants from cytokine-
activated BMDM failed to induce significant PTE cell apoptosis (Figure 3-14a). The
level of apoptosis in PTE cells cultured alone under control conditions with non-
activated media was higher than that evident in cytokine activated PTE cells alone
(Compare to Figure 3-10a). Incubation of PTE cells with conditioned supernatant
from non-activated or cytokine activated BMDM did not affect PTE cell
proliferation or cell number (Figure 3-14b and c). These experiments were performed
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with BMDM derived from two separate mice. Statistical analysis was not performed
since n is <2 for independent experimental data. It should be noted that this was the
result of time constraints and work was prioritised. However, I would have liked
further time to ensure that these data were not statistically significant even after 3 or
4 independent experiments. This finding, is in contrast to previous published work
demonstrating that supernatants from cytokine activated Mcf) can indeed induce
apoptosis of primary murine tubular epithelial cells (Tesch et al., 1999). However,
my results are in accordance with previous work from our group as activated BMDM
conditioned supernatants did not induce apoptosis of mesangial cells in vitro
(Duffield et al., 2000).
Since the transfer of conditioned supernatant from activated BMDM failed
to induce PTE cell apoptosis, I investigated whether direct cell contact between
BMDM and the target cell was required. This was tested as previously described for
the MDCK cells. 5x104 PTE cells were plated onto tissue-culture inserts (TCI) and
left to grow until confluent. The inserts were then placed on top of the TCI
companion plates containing 1.25xl05 BMDM per well. Control wells comprised of
only the PTE cells on the inserts with no BMDM in the bottom of the wells. The
experimental set up was similar to that of MDCK cells (Figure 3-8), except that PTE
medium with 1% FCS was used. This medium was placed in both the upper and
lower compartment and the cultures were then incubated in the presence of 1 pg/ml of
LPS and lOOU/ml of IFN-y. After 24h of incubation the cultures were fixed with
formaldehyde and target cell apoptosis and mitosis was analysed by fluorescence
microscopy following Hoechst 33342 staining.
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There was a trend for higher PTE cell apoptosis when the PTE cells on the
inserts were cultured with cytokine activated BMDM (Figure 3-15a) but this did not
reach statistical significance (p=0.38, activated PTE alone TCI vs activated Co-
culture TCI). These data indicates that direct cell-to-cell contact or 'close proximity'
may be important in the induction of PTE cell apoptosis by cytokine activated
BMDM. There was also a non-significant trend for lower PTE cell proliferation,
when PTE cells on TCI were cultured in the presence of cytokine activated BMDM
(p=0.40, activated PTE alone TCI vs activated Co-culture TCI).
This finding differed from the work of Lange-Sperandio et al work since
they demonstrated comparable levels of tubular cell apoptosis regardless of whether
activated M(j) and tubular cells were separated from each other by an insert or in
direct contact thereby suggesting that direct cell contact was not a critical factor
(Lange-Sperandio et al., 2003). It must, however, be noted that in their study they
plated the M<)> onto the inserts and the tubular cells were placed in the bottom of the
wells. Thus, the cells had a different spatial orientation to each other compared to my
experiments. The experimental protocol adopted in my experiments is more likely to
























Figure 3-14 Conditioned supernatant from activated BMDM fail to
induce murine PTE cell apoptosis
Mature BMDM (2.5x105 mature BMDM/well) were cultured in the presence or
absence of LPS (1 jig/ml) and IFN-y (100U/ml). After 24h incubation, the
conditioned BMDM supernatants were harvested, clarified by centrifugation
and added to PTE cells (1,25x105/well). The wells were fixed with
formaldehyde and counterstained with Hoechst 33342 after 24h incubation
with BMDM supernatants, media alone or media supplemented with LPS and
IFN-y. The level of PTE cell apoptosis and proliferation was scored by
fluorescent microscopy. Conditioned supernatants from activated BMDM did
not induce significant PTE cell apoptosis (A). Also, no effect on PTE cell
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Figure 3-15 Cell contact or 'close proximity' is important for activated
BMDM induction of PTE cell apoptosis.
5x104 CellTracker green labeled PTE cells were plated onto the semi¬
permeable membranes of TCI and left to grow until confluent. 1.25x105
mature BMDM were plated in the wells of the TCI companion plates. Some
inserts containing the PTE cells were then placed above the BMDM. Cells
were incubated the presence of LPS (1p,g/ml) and IFN-y (100U/ml). Following
24h, the wells were fixed with formaldehyde and counterstained with Hoechst
33342. The level of PTE cell apoptosis and proliferation was analysed by
fluorescent microscopy. Activated BMDM do not induce significant PTE cell
apoptosis when physically separated from the target PTE cells (A). No effect
upon PTE proliferation (B) or total cell number (C) was evident (n=3).
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3.3 SUMMARY
The experiments described in this chapter shed light upon the interaction of
M(j) with renal tubular epithelial cells in vitro. I investigated the effect of activated
BMDM upon both MDCK cells and murine primary tubular epithelial cells and some
findings were common to both cell types. For example, although non-activated
BMDM were not cytotoxic to MDCK or PTE cells, co-culture with cytokine
activated BMDM induced significant levels of apoptosis. Higher levels of apoptosis
was evident in experiments involving MDCK cells but this may well reflect the
increased proliferation seen with cell lines compared to primary cells, since
proliferating cells may be more vulnerable to undergoing apoptosis.
Studies with pharmacological inhibitors of NO synthase as well as the use
ofBMDM derived from iNOS KO or WT mice indicated that BMDM cytotoxicity is
dependent upon iNOS-derived NO. Indeed, cytokine activated iNOS KO BMDM
were not cytotoxic and were comparable to control non-activated BMDM. It is
pertinent that the pharmacological inhibition of iNOS with L-NIL does not affect the
release of TNF-a or the expression of FasL by cytokine activated BMDM (Anya
Adair, personal communication). This suggests that NO is the prime mechanism
involved in the induction of tubular cell death by cytokine activated BMDM under
these in vitro conditions.
Differences were observed in the effect of BMDM upon MDCK and PTE
cell proliferation. MDCK cell proliferation was significantly suppressed by both non-
activated and activated BMDM from iNOS WT and iNOS KO mice (with a trend
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evident when BMDM derived from FVB/N mice were utilised). This effect was
independent of pharmacological inhibition of NO production. In contrast, no effect
upon PTE cell proliferation was evident in these studies.
I observed that activated BMDM ingested apoptotic PTE cells but this was
not observed with apoptotic MDCK cells. The reasons for this are unclear but it may
reflect the difference in cell size between MDCK and PTE cells. Lastly, experiments
involving the use of conditioned supernatant transfer or tissue culture inserts suggest
that direct cell-to-cell contact or 'close proximity' between the target tubular
epithelial cell and BMDM is an important requirement for BMDM induction of
tubular cell death; a finding at odds with previous reports in the literature (Lange-
Sperandio et al., 2003; Tesch et al., 1999).
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Chapter 4.





M<j) play a critical role during the initiation, progression and resolution of
renal inflammation (Kluth et al., 2004). An accumulating body of data indicates that
M<J) play an active role in inducing tubular epithelial cell apoptosis in vivo (Duffield
et al., 2005a; Lange-Sperandio et al., 2002; Lenda et al., 2003; Tesch et al., 1999).
However, despite the documented association between the severity of the M(f)
infiltrate and the level of tubular epithelial cell apoptosis, there is currently no data
regarding the mechanism employed by M(j) to induce tubular cell apoptosis in vivo.
The results from the in vitro co-culture experiments in the previous chapter
indicated a key role for M<}>-derived NO in inducing tubular cell death in vitro.
Therefore the next pertinent step was to seek a role for M(j)-derived NO in inducing
tubular cell apoptosis during tubulointerstitial inflammation in vivo. In this section of
work, I employed the model of experimental hydronephrosis induced by unilateral
ureteric obstruction (UUO). UUO is an excellent neutrophil and lymphocyte
independent in vivo model of renal inflammation (Shappell et al., 1998) and is
characterised by marked M(j) infiltration and significant levels of tubular epithelial
cell apoptosis (Diamond, 1995; Hughes and Johnson, 1999).
In this chapter I will describe the results obtained after inducing UUO in
iNOS WT and iNOS KO mice. I will also present the results obtained after




4.2.1 Obstructed kidneys exhibit prominent infiltration of
tubulointerstitial M<j) at day 7 following UUO
UUO was induced by ligation of the left ureter under general anaesthesia
and the kidneys were removed at day 7. Normal non-manipulated kidneys served as
controls. Tubulointerstitial M(J) infiltration was detected by staining kidney sections
for the specific murine M(f> marker F4/80. Normal non-obstructed kidneys exhibited
occasional scattered F4/80 positive resident M<)>, whilst obstructed kidneys developed
a prominent M<}> infiltrate in the tubulointerstitium (Figure 4-1). The degree of
tubulointerstitial M<() infiltration was quantified by careful computer-assisted image
analysis (Figure 4-2).
4.2.2 iNOS positive M<|) are present within the tubulointerstitium in
obstructed kidneys
The obstructed kidneys were stained for iNOS and infiltrating iNOS
positive cells were present in the interstitium of the obstructed kidney at day 7
(Figure 4-3). In order to determine whether interstitial infiltrating M(j) expressed
iNOS, I performed double immunofluorescent staining for iNOS and F4/80. This
demonstrated the presence of infiltrating M<J) expressing iNOS within the
tubulointerstitium of obstructed kidneys at day 7 (Figure 4-4).
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Figure 4-1 Photomicrographs of non-obstructed and hydronephrotic
kidney (day 7) after immunostaining for the M<j> marker F4/80.
Digital camera photographs of a non-obstructed kidney (A) and a
hydronephrotic kidney after 7 days of UUO (C). The kidneys were fixed in
Methyl-carnoys solution and underwent processing for histology. Tissue
sections were immunostained for the marker F4/80. Normal non-
obstructed kidneys exhibited occasional F4/80 positive resident M(|) (example
arrowed) (B). In contrast, a prominent population of infiltrating F4/80 positive
Mcj> (example arrowed) was evident in the interstitium of obstructed kidneys
(D). (x100 original magnification)
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Non-obstructed D7 UUO
Figure 4- 2 Quantitative analysis of tubulointerstitial M<j> infiltration in
non-obstructed and hydronephrotic kidneys (day 7 post UUO).
Immunostaining was performed for the M(|) marker F4/80 and the level of M(f>
infiltration was quantified by computer assisted image analysis.
Hydronephrotic kidneys removed 7 days following UUO exhibited a





Figure 4- 3 Obstructed kidneys exhibit tubulointerstitial infiltration
with iNOS positive cells.
Obstructed kidneys were removed at day 7 following UUO and the tissue
sections were immunostained for iNOS. Obstructed kidneys exhibit a
population of iNOS positive interstitial cells (example arrowed) (A). The
specificity of iNOS immunostaining is indicated by incubation of day 7 UUO
tissue sections with an irrelevant isotype antibody (negative control) since no
significant interstitial immunostaining is evident (B). (x100 original
magnification).
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Figure 4- 4 Fluorescent photomicrographs showing iNOS positive M<j>
within the tubulointerstitium of obstructed kidneys (day 7 post UUO).
Obstructed kidneys were removed at day 7 and tissue sections underwent
double immunofluorescent staining for iNOS and F4/80. Fluorescent
photomicrographs showing iNOS positive cells stained green (A) and F4/80
positive interstitial M(|> stained red (B). The merged image demonstrates
colocalisation (yellow) of iNOS and F4/80 indicating the presence of
infiltrating M<t> expressing iNOS (C). An additional merged image
demonstrating multiple iNOS positive infiltrating M(|) (examples arrowed) (D).
(x1000 original magnification).
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4.2.3 iNOS KO mice exhibit increased M<J> infiltration in experimental
hydronephrosis
iNOS WT and iNOS KO mice underwent UUO under general anaesthesia.
The kidneys were removed at day 7, fixed in 10% formalin and Methyl carnoys and
embedded in paraffin (n=5 per group). Tissue sections were immunostained for the
specific M<j) marker F4/80. The degree of tubulointerstitial Mcj) infiltration (expressed
as F4/80 positive surface area) was quantitated by computer-assisted image analysis.
The obstructed kidneys of iNOS KO mice exhibited a significantly increased M<|)
infiltrate (Figure 4-5c). Morphometric measurement of tubular luminal space was
also performed. Importantly, no difference in the percentage tubular luminal space
occupying the cortical area was observed between experimental groups, thereby
excluding this potential confounding factor (Figure 4-5d).
4.2.4 iNOS KO mice exhibit a trend toward lower levels of tubular
epithelial apoptosis at day 7 of UUO
Tubular epithelial cell apoptosis was evaluated in day 7 obstructed kidneys
of iNOS WT and iNOS KO mice by analysis of PAS stained tissue sections. This
method was able to discriminate between proximal (Figure 4-6a) and distal (Figure
4-6b) tubular epithelial cell apoptosis and enables the quantification of tubular cell
death in these different tubular compartments. Interestingly, iNOS KO mice
exhibited a slightly reduced level of both proximal and distal tubular cell apoptosis
despite the significantly increased tubulointerstitial M(f> infiltrate. The reduction in
tubular cell apoptosis did not, however, reach statistical significance (Figure 4-6c).
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To further investigate the interesting observation that the obstructed kidneys
of iNOS KO mice exhibited a trend towards lower levels of both proximal and distal
tubular epithelial cell apoptosis I increased the number of animals in each group to 7
per group. I also used the TUNEL assay to determine the level of tubular epithelial
cell death (Figure 4-7a) in the obstructed kidneys of iNOS WT and iNOS KO mice at
day 7 following UUO. The iNOS KO mice still exhibited again a trend toward a
lower level of tubular epithelial cell apoptosis in obstructed kidneys although this did
not reach statistical significance despite increasing the number of animals studied
(Figure 4-7b).
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Figure 4- 5 Quantitative analysis of tubulointerstitial M<|> infiltration
and tubular dilatation in the cortex of iNOS WT and iNOS KO mice at
day 7 following UUO.
Immunostaining was performed for the M<j> marker F4/80. iNOS KO mice
displayed marked interstitial M<j> infiltration (x100 magnification) (A) that was
greater than that evident in iNOS WT mice (B). Quantification of M(j)
infiltration by computer assisted image analysis demonstrated that iNOS KO
mice exhibited a significant increase in tubulointerstitial M<|> infiltration
(*p<0.05 vs iNOS WT mice). (C). The area occupied by the tubular lumina
was quantified by computer-assisted image analysis. The tubular luminal
space is expressed as a percentage of total cortical area. No significant
difference in the degree of tubular luminal space was evident between















Figure 4- 6 Detection and quantitation of apoptotic proximal and distal
tubular epithelial cells in the obstructed kidneys of iNOS WT and iNOS
KO mice at day 7 following UUO
PAS staining was used to identify apoptotic proximal (A) and distal (B)
tubular epithelial cells (x1000 magnification). iNOS KO mice exhibit a trend
towards lower levels of both proximal and distal tubular epithelial cell
apoptosis, though this was not statistically significant (p=0.14 proximal and
p=0.23 distal apoptosis, vs iNOS WT mice) (C), (n=5 mice per group).
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4.2.5 iNOS WT mice but not iNOS KO mice, exhibit a significant
correlation between interstitial M<j> infiltration and tubular
epithelial cell apoptosis at day 7 following UUO
Previous work has demonstrated a highly significant correlation between the
level of M(J> infiltration and the degree of tubular cell apoptosis in experimental
hydronephrosis as well as the immunological model of nephrotoxic nephritis (Lange-
Sperandio et al., 2002; Tesch et ah, 1999). I therefore analysed the correlation
between the degree of M(j) infiltration (F4/80 positive area) and the levels of tubular
epithelial cell apoptosis evident in each genotype. iNOS WT mice exhibited a
significant positive correlation between M(J> infiltration and the level of tubular
epithelial cell death (R2 = 0.61, p<0.04, Figure 4-8a), thereby indicating a clear
relationship between these parameters. In contrast, there was no correlation between
Mcj) infiltration and the level of tubular epithelial cell death in iNOS KO mice (R =
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Figure 4- 7 Detection and quantitation of TUNEL positive apoptotic
tubular epithelial cells in the obstructed kidneys of iNOS WT and iNOS
KO mice at day 7 following UUO.
Tubular epithelial cell apoptosis was detected by TUNEL staining (A). (x1000
magnification). iNOS KO mice exhibit a trend towards a lower level of tubular
epithelial cell apoptosis, though this was not statistically significant (p=0.19,
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Figure 4- 8 M<j> infiltration in iNOS WT mice but not iNOS KO mice
significantly correlates with tubular epithelial cell apoptosis.
Tubular epithelial cell apoptosis was detected by TUNEL staining and M4>
infiltration was determined by F4/80 immunostaining. (A) Mc|) infiltration is
significantly correlated with the level of tubular cell apoptosis in iNOS WT
mice (R2= 0.61, p<0.04). (B) In contrast, no significant correlation was
evident in iNOS KO mice (R = 0.017, p=0.78). Correlation was analysed with
Pearsons correlation coefficient (n=7 mice per group).
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4.2.6 Experimental hydronephrosis does not affect the level of
tubular epithelial cell proliferation in iNOS WT and iNOS KO
mice
Tubular epithelial cell proliferation in the obstructed kidney of iNOS WT
and iNOS KO mice at day 7 following UUO was determined by analysis of PAS
stained tissue sections as mitotic figures were readily identifiable (see Figure 4.10a
and b). This method allowed the specific quantification of proximal and distal
tubular cell mitosis. There was no significant difference in the levels of proximal or
distal tubular cell mitosis between iNOS WT and iNOS KO mice (Table 4-1).
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Table 4-1 Quantification of proximal and distal tubular epithelial cell
proliferation in iNOS WT and iNOS KO mice at day 7 following UUO.
iNOS WT mice iNOS KO mice
Mitotic cells/hpf
Proximal 0.13 ±0.03 0.18 ±0.06
Distal 0.22 ±0.06 0.19 ±0.09
(n=7 mice per group)
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4.2.7 Pharmacological blockade of iNOS by administration of L-NIL
in the drinking water during experimental hydronephrosis
Since the obstructed kidneys of iNOS KO mice exhibited an increased level
of tubulointerstitial M(j) infiltration, I decided to circumvent this confounding effect
by using a pharmacological approach. L-NIL, a specific irreversible iNOS inhibitor,
was administered in the drinking water of mice in order to pharmacologically inhibit
the enzyme iNOS during the model of experimental hydronephrosis. UUO was
performed in FVB/N mice and L-NIL (lmg/ml) was administered in the drinking
water between day 5 and day 7.1 chose to commence L-NIL administration for a 48
hour period commencing at day 5 in order to minimise any potential impact upon M(f)
infiltration. This dose and route of administration of L-NIL was chosen since it had
previously been demonstrated to effectively inhibit iNOS in vivo (Reilly et al., 2002;
Westenfeld et al., 2002). In order to prove that this dose was effective in blocking
iNOS in the study presented in this thesis, I would have liked to perform an
enzymatic assay of iNOS activity from L-NIL treated day 7 obstructed kidney tissue
homogenates. NOS activity in kidney homogenates can be measured using a
radiolabeled citrulline assay that monitors the conversion of tritiated [3H]-arginine to
[3H]-citrulline. The contribution of iNOS activity to total NOS activity can be
measured by the inclusion of a calcium chelator in the above reaction since iNOS
activity is Ca2+ independent (Miyajima et al., 2001). However, time constraints
during this thesis, prohibited the development of such an assay which utilised
radiolabeled substrate (tritiated arginine) for the measurement of iNOS activity.
Urinary nitrate levels were not measured from the obstructed kidneys, since iNOS
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blockade was undertaken for only 48 hours and hence the urinary nitrate levels
would not be meaningful as the urine had accumulated over the preceding 7 days.
The obstructed kidneys were removed for histological analysis at day 7
following 48 hrs of iNOS blockade. Administration of the inactive isomer D-NIL
(lmg/ml) served as control.
4.2.8 Pharmacological blockade of iNOS by L-NIL does not affect the
degree of tubulointerstitial M<j> infiltration in experimental
hydronephrosis
The level of M(j) infiltration (F4/80 positive surface area) was analysed by
computer assisted image analysis. This analysis indicated that pharmacological
inhibition of iNOS between day 5 and day 7 did not have any significant effect upon
the level of Mcj) infiltration at day 7 (3.2±0.7 vs 3.9±0.9 % F4/80 positive surface
area; L-NIL vs control; p>0.05).
4.2.9 Pharmacological blockade of iNOS by L-NIL reduces tubular
epithelial cell apoptosis but does not affect the level of tubular
epithelial cell proliferation in experimental hydronephrosis
Tubular epithelial cell apoptosis was determined by TUNEL staining
(Figure 4-9a). Administration of L-NIL significantly reduced the level of tubular cell
apoptosis compared to control D-NIL (Figure 4-9b). The level of tubular epithelial
cell proliferation was determined by counting the number of tubular cell undergoing
mitoses using PAS stained tissue sections with both proximal (Figure 4-10a) and
distal (Figure 4-10b) tubular cell proliferation being quantified. In contrast to the
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effect upon tubular cell apoptosis, L-NIL administration did not affect the level of
tubular cell proliferation (Figure 4-10c).
4.2.10 Administration of L-NIL reduces interstitial cell apoptosis but
does not affect interstitial cell proliferation in experimental
hydronephrosis
Interstitial cell apoptosis and proliferation was similarly determined by
TUNEL (Figure 4-11 a) and PAS staining respectively (Figure 4-12a).
Pharmacological blockade of iNOS by L-NIL also resulted in a significant reduction
in the level of interstitial cell apoptosis (Figure 4-1 lb) with no effect upon interstitial






Figure 4- 9 Pharmacological blockade of iNOS reduces tubular
epithelial cell apoptosis at day 7 following UUO.
Mice were administered L-NIL (1mg/ml), an irreversible pharmacological
inhibitor of the enzyme iNOS, or the isomeric control D-NIL (1mg/ml) in the
drinking water from day 5 after UUO. The obstructed kidneys were removed
at day 7 and tissue sections underwent TUNEL staining to detect apoptotic
cells. High power view (x1000 magnification) of a TUNEL positive apoptotic
tubular cell (A). The level of tubular cell apoptosis in obstructed kidneys is
significantly reduced following the administration of L-NIL (B) *p<0.05 vs








CONTROL L-NIL CONTROL L-NIL
Figure 4-10 Pharmacological blockade of iNOS does not affect
proximal or distal tubular epithelial cell proliferation at day 7 following
UUO.
Mice were administered L-NIL (1mg/ml), an irreversible pharmacological
inhibitor of the enzyme iNOS, or the isomeric control D-NIL (1mg/ml) in the
drinking water from day 5 after UUO. The obstructed kidneys were removed
at day 7 and tissue sections underwent PAS staining to detect mitotic cells.
High power view (xlOOOmagnification) of a mitotic proximal tubular cell (A)
and a mitotic distal tubular cell (B). The level of tubular cell proliferation in
obstructed kidneys is unaffected following the administration of L-NIL (C)
(n=7- 8 mice per group).
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Figure 4-11 Pharmacological blockade of iNOS reduces interstitial cell
apoptosis at day 7 following UUO.
Mice were administered L-NIL (1mg/ml), an irreversible pharmacological
inhibitor of the enzyme iNOS, or the isomeric control D-NIL (1mg/ml) in the
drinking water from day 5 after UUO. The obstructed kidneys were removed
at day 7 and tissue sections underwent TUNEL staining to detect apoptotic
cells. High power view (x1000 magnification) of a TUNEL positive apoptotic
interstitial cell (A). The level of interstitial cell apoptosis in obstructed kidneys
is significantly reduced following the administration of L-NIL (B) *p<0.05 vs
control (n=7-8 mice per group).
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Figure 4-12 Pharmacological blockade of iNOS does not affect
interstitial cell proliferation at day 7 following UUO
Mice were administered L-NIL (1mg/ml), an irreversible pharmacological
inhibitor of the enzyme iNOS, or the isomeric control D-NIL (1mg/ml) in the
drinking water from day 5 after UUO. The obstructed kidneys were removed
at day 7 and tissue sections underwent PAS staining to detect mitotic cells.
High power view (x1000 magnification) of a mitotic interstitial cell (A). The
level of interstitial cell proliferation in obstructed kidneys is unaffected
following the administration of L-NIL (B) (n=7-8 mice per group).
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4.2.11 Pharmacological blockade of iNOS by L-NIL increases
tubulointerstitial fibrosis in experimental hydronephrosis
Tubulointerstitial fibrosis was assessed by immunohistochemical staining
for collagen III, which is deposited by fibroblasts and myofibroblasts and is a
representative collagen of the scarred and injured tubulointerstitium (Mazzali et al.,
2003). Careful morphometric analysis of collagen III immunostaining indicated that
pharmacological blockade of the enzyme iNOS resulted in increased collagen III
deposition (Figure 4-12).
4.2.12 Pharmacological blockade of iNOS by L-NIL does not effect
the myofibroblast accumulation in experimental
hydronephrosis
Kidney tissue sections were stained for a-SMA, which is expressed by
tubulointerstitial myofibroblasts (Hughes et al., 1999). Interstitial myofibroblasts
play an important role in the pathogenesis of tissue fibrosis and scarring since they
actively produce extracellular matrix molecules such as collagens types I, III and IV.
The area of the renal tubulointerstitium occupied by a-SMA staining was assessed
morphometrically as an indirect measure of the tubulointerstitial myofibroblast
population. Interestingly, despite the increased level of interstitial collagen III
deposition, this analysis indicated no significant difference in a-smooth muscle actin
staining following short-term blockade of iNOS (Figure 4-14).
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CONTROL L-NIL
Figure 4-13 Pharmacological blockade of iNOS increases
tubulointerstitial deposition of collagen III at day 7 following UUO.
Mice were administered L-NIL (1mg/ml), an irreversible pharmacological
inhibitor of the enzyme iNOS, or the isomeric control D-NIL (1mg/ml) in the
drinking water from day 5 after UUO. The obstructed kidneys were removed
at day 7. Photomicrographs of collagen III immunostaining at day 7 in control
mice (A) and mice treated with L-NIL (B). (x100 magnification). The
administration of L-NIL increases the tubulointerstitial deposition of collagen




Figure 4-14 Pharmacological blockade of iNOS does not affect the
accumulation of interstitial myofibroblasts at day 7 following UUO.
Mice were administered L-NIL (1mg/ml), an irreversible pharmacological
inhibitor of the enzyme iNOS, or the isomeric control D-NIL (1mg/ml) in the
drinking water from day 5 after UUO. The obstructed kidneys were removed
at day 7 and tissue sections were stained for a-SMA which is a marker for
myofibroblasts. Photomicrographs of a-SMA immunostaining at day 7 in
control mice (A) (x100 original magnification). The administration of L-NIL




The experiments described in this chapter shed light upon the interaction of
M(j) and renal tubular epithelial cells in vivo. I employed the model of experimental
hydronephrosis induced by UUO to seek a role for iNOS-derived NO in inducing
tubular cell apoptosis during tubulointerstitial inflammation in vivo.
Following seven days of UUO, there was a marked increase in the level of
F4/80 positive M(j) within the tubulointerstitium. Further characterisation of these
interstitial M(j) showed that many M<|) stained positive for iNOS. UUO was induced
in iNOS WT and iNOS KO mice. The obstructed kidneys of iNOS KO mice
exhibited significantly higher M<() infiltration than iNOS WT mice. I therefore
analysed if there was a correlation between the level of Mx() infiltration and the
degree of tubular cell apoptosis in each genotype. M(j) infiltration in iNOS WT mice
but not iNOS KO mice, exhibited a positive correlation with TEC apoptosis; a
finding found in other studies (Lange-Sperandio et al., 2002; Tesch et al., 1999).
In view of the confounding effect upon M(J) infiltration seen in the iNOS
KO mice, I adopted a pharmacological approach of inhibiting the activity of the NO-
generating enzyme iNOS during experimental hydronephrosis. L-NIL was
administered in the drinking water between day 5 and day 7 following UUO. In order
to minimise any potential impact upon M(J) infiltration, I chose to commence L-NIL
administration for a 48 hour period commencing at day 5. I observed that this drug
treatment did not affect the level of tubulointerstitial M(() infiltration.
Pharmacological blockade of iNOS by L-NIL reduced the levels of TEC and
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interstitial cell apoptosis but did not affect their proliferation. Interestingly,
tubulointerstitial fibrosis was significantly increased after L-NIL administration,









The results from the in vivo experiments in the previous chapter indicated a
key role for the enzyme iNOS in the induction of tubular epithelial cell and
interstitial cell death in vivo in the model of experimental hydronephrosis. In
contrast, iNOS did not play a role in modulating the level of tubular epithelial cell
and interstitial cell proliferation, although interstitial fibrosis was increased by
inhibition of iNOS. Since my studies demonstrated infiltrating iNOS positive M(f> in
the interstitium of obstructed kidneys, I went on to investigate the effect of M(J>
ablation in this model.
I used a model of conditional M(j) ablation strategy (Cailhier et al., 2005) to
investigate the effect ofM(j) depletion upon tubular cell death in vivo in the model of
experimental hydronephrosis. In this chapter I will describe the results obtained after
ablating interstitial inflammatory M(j) during the course ofUUO.
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5.2 RESULTS
5.2.1 Administration of Diphtheria toxin (DT) reduces
tubulointerstitial M<j> infiltration in experimental hydronephrosis
CD1 lb-DTR mice on the FVB/N background underwent UUO at day 0 and
diphtheria toxin (DT) was administered intraperitoneally on day 5 (20ng/g BW) and
day 6 (lOng/gBW) following UUO. Control mice were injected with an equal
volume of vehicle (PBS) with 5 mice per group. The kidneys were removed at day 7
and underwent histological processing. Tubulointerstitial M(j) infiltration was
detected by staining the kidney sections for the specific Mcj) marker F4/80. The
degree ofM(|) infiltration was quantified by careful computer-assisted image analysis.
DT treatment induced a significant 2-fold reduction in tubulointerstitial Mcj)
accumulation in obstructed kidneys at day 7 (Figure 5-lc).
1 then determined whether increased Mcj) ablation could be achieved by
increasing the dose of DT. CD 1 lb-DTR mice underwent UUO at day 0 and DT
(25ng/g BW) or an equal volume of PBS was injected intraperitoneally on days 5, 6
and 7 following UUO. Morphometric analysis of F4/80 positive tubulointerstitial Mcf)
indicated that 3 doses of DT resulted in a 3-fold reduction of tubulointerstitial M(|)
(Figure 5-1 d) although there was a slightly higher level of Mcj) infiltration in the mice
receiving PBS compared to the control group for the study involving the
administration of 2 doses ofDT (compare Figure 5-lc and d).
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Figure 5-1 Tubulointerstitial M<j) accumulation is reduced after DT
treatment during experimental hydronephrosis.
F4/80 immunostaining of day 7 UUO kidneys after 3 doses of PBS (A) and
after 3 doses of DT (B). Quantification of M<{) infiltration by computer assisted
image analysis demonstrated a 2-fold reduction of interstitial M<|) infiltration
after 2 doses of DT (C) and a 3-fold reduction after 3 doses of DT (D)
(*p<0.01 vs PBS treated mice, (n=5-6 mice per group).
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5.2.2 M<|> depletion does not ameliorate tubular cell apoptosis nor
affect the level of tubular cell proliferation in experimental
hydronephrosis.
The effect of M(j) depletion after 2 and 3 doses of DT upon tubular cell and
interstitial cell apoptosis was evaluated by TUNEL staining or PAS staining (to
distinguish between proximal and distal apoptosis) of tissue sections at day 7
following UUO. M(J) depletion had no effect upon the level of tubular cell or
interstitial cell apoptosis in mice receiving 2 doses of DT (Figure 5-2). In addition
apoptosis of proximal and distal tubular cells or interstitial cells was not reduced in
mice treated with 3 doses ofDT (Figure 5-3a).
PAS staining was used to quantify tubular cell and interstitial cell
proliferation. Mcj) ablation following 2 doses of DT did not have any effect upon
tubular or interstitial cell apoptosis (Figure 5-2b) and there was no effect upon the
numbers of tubular cells undergoing mitosis in mice treated with 3 doses of DT
(Figure 5-3b). In the light of data previously presented in thesis, it was surprising that














PBS x2 DTx2 PBS x2 DTx2 PBS x2 DTx2
Figure 5- 2 2-fold M<)> depletion does not affect tubular cell nor
interstitial cell apoptosis or proliferation at day 7 following UUO.
CD11b-DTR mice were administered two doses of DT i.p at day 5 (20ng/g
BW) and day 6 (10 ng/g BW) and control mice received an equal volume of
PBS. The obstructed kidneys were removed at day 7 and tissue sections
underwent TUNEL staining to detect apoptotic cells and PAS staining to
detect mitotic cells. DT treatment did not reduce the level of TEC or
interstitial cell apoptosis (A) and the level of proliferation was unaffected


































PBS x3 DT x3 PBS x3 DT x3
Figure 5- 3 3-fold M<|) depletion does not affect tubular cell or
interstitial cell apoptosis or proliferation at day 7 following UUO.
CD11b-DTR mice underwent UUO at day 0 and DT (25ng/g BW) or and
equal volume of PBS was injected i.p on days 5, 6 and 7. The obstructed
kidneys were removed at day 7 and tissue sections underwent PAS staining.
DT treatment did not reduce the level of tubular cell or interstitial cell
apoptosis (A) and the level of tubular cell proliferation was unaffected
following DT administration (B), (n=5-6 mice per group).
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5.2.3 M<t> depletion reduces tubulointerstitial fibrosis in experimental
hydronephrosis
Tubulointerstitial fibrosis of kidney sections at day 7 following UUO was
assessed by immunostaining for collagens I and III and by picrosirius red staining for
fibrillary collagen. The percentage area for each stain was quantified by computer
assisted image analysis. Deposition of collagen I was diminished in mice treated with
2 doses of DT (Figure 5-4a) and also in mice treated with 3 doses of DT (Figure 5-
5c). Pro-collagen I gene expression was quantified by real-time RT-PCR (kindly
performed by Sarah Farnworth and Dr. Alison MacKinnon, MRC Centre for
Inflammation Research, University of Edinburgh) and analysis indicated that there
was a trend towards reduced pro-collagen I gene expression in mice treated with 3
doses of DT but this was not statistically significant (2.9±0.6 vs 24.3±14.4, DT vs
PBS, p=0.13) The expression of pro-collagen I was corrected for the house keeping
gene ribosomal RNA 18S. These data indicated that M(f> depletion induced by DT
treatment had an anti-fibrotic effect.
Collagen III deposition was also reduced in the obstructed kidneys of mice
treated with 3 doses of DT (Figure 5-6c). There was a trend for reduced levels of
collagen III deposition in the obstructed kidneys of mice treated with 2 doses of DT
(Figure 5-4b). Lastly, although picrosirius red staining showed a trend towards
reduced levels of fibrillary collagen deposition, this was not statistically significant
(Figure 5-4c).
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PBS x2 DT x2
Figure 5- 4 The effect of 2 doses of DT (inducing a 2-fold M<|> depletion)
upon collagen deposition at day 7 following UUO.
Quantitation of tubulointerstitial fibrosis of kidneys at day 7 following UUO
was assessed by computer assisted image analysis after staining for
collagen I (A). DT treatment and the resultant 2-fold Mcf) depletion resulted in
a significant reduction in collagen I deposition (*p<0.01 vs PBS x2 treated
mice). There was a trend for reduced levels of collagen III deposition
(p=0.055 vs PBS x2) (B) and fibrillary collagen deposition (latter assessed by
picrosirius red staining, p=0.057) (C), n=5 mice per group).
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Figure 5- 5 3-fold M<)> depletion reduces collagen I deposition at day 7
following UUO.
Collagen I immunostaining of day 7 UUO kidneys after 3 doses of PBS (A)
and after 3 doses of DT (B). Collagen I deposition was quantified by
computer assisted image analysis and this was significantly reduced in mice




PBS x3 DT x3
Figure 5- 6 3-fold M<|> depletion reduces collagen III deposition at day 7
following UUO.
Collagen III immunostaining of day 7 UUO kidneys after 3 doses of PBS (A)
and after 3 doses of DT (B). Collagen III deposition was quantified by
computer assisted image analysis and this was significantly reduced in mice
treated with 3 doses of DT(C). (*p<0.01 vs PBS x3 treated mice) (n=5- 6
mice per group).
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5.2.4 M<j> depletion in experimental hydronephrosis results in a trend
towards lower levels of myofibroblast accumulation
The accumulation of myofibroblasts was assessed by computer assisted
image analysis after staining day 7 UUO kidneys with a-SMA. Mice treated with 2
does ofDT displayed a trend towards lower levels of myofibroblast accumulation but
this was statistically not significant (Figure 5-7c). Similar results were found in mice
treated with 3 doses of DT (Figure 5-7d). a-SMA gene expression was quantified by
RT-PCR (kindly performed by Sarah Farnworth and Dr. Alison MacKinnon (Centre
for Inflammation Research, University of Edinburgh) and analysis indicated that a-
SMA gene expression was significantly reduced in mice treated with 3 doses of DT
(0.00049+0.00032 vs 0.0051±0.0015, DT vs PBS, P<0.01) The expression of a-
SMA was corrected for the house keeping gene ribosomal RNA 18S.
5.2.5 iNOS positive M<J> are present in the kidneys of M<|> depleted
mice
Since Mcj) depletion did not affect the level of tubular cell apoptosis, I went
on to investigate potential explanations. Mice treated with 3 doses of DT still had
infiltrating M(|) present within the tubulointerstitium since DT treatment induced a 3-
fold reduction and did not completely deplete all infiltrating M(J>. The work so far has
indicated the M(j)-derived NO is a key mediator for TEC apoptosis in vitro with
iNOS-derived NO being key in UUO in vivo. I therefore double stained the kidney
sections of M<j) depleted mice for F4/80 and iNOS. Interestingly the presence of M(j)
expressing iNOS was still observed in kidney sections which had received 3-doses of
DT (Figure 5-8).
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Figure 5-7 A trend towards lower levels of myofibroblast
accumulation following M<|) ablation.
Photomicrographs of a-SMA immunostaining (x100) at day 7 following UUO
in PBS treated control mice (A) and mice treated with DT (B). Quantification
of percentage area of a-SMA staining by computer assisted image analysis
(C) and (D). There was a non-significant trend towards lower levels of
myofibroblast accumulation in mice receiving either 2 doses (p=0.051) or 3




Figure 5- 8 Fluorescent photomicrographs showing the presence of
iNOS positive M<|> in obstructed kidneys receiving 3-doses of DT.
CD11b-DTR mice underwent UUO at day 0 and DT (25ng/gBW) i.p on days
5, 6 and 7. The obstructed kidneys were removed at day 7 and tissue
sections underwent double immunofluorescent staining for F4/80 and iNOS.
Fluorescent photomicrographs showing F4/80 positive M<j> stained red (A)
and iNOS positive cell stained green (B). The merged image demonstrates
colocalisation (yellow) of iNOS and F4/80 indicating the presence of
infiltrating M<J> expressing iNOS in the mice treated with D (C).
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5.3 TGF-|3 expression following M<t> ablation
Since M(j) depletion ameliorated tubulointerstitial fibrosis, I investigated if
TGF-|3 expression was altered in mice receiving DT since numerous studies have
demonstrated a critical role for IGF-(3 during kidney fibrosis (Choi et al., 2005;
Kelly et al., 2004; Sato et al., 2003).
TGF-J3 expression was detected by staining the kidney sections with a
chicken polyclonal anti-TGF-|3 antibody, which recognises murine TGF-|3.
Specificity of staining was determined by staining tissue sections with the isotype
control antibody (chicken IgG). Although I have not formally quantified the level of
TGF-|3 expression the preliminary results suggest that a 3-fold M(|) depletion did not
markedly affect the level of TGF-|3 expression (Figure 5-9a) as the level of TGF-(3
expression was similar in control mice receiving PBS (Figure 5-9b). I did not,
however, analyse the expression of factors that can activate TGF-|3 such as
thrombospondin as altered expression of such factors would affect the level of active
TGF-|3 in the kidney (Daniel et al., 2003). TGF-|3 gene expression was quantified by
RT-PCR (kindly performed by Sarah Farnworth and Dr. Alison MacKinnon in the
MRC Centre for Inflammation Research, University of Edinburgh) and analysis
indicated that a 3-fold M(j) depletion did not affect the level of TGF-|3 gene
expression (26.6±2.7 vs 20.7±6.3, DT vs PBS). The expression of TGF-|3 was
corrected for the house keeping gene (3-actin.
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Figure 5- 9 Photomicrographs of TGF-p immunostaining of day 7
obstructed kidneys after 3 doses of PBS or 3 doses of DT.
CD11b-DTR mice underwent UUO at day 0 and DT (25ng/gBW) or and equal
volume of PBS was injected i.p on days 5, 6 and 7. The obstructed kidneys
were removed at day 7 and tissue sections were immunostained for TGF-p.
Photomicrographs (x100 magnification), showing TGF-{5 staining after 3
doses of PBS (A) and after 3 doses of DT (B). The specificity of TGF-p
staining is indicated by incubation of tissue sections with an irrelevant isotype




In the experiments described in this chapter, a conditional M(j) ablation
strategy was used to investigate the effect of M(j) depletion upon tubular cell death in
vivo in the model of experimental hydronephrosis. Mice underwent UUO and were
either treated with 2 doses of DT or 3 doses ofDT, while control mice received equal
volumes of vehicle. Administration of 2 or 3 doses of DT resulted in a 2-fold or 3-
fold reduction of tubulointerstitial Mc() infiltration respectively. DT administration
did not reduce the level of tubular epithelial cell or interstitial cell apoptosis or affect
their level of proliferation. Interestingly, phenotyping of the interstitial M(j) still
present in the DT treated obstructed kidneys, demonstrated the presence of iNOS
positive M(j) within the tubulointerstitium
Interestingly tubulointerstitial fibrosis was ameliorated after M(j) depletion
and a-SMA gene expression was reduced, although no effect was seen upon of
interstitial myofibroblast accumulation.
Lastly preliminary staining for TGF-J3 expression and RT-PCR quantitation






In this thesis I examined the cytotoxic mechanism underlying M(j)-mediated
tubular epithelial cell death in vitro and in vivo. I used the well established
microscopically quantifiable co-culture assay (Duffield et al., 2000), the model of
experimental hydronephrosis (Diamond, 1995; Lange-Sperandio et al., 2002; Lenda
et al., 2003) and a conditional M<|) ablation strategy in these studies. This area of
renal cell biology has been studied previously (Lange-Sperandio et al., 2003; Tesch
et al., 1999) but - these reports did not determine the mechanisms underlying M(j)-
mediated apoptosis of tubular cells.
The experiments described in Chapter 3 shed light upon the interaction of
murine BMDM with renal tubular epithelial cells in vitro. The first major finding of
my in vitro co-culture studies was that, although non-activated BMDM were not
cytotoxic to MDCK cells or PTE cells, cytokine-activated BMDM induced
significant levels of tubular cell apoptosis. The level of PTE cell apoptosis evident
was less than the level of MDCK cell apoptosis. This may reflect various factors
including the different species of origin of the tubular cells and their proliferative
status. In addition, the data suggested that murine M<)) were able to phagocytose
apoptotic PTE cells but not MDCK cells and this may be at least partly responsible
for the differing level of 'free' apoptotic cells evident in the assays as apoptotic cells
may be rapidly recognised, ingested and degraded (Barres et al., 1992).
The in vitro studies also demonstrated that the induction of tubular cell
apoptosis by cytokine activated BMDM was significantly reduced by inhibitors of
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NO synthase. Furthermore, experiments using cytokine activated BMDM derived
from either iNOS KO or WT mice indicated that BMDM cytotoxicity was dependent
upon iNOS-derivedNO.
These data are in accordance with previous reports indicating that NO is an
important mediator of M(j) cytotoxicity towards various target cells (Cui et al., 1994;
Duffield et al., 2000). Despite the fact that previous work has indicated the
involvement of NO in M(|> induction of apoptosis in various cells including
mesangial cells (Duffield et al., 2000) and vascular smooth muscle cells (Boyle et al.,
2002), other death effectors such as TNF-a (Boyle et al., 2003; Duffield et al., 2001)
and FasL (Boyle et al., 2001; Boyle et al., 2002) have also been implicated. In
addition, Meldrum et al used a pegylated form of soluble TNFR1 to inhibit the action
of TNF-a in a rat model of UUO (Meldrum et al., 2006). This study demonstrated a
reduced level of renal tubular cell apoptosis and the authors suggest that TNF-a is a
key mediator of tubular cell death in this model. The authors did not, however,
determine whether the inhibition of TNF-a affected M<|) infiltration, iNOS
expression or NO production by Mtj). Also Guo et al performed UUO in mice
deficient in either the TNFR1 or TNFR2 receptors and demonstrated that TNF-a
contributed to the interstitial pathology (Guo et al., 1999) but tubular cell apoptosis
was not examined in this study. Work in our laboratory has investigated the effect of
pharmacological inhibition of iNOS upon the production of other potential death
effectors and demonstrated that L-NIL treatment of cytokine stimulated BMDM does
not affect TNF-a release or FasL expression in vitro (Anya Adair, personal
communication). This suggests that NO is the prime mechanism involved in the
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induction of tubular cell death by cytokine activated BMDM under the in vitro
conditions employed in these studies.
The effect of BMDM upon the level of target cell proliferation varied
according to the nature of the target cell. The proliferation of MDCK cells was
reduced by incubation with both non-activated and activated BMDM from iNOS WT
and iNOS KO mice (with a trend evident when BMDM derived from FVB/N mice
were utilised). This effect was independent of pharmacological inhibition of NO
production. BMDM secrete significant levels of TGF-|3 and this cytokine has been
documented to inhibit MDCK cell proliferation (Nicolas et al., 2003; Yang et al.,
1998) and therefore it is possible that non-activated iNOS WT and KO BMDM
secrete more TGF-|3 than non-activated BMDM derived from FVB/N mice. In
contrast, M(|) exerted no significant effects upon PTE cell proliferation in this study
and this may reflect the significantly lower level of proliferation of these primary
cells.
I undertook studies involving the transfer of conditioned supernatants from
cytokine activated or control BMDM to cultures of tubular epithelial cells and these
conditioned supernatants failed to induce tubular cell death. This finding was in
contrast to previous published work demonstrating that supernatants from cytokine
activated M(j) induced apoptosis of immortalised or primary murine tubular epithelial
cells (Lange-Sperandio et al., 2003; Tesch et al., 1999). Also, previous work by
Lenda et al (Lenda et al., 2003) has demonstrated that the ability of conditioned Mc|)
medium to induce apoptosis could be modulated since blockade of the CSF-1
receptor reduced M(f> activation (determined by expression of activation markers and
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reactive oxygen species generation) and the ability of M((> conditioned supernatant to
induce tubular cell apoptosis. However, my results are in accordance with previous
work from our group as activated BMDM conditioned supernatants did not induce
apoptosis of mesangial cells in vitro (Duffield et ah, 2000). The differing results
found by various investigators may reflect differences in the experimental methods
and cells used in the studies.
Lastly, the experiments involving the use of tissue culture inserts suggested
that either direct cell-to-cell contact or 'close proximity' between the target tubular
epithelial cell and BMDM was an important requirement for BMDM induction of
tubular cell death. It is important to note that my experimental protocol involved the
tubular epithelial cells being plated on the inserts with the M(j) being located in the
bottom of the wells as this arrangement reflects the spatial orientation that is likely to
be present in vivo. However, the work of Lange-Sperandio et al (Lange-Sperandio et
al., 2003), suggested that cell contact was not a critical factor since they
demonstrated comparable levels of tubular cell apoptosis regardless of whether
activated M(() and tubular cells were separated from each other by an insert or in
direct contact. My results also raise the possibility that a short acting cytotoxic
mediator may be involved and this may be degraded or neutralised if it is unable to
act rapidly upon a target cell. It should be noted, however, that the spatial orientation
found in vivo was not present in the co-culture studies but this is also the case for
other investigators.
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The in vitro data indicated a prominent role for M<))-derived NO in inducing
tubular epithelial cell apoptosis and therefore I employed the experimental model of
hydronephrosis induced by UUO, to test the in vivo relevance of the findings. The
neutrophil and lymphocyte independent model of UUO was chosen for several
reasons. First, UUO is characterised by a prominent M(|) infiltrate and significant
levels of tubular cell apoptosis (Diamond, 1995; Hughes et al., 1999). Indeed, the
tubular cell apoptosis present in this model is believed to underlie the development
of severe renal tubular atrophy (Gobe and Axelsen, 1987). In addition it is
characterised by interstitial fibrosis which represent an additional important
experimental read-out.
There was a marked increase in the level of F4/80 positive Mcj) within the
tubulointerstitium at the day 7 time-point of UUO in FVB/N mice. Double
immunolabeling revealed F4/80 positive Mcj) that were strongly iNOS positive within
the tubulointerstitium of obstructed kidneys indicating that infiltrating Mc() may
express iNOS in vivo. In order to determine the role of iNOS-derived NO, UUO was
induced in iNOS WT and KO mice. Unexpectedly, the obstructed kidneys of iNOS
KO mice displayed a significantly increased tubulointerstitial M(j) infiltrate compared
to iNOS WT mice. The reasons for this are unclear as the kinetics of Mcj) trafficking
through the tubulointerstitium in the model is unknown at present. However, it is
possible that the increased M<|) infiltrate in the iNOS KO mice may result from a
reduced level of Mcj) death, since Mcj) may undergo apoptosis during renal
inflammation (Lan et al., 1997) and such death may involve Mcj) expression of iNOS
(Albina et al., 1993). The increased Mcj) infiltrate may also be a consequence of
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increased recruitment to the inflamed tubulointerstitium as iNOS deficient Mcfi
secreted increased levels of the CC chemokine MCP-1 (Speyer et al., 2003) and this
chemokine is involved in M()) recruitment to the inflamed tubulointerstitium (Tesch
et al., 1999).
Despite the confounding increased M<)> infiltrate, the obstructed kidneys of
iNOS KO mice, exhibited a trend towards less tubular cell apoptosis compared to
iNOS WT mice although this never reached statistical significance. I performed
additional analysis of the correlation between the degree of M<j) infiltration and the
levels of tubular cell apoptosis evident in each genotype since a positive correlation
has been previously demonstrated in the experimental models of UUO and NTN
(Lange-Sperandio et al., 2002; Tesch et al., 1999). Correlation analysis demonstrated
that iNOS WT mice exhibited a significant positive correlation between the degree of
M(j) infiltration and the level of tubular cell death whilst this relationship was absent
in iNOS KO mice. These experiments raise several issues. They suggest that there is
a significant level of M(|) independent tubular cell death in the UUO model. In
addition, in view of the lack of any correlation between iNOS KO M<j) infiltration
and tubular apoptosis, iNOS KO M(j) do not appear to upregulate additional death
effector mechanisms in this model. It is also possible that the tubular cells within the
obstructed kidneys of iNOS KO mice may be more vulnerable to apoptosis as iNOS
expression by mesangial cells can protect the cells from undergoing apoptosis
(Nitsch et al., 1997). Additional studies examining the level of tubular cell death in
iNOS WT mice that have received either an iNOS WT or KO bone marrow
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transplant would be informative as this would predominantly restrict the iNOS
deficiency to infiltrating Mcj).
In order to circumvent the confounding effect of increased Mcj) infiltration
seen in iNOS KO mice and UUO, I chose a pharmacological approach to inhibit
iNOS during UUO. L-NIL, a specific irreversible iNOS inhibitor, was administered
in the drinking water of mice between day 5 and day 7 in order to minimise any
potential impact upon Mcj) infiltration. L-NIL treatment did not affect the level of
interstitial Mcj) infiltration but significantly reduced the level of tubular cell apoptosis
compared to the control group. L-NIL had no effect upon tubular cell proliferation.
However, since L-NIL administration resulted in a partial inhibition of tubular cell
apoptosis, it may be the case that additional pro-apoptotic mediators are utilised by
the infiltrating inflammatory Mcj) to induce tubular cell apoptosis in vivo (Nikolic-
Paterson, 2003). For example, Mcj> production ofMMPs may result in degradation of
TBM and resultant tubular cell apoptosis by anoikis in the murine model of Alports
syndrome (Frisch and Francis, 1994; Rodgers et al., 2003). A role for TNF-a in the
induction of tubular cell death in the rat UUO model has also been proposed since
obstructed rat kidneys up-regulated both TNF-a and FasL (Misseri et al., 2005) and
blockade of the actions of TNF-a by systemic administration of a pegylated form of
soluble TNF receptor type 1 is protective (Meldrum et al., 2006). However, the level
of Mcj) infiltration was not quantified in this study and it is likely that TNF-a
inhibition may have reduced Mcj) infiltration.
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Pharmacological blockade of iNOS also reduced the level of interstitial cell
apoptosis. These apoptotic interstitial cells might have been dying myofibroblasts but
this is difficult to determine unequivocally even with double staining for a-SMA and
TUNEL since the majority of apoptotic renal cells are located within the
phagolysosomes of neighbouring non-apoptotic cells (Coles et ah, 1993). Despite the
reduction of interstitial cell apoptosis, I found that L-NIL treatment did not affect the
level of myofibroblast accumulation. This might have been due to the fact that the
period of pharmacological blockade of iNOS was relatively short (48hrs).
L-NIL treatment significantly increased the tubulointerstitial deposition of
collagen III that is characteristically found in tubulointerstitial scarring suggesting
that iNOS-derived NO may be anti-fibrotic. Interestingly Hochberg et al
demonstrated that iNOS KO mice developed increased levels of fibrosis following
UUO (Hochberg et al., 2000). Primary murine renal fibroblasts are also susceptible
to NO-mediated apoptosis in vitro (Claire Taylor, personal communication) and it is
possible that the increased fibrosis may reflect diminished induction of interstitial
fibroblast apoptosis by M(|).
The interpretation of the data from the obstructed kidneys of iNOS KO mice
was complicated by the increased Mcf> infiltration evident in the iNOS KO mice.
However, pharmacological blockade of the generation of pro-apoptotic NO by iNOS
reduced tubular cell apoptosis without affecting M({) infiltration and this reinforces
the importance of M(j) phenotype as well as Mc|) numbers during renal inflammation.
This paradigm has been supported by the work of Anders et al (Anders et al., 2003)
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as inhibition of the CC chemokine ligand 5/RANTES in a model of immune complex
glomerulonephritis resulted in diminished glomerular M(|) number but increased
glomerular M<j) expression of iNOS and an associated increase in glomerular injury.
My data indicating that pharmacological blockade of iNOS-derived NO
ameliorated the level of tubular cell apoptosis is not in accordance with previous
work by Miyajima et al (Miyajima et al., 2001). They obstructed the kidneys of
iNOS KO and iNOS WT mice and demonstrated increased levels of tubular
epithelial cell apoptosis in iNOS KO mice. In contrast, I found a trend for reduced
levels of tubular epithelial cell apoptosis in the iNOS KO mice (despite increased M(|)
infiltration) and, unlike the iNOS WT mice, no correlation between the level of M<j)
infiltration and tubular epithelial cell apoptosis. In addition, Miyajima et al subjected
rat renal tubular epithelial cells to mechanical stretch in vitro and demonstrated that
stretch-induced apoptosis was increased when a NOS inhibitor was added to the cells
thereby implicating NO as a protective factor in stretch induced tubular cell
apoptosis in vitro and UUO in vivo (Miyajima et al., 2001). The reasons for the
apparent discrepancies between this study and my results are unclear. Although
previous work has suggested that strain differences as they may affect the amount of
NO generated by M<j> (Mills et al., 2000).
Lastly, it should be noted that a significant level of M(|) independent tubular
cell death occurs in the UUO model and it is undoubtedly the case that additional
pro-apoptotic stimuli including mechanical stretch, hypoxia, ischemia etc are likely
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to play a role in the apoptosis of tubular epithelial cells in vivo (Cachat et ah, 2003;
Fine et ah, 1998; Kiley et ah, 2005).
The results presented in Chapter 3 and 4 indicated that inflammatory Mtj)
play an important role in inducing tubular epithelial cell apoptosis in vitro and are
likely to be involved in vivo. In Chapter 5 I described my experiments involving
conditional M(j> ablation in UUO. The administration of DT to CDllb-DTR
transgenic mice results in the rapid ablation of resident/infiltrating M({> and
circulating monocytes (Cailhier et ah, 2005; Cailhier et ah, 2006; Duffield et ah,
2005a). Work from our group has demonstrated that a single dose of DT (25ng/g
body weight) i.p induces circulating monocyte depletion for 24-48 hrs and peritoneal
M(j) for 72hrs (Cailhier et ah, 2005). This dose of DT resulted in the ablation of
resident M(j) in normal kidneys of CDllb-DTR mice at 24 hours (Cailhier et ah,
2005). In my initial studies, CDllb-DTR mice underwent UUO and mice were
administered two doses ofDT i.p at day 5 (20ng/g BW) and day 6 (lOng/gBW). This
treatment resulted in a 2-fold reduction in the level of interstitial M<|) infiltration
compared to control mice receiving PBS. I then determined whether increased M<J)
ablation was possible by increasing the dose of DT. CDllb-DTR mice underwent
UUO and mice were administered three doses of DT i.p on days 5, 6 and 7 (25ng/g
BW) while control animals received an equal volume of PBS. 3 doses ofDT resulted
in a 3-fold reduction of interstitial M(|) infiltration but despite the increased dose of
DT this did result in the complete ablation of all interstitial M(j) in the obstructed
kidneys.
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Surprisingly, my studies demonstrated that mice treated with either 2 or 3
doses of DT did not exhibit any reduction in the level of tubular or interstitial cell
apoptosis. In addition DT treatment did not have any effect upon the level of
proliferation of tubular nor interstitial cells. These findings are in contrast with many
other studies where Mcf> have been implicated in the deleterious induction of tubular
cell apoptosis in vivo (Lange-Sperandio et al., 2002; Lenda et al., 2003; Tesch et ah,
1999). In addition, M(|> depletion in the immunological murine model of progressive
NTN does result in reduced levels of tubular cell apoptosis and proliferation
(Duffield et ah, 2005a).
What may account for these findings? First, it is undoubtedly true that M<{>
are professional phagocytes and play a critical role in the recognition and clearance
of apoptotic cells. Therefore, it is possible that M<|> depletion resulted in a
simultaneous reduction in both the level of tubular cell apoptosis and the phagocytic
clearance of apoptotic tubular cells (i.e. a phagocytosis defect). However, apoptotic
tubular cells may also by cleared by desquamation into the tubular lumen (although I
saw little evidence of this in my studies) or ingestion by neighbouring epithelial cells
in addition to interstitial infiltrating Mc{). These data also suggest that the phenotype
(i.e. activation status) of the infiltrating M(j), rather than M<|) numbers per se is likely
to be important as shown previously in a murine model of experimental
glomerulonephritis (Anders et al., 2003). For example, it is possible that the
remaining interstitial M([) present in the DT treated mice could still produce sufficient
pro-inflammatory mediators capable of inducing tubular cell death. I performed
immunofluorescent double staining for iNOS and F4/80 and iNOS positive
211
interstitial M(|) are present in the obstructed kidneys of DT treated mice. The failure
of M<|) ablation to reduce tubular cell apoptosis may thus result from the persistent
presence of a population of iNOS positive interstitial M(j).
M(J) depletion did, however, ameliorate tubulointerstitial fibrosis as assessed
by staining for interstitial collagens suggesting that Mcj) play an important role in
modulating interstitial fibrosis. The potential mechanisms by which M(j) promote
interstitial matrix deposition include the direct release of cytokines such as TGF-|3 by
M(|) or M(j> stimulation of other renal cells to release pro-fibrotic factors. In addition,
M(j) generate factors such as thrombospondin that can activate latent TGF-(5 to the
active form (Daniel et al., 2003; Daniel et al., 2004).
I undertook somewhat preliminary studies of TGF-(3 expression in the M(j)
and this suggests that the level of TGF-(3 detectable by immunostaining was not
obviously affected by DT treatment. It is important to note, however, that this may
not indicate the level of bioactive TGF-|3 and it is therefore possible that the level of
active TGF-|3 may have differed between groups. Interestingly, real-time PCR
analysis demonstrated that TGF-(3 gene expression was not affected by DT treatment.
M<|) ablation did not affect the level of myofibroblast accumulation
identified after staining for a-SMA despite the reduced deposition of extracellular
matrix. Interestingly, M(j) ablation reduced the level of a-SMA gene expression
assessed by real-time PCR. My findings are partially compatible with the reduced
fibrosis noted following M(j) ablation during murine NTN although this study did
show reduced myofibroblast accumulation (Duffield et ah, 2005a).
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A summary diagram ofNO release and the resulting biological cascade that
may ultimately lead to tubular epithelial cell apoptosis is illustrated in Figure 6.1 and
a simplified schema for the role ofNO and inflammatory M(j) in the events leading to
end-stage renal failure is shown in Figure 6.2.
The work described in this thesis will hopefully contribute to a better
understanding of the roles of inflammatory M<|) in tubulointerstitial inflammation of
the kidney. Further characterisation of the role of Mcj) and M<j)-derived mediators are






Figure 6-1 Summary diagram depicting the potential mechanisms
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Figure 6- 2 Summary diagram depicting the role of NO, inflammatory
M(j> and possible pathways leading to end-stage renal failure.
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6.2 FUTURE WORK
This work raises several questions that could be pursued by additional
studies.
(1) The in vitro work could be extended to include cytokine priming of the
tubular cells with pro-inflammatory cytokines as this may upregulate receptors such
as Fas etc that may increased the susceptibility of tubular cells to death effectors
other than NO. Also, my primary tubular cell cultures comprised a mixed population
of tubular cells and it would be of interest to undertake co-culture studies of purified
proximal and distal tubular cells. Most experimental studies have been performed in
rodents and the rodent M(j) may use iNOS to a greater extent than human M(|).
However, iNOS positive Mcj) are present in renal biopsies from renal transplant
recipients with chronic allograft nephropathy (Anya Adair, personal
communication). It would therefore be informative to undertake studies using human
monocyte-derived M(j) and either human tubular cell lines or primary human tubular
cells. In this work, I have focused upon iNOS-derived NO but NO may react with
reactive oxygen species (ROS) to form the cytotoxic mediator peroxynitrite. It would
thus be interesting to undertake studies employing inhibitors of ROS generation
including studies employing both iNOS and ROS inhibitors seeking synergy.
(2) In this work I studied a single time point in the UUO model and it would
be informative to undertake more extended in vivo studies examining both earlier and
later time points in order to examine the kinetics of various processes such as M<j)
infiltration, tubular cell apoptosis and interstitial fibrosis. Also, an extended period of
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L-NIL treatment in the UUO model would be interesting as this may result in
reduced accumulation of interstitial myofibroblasts.
(3) It would be interesting to perform UUO in irradiated iNOS WT mice
reconstituted with bone marrow derived from iNOS KO mice or control iNOS WT
mice, as this would localise the defective expression of iNOS to the infiltrating
leukocyte population. This experiment would give information regarding Mc|)-derived
NO in the induction of tubular cell apoptosis in vivo and the increased levels of
tubulointerstitial fibrosis evident in the obstructed kidneys of iNOS KO mice.
(4) L-NIL treatment resulted in comparable levels of M<|> infiltration and a-
SMA immunostaining but increased interstitial fibrosis. It would be interesting to
quantify the expression of TGF-(3 as well as the expression of activators of TGF-P
such as thrombospondin in obstructed kidneys from both the L-NIL treatment and
DT treatment experiments. Study of the renal expression ofMMPs and TIMPs would
also be informative. In addition, further work carefully investigating and quantifying
the phenotype of the infiltrating Mij) would be of interest. This could be performed by
single or double immunostaining but methods are now available in the lab for
enzymatic dissociation of renal tissue and analysis of infiltrating leukocyte
populations by flow cytometry. M(j) expression of TNF-a and FasL in DT treated
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Cell Injury, Repair, Aging and Apoptosis
Nitric Oxide Is an Important Mediator of Renal
Tubular Epithelial Cell Death in Vitro and in Murine
Experimental Hydronephrosis
Tiina Kipari, Jean-Francois Cailhier,
David Ferenbach, Simon Watson, Kris Houlberg,
David Walbaum, Spike Clay, John Savill, and
Jeremy Hughes
From the Phagocyte Laboratory, Medical Research Council Centre
for Inflammation Research, The Queen's Medical Research
Institute, Edinburgh, Scotland
Macrophages play a pivotal role in tissue injury and
fibrosis during renal inflammation. Although macro¬
phages may induce apoptosis of renal tubular epithe¬
lial cells, the mechanisms involved are unclear. We
used a microscopically quantifiable co-culture assay
to dissect the cytotoxic interaction between murine
bone marrow-derived macrophages and Madin-Darby
canine kidney cells and primary murine renal tubular
epithelial cells. The induction of tubular cell apopto¬
sis by cytokine-activated macrophages was reduced
by inhibitors ofnitric oxide synthase whereas tubular
cell proliferation was unaffected. Furthermore, cyto¬
kine-activated macrophages derived from mice tar¬
geted for the deletion of inducible nitric oxide syn¬
thase were noncytotoxic. We then examined the role
of nitric oxide in vivo by inhibiting inducible nitric
oxide synthase in the model of murine experimental
hydronephrosis. I.W6-( 1 - iminoethyl)-lysine was ad¬
ministered in the drinking water between days 5 and
7 after ureteric obstruction. Macrophage infiltration
was comparable between groups, but treatment sig¬
nificantly inhibited tubular cell apoptosis at day 7.
Tubular cell proliferation was unaffected. Inducible
nitric oxide synthase blockade also reduced intersti¬
tial cell apoptosis and increased collagen m deposi¬
tion. These data indicate that nitric oxide is a key
mediator ofmacrophage-directed tubular cell apopto¬
sis in vitro and in vivo and also modulates tubuloin-
terstitial fibrosis. (Am J Pathol 2006, 169:388-399; DOI:
10.2353/ajpath.2006.050964)
Macrophages are remarkably versatile cells that play a
major role in many key biological processes including
host defense, wound healing, development, tissue re¬
modeling, acute inflammation, and the clearance of ap-
optotic cells.1""5 Macrophages may induce apoptosis of
host cells and this is beneficial in the context of develop¬
mental sculpting of tissues4,6,7 but is usually deleterious
during renal inflammation 8-10 Recent work indicates that
macrophages may induce tubular epithelial cell apopto¬
sis in both immunological and nonimmunological tubulo-
interstitial inflammation.11-14 Tesch and colleagues11 in¬
duced nephrotoxic glomerulonephritis in mice targeted
for the deletion of monocyte chemoattractant protein-1
(MCP-1). The resultant diminished tubulointerstitial mac¬
rophage infiltrate was associated with a reduction in tu¬
bular epithelial cell apoptosis. This finding was reinforced
by our recent work that used conditional macrophage
ablation in progressive nephrotoxic glomerulonephritis
because macrophage ablation significantly reduced the
level of tubular epithelial cell apoptosis.14 The role of
macrophages in the nonimmunological model of experi¬
mental hydronephrosis induced by unilateral ureteric
obstruction has also been studied.12,13 Lenda and col¬
leagues12 obstructed the kidneys of colony-stimulating-
factor-1 (CSF-l)-deficient mice and demonstrated a
reduced interstitial macrophage infiltrate associated with
a reduced level of tubular epithelial cell death. Lange-
Sperandio and colleagues13 obstructed the kidneys of
triple E-, P-, and L-selectin knockout mice or wild-type
control mice within the first 48 hours after birth. Triple
selectin knockout mice exhibited diminished tubulointer¬
stitial macrophage infiltration and reduced levels of tubu¬
lar epithelial cell death compared to control mice.
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Although tubular cell apoptosis is invariably present
during renal injury, excessive levels of tubular cell death
are highly undesirable and result in renal tubular atrophy,
hypocellular scarring and eventual organ failure.15 In¬
deed, the tubulointerstitium of the kidney plays an impor¬
tant role in all renal diseases irrespective of the nature of
the original injury16 because there is a striking correlation
between the severity of the tubulointerstitial changes in
human biopsies and the subsequent development and
progression of chronic renal failure to end-stage renal
failure requiring dialysis.17
Currently, despite the documented correlation be¬
tween the severity of macrophage infiltration and the level
of tubular epithelial cell apoptosis,12"14 there is scant
data regarding the mechanisms involved in macrophage-
mediated tubular cell apoptosis. Inflammatory macro¬
phages produce myriad proapoptotic mediators that may
kill neighboring cells, including nitric oxide (NO), tumor
necrosis factor-a (TNF-a), as well as Fas ligand
(FasL).18-20 Previous in vitro studies addressing this is¬
sue used both macrophage and murine tubular cell
lines21 with cytokine-activated J774 macrophages induc¬
ing apoptosis of murine PKSV-PR proximal tubular cells.
This study and previous work by Tesch and colleagues,11
however, did not determine the nature of the macrophage
death effector although no role for TNF-a, FasL, or trans¬
forming growth factor-0 was demonstrable.21
In this study we have used a well-established micro¬
scopically quantifiable co-culture assay18 and the model
of experimental hydronephrosis12,13,22 to examine the
cytotoxic mechanism underlying macrophage-mediated
tubular epithelial cell death in vitro and in vivo. We dem¬
onstrate an important role for macrophage-derived NO in
the induction of tubular cell apoptosis in vitro and during
tubulointerstitial inflammation in vivo. In addition, our data




Tissue culture reagents were purchased from Life Tech¬
nologies (Paisley, UK). Tissue culture plastics were ob¬
tained from Costar (Loughborough, Leicestershire, UK)
and Falcon (Runcorn, Cheshire, UK). Cytokines were
purchased from R&D Systems (Abingdon, Oxon, UK) and
Peprotech EC Ltd. (London, UK). L-A/^l-iminoethyO-ly-
sine (L-NIL) and the control inactive isomer d-N6-^-imi-
noethyl)-lysine (D-NIL) were purchased from Fluorochem
Ltd. (Old Glossop, Derbyshire, UK). All other reagents
were from Sigma-Aldrich Co. Ltd. (Poole, UK) unless
otherwise stated.
ExperimentalAnimals
Inducible nitric oxide synthase (iNOS) knockout23 and
wild-type control mice were obtained from B and K Uni¬
versal (Hull, UK). iNOS knockout and wild-type mice were
on the 129/sv background. CB7BL/6 and FVB/N mice
were bred at the University of Edinburgh.
Preparation of Bone Marrow-Derived
Macrophages
Bone marrow-derived macrophages were used in these
studies and were prepared from FVB/N mice, C57BL/6,
or iNOS knockout and wild-type mice as described pre¬
viously.18 Briefly, bone marrow was isolated from femurs
by standard sterile techniques and matured for 7 days in
sterile Teflon wells in Dulbecco's modified Eagle's me¬
dium (DMEM)/F12 medium with 10% heat inactivated
fetal calf serum (FCS), penicillin (100 U/ml), streptomycin
(100 ijlg/ml), and 10% L929 cell-conditioned medium as a
source of M-CSF. Macrophages were greater than 98%
positive for the macrophage marker F4/80 by flow
cytometry.
Renal Tubular Epithelial Cell Culture
Madin-Darby canine kidney (MDCK) cells (a gift from Dr.
J. Davie, University of Edinburgh) were cultured as de¬
scribed previously.24 Briefly, cells were grown as a
monolayer culture in 75-cm2 culture flasks and main¬
tained with Eagle's minimum essential medium contain¬
ing 1% nonessential amino acids, 100 U/ml penicillin, 100
;j,g/ml streptomycin, and 10% heat-inactivated FCS in a
humidified atmosphere of 5% C02 at 37°C. Murine pri¬
mary tubular epithelial (PTE) cells were derived from the
kidneys of C57BL/6 mice after microdissection and brief
collagenase digestion.25 PTE cells were grown as a
monolayer culture in 25-cm2 culture flasks and main¬
tained with DMEM/F12 medium containing insulin (10
/j.g/ml), transferrin (5.5 ju,g/ml), selenium (5 ng/ml), epi¬
dermal growth factor (25 ng/ml), and dexamethasone (36
ng/ml). PTE cells were cytokeratin-positive and vimentin-
negative by immunochemistry.
Co-Culture Studies
MDCK or PTE cells were prelabeled with fluorescent
CellTracker Green whereas in some experiments mature
macrophages (7 to 10 days) were prelabeled with fluo¬
rescent CellTracker Orange (both CellTracker dyes ob¬
tained from Molecular Probes, Eugene, OR). Cells were
washed with serum-free medium and incubated for 30
minutes (macrophage) or 1 hour (epithelial cells) in se¬
rum-free medium containing the respective CellTracker
dye at a concentration of 5 ng/ml. Cells were washed in
medium containing 10% FCS to remove unbound Cell¬
Tracker dye. Epithelial cells were then trypsinized and
added to 48-well plates at a density to cover 60 to 70% of
the well surface: 1 X 104 MDCK cells/well and 1.5 x 104
PTE cells/well. Wells were washed after 2 to 4 hours to
remove nonadherent cells. Macrophages were added to
epithelial cells at a ratio of two macrophages to one
epithelial cell. MDCK experiments were conducted in
DMEM/F12 medium containing 10% FCS, and PTE cell
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experiments were conducted in PTE cell medium con¬
taining 0.1% FCS.
Selected co-cultures were activated with lipopolysac-
charide (LPS) (1 p,g/ml) and murine interferon-y (IFN-y)
(100 U/ml), with nonactivated co-cultures being exposed
to medium alone. After 24 hours of incubation, the undis¬
turbed co-cultures underwent in situ fixation with formal¬
dehyde (4% final concentration) to ensure retention of
apoptotic cells.18 Fixed co-cultures were then stained
with Floechst 33342 at 1 /j,g/ml in phosphate-buffered
saline (PBS) for 15 minutes. Using inverted fluorescent
microscopy, nonoverlapping fields from each well were
randomly and blindly chosen so that at least 200 epithe¬
lial cells were counted per well. Apoptotic epithelial cells
were identified by their green condensed cytoplasm and
pyknotic nuclei. Mitotic epithelial cells were discernible
by their characteristic chromatin pattern. The number of
apoptotic or mitotic epithelial cells was counted and ex¬
pressed as apoptotic or mitotic cells per high-power field
or as a percentage of the total number of epithelial cells
(percent apoptosis). All experimental conditions were
performed in triplicate and experiments performed on at
least three separate occasions. Macrophage and primary
PTE cell cultures were derived from at least three different
animals.
The Model of Experimental Hydronephrosis
Experimental hydronephrosis was induced by performing
unilateral ureteric obstruction.26 The left ureter of age-
matched male FVB/N mice was ligated under inhalational
anesthesia. Mice were administered either L-NIL or the
control inactive isomer D-NIL in the drinking water (1
mg/ml) for 48 hours before sacrifice at day 7 (n = seven
to eight per group).27,28 The removed kidneys were cut
longitudinally and fixed in either 10% buffered formalin or
methyl Carnoy's solution (60% methanol, 30% chloro¬
form, and 10% acetic acid) and embedded in paraffin. All
experiments were performed in accordance with the UK
Government Home Office regulations.
Renal Morphology and Immunohistochemistry
To examine renal histology, 4-/u,m sections were stained
with periodic acid-Schiff (PAS) reagent and counter-
stained with hematoxylin. Tubulointerstitial macrophage
infiltration was quantified after immunostaining for the
murine macrophage marker F4/80. Briefly, methyl Car¬
noy's fixed tissue sections were deparaffinized, rehy-
drated in ethanol, and incubated in 3% H202 in methanol
to block endogenous peroxidase activity. Tissue sections
were then incubated with rat monoclonal antibody
(lgG2b) directed against mouse F4/80 (1/1000 dilution;
Caltag Laboratories, Northampton, UK) at 4°C overnight,
followed by a mouse-adsorbed biotinylated rabbit anti-rat
IgG (1/1000 dilution; Vector Laboratories, Peterborough,
UK) at room temperature for 30 minutes. For iNOS immu¬
nostaining, tissue sections were incubated with a poly¬
clonal rabbit antibody (1/50 dilution; Abeam Laborato¬
ries, Cambridge, UK) at 4°C overnight, followed by a
biotinylated goat anti-rabbit IgG (1/300 dilution; DakoCy-
tomation, Glostrup, Denmark) at room temperature for 30
minutes. The tubulointerstitial myofibroblast population
was quantified after immunostaining for the myofibroblast
marker a-smooth muscle actin. Tissue sections were in¬
cubated with monoclonal mouse anti-human a-smooth
muscle actin that cross-reacts with murine a-smooth
muscle actin [clone 1A4 (lgG2a), 1/1000 dilution; Sigma-
Aldrich Co. Ltd., Poole, UK] at 4°C overnight, followed by
a biotinylated rat-anti-mouse lgG2a (1/100 dilution;
Zymed Laboratories, San Francisco, CA) at room temper¬
ature for 30 minutes. Tubulointerstitial fibrosis was quan¬
tified after immunostaining for collagen III. Tissue sec¬
tions were incubated with goat-anti-human type III
collagen antibody, which also detects murine type III
collagen (1/50 dilution; Cambridge Bioscience Ltd.,
Cambridge, UK) at 4°C overnight, followed by a biotinyl¬
ated rabbit-anti-goat IgG (1/100 dilution; Vector Labora¬
tories) at room temperature for 30 minutes.
After washing in PBS, sections were incubated in
horseradish peroxidase-conjugated avidin D (1/2000 di¬
lution; Vector Laboratories) at room temperature for 20
minutes. Color was developed using diaminobenzidine
as the chromogen and counterstained with methyl green
or hematoxylin. An irrelevant isotype control primary an¬
tibody served as negative control. Positive control tissue
included sections from diseased mice that were known to
express F4/80-positive macrophages or exhibit signifi¬
cant renal scarring. Interstitial macrophage infiltration
was quantified in a blinded manner by analyzing 10
sequentially selected nonoverlapping fields of renal cor¬
tex of F4/80-stained sections at x 100 magnification using
computer-assisted image analysis (ImageJ 1.30h; Na¬
tional Institutes of Health, Bethesda, MD; http://rsb.info.
nih.gov/ij/Java1.3.7 _03).14,29,30 Macrophage infiltration
was expressed as the percentage of tissue surface area
positive for F4/80 staining.14,31 Tubulointerstitial collagen
III deposition was quantified in a similar manner while
myofibroblast accumulation was expressed as the per¬
centage of tissue surface area positive for a-smooth mus¬
cle actin staining excluding blood vessels.
Double-lmmunofluorescence Staining for
iNOS and F4/80
Methyl Carnoy's fixed tissue sections were deparaf¬
finized, rehydrated, and incubated in 3% H202 in meth¬
anol to block endogenous peroxidase activity. Nonspe¬
cific binding was blocked by incubation in 2% goat
serum, 1% bovine serum albumin, 0.1% Triton X-100, and
0.05% Tween 20 for 30 minutes at room temperature.
Tissue sections were then sequentially incubated in the
following antibodies: 1) polyclonal rabbit anti-iNOS (1/50
dilution; BD Biosciences Pharmingen, Oxford, UK); 2)
AlexaFluor-488-conjugated goat anti-rabbit IgG (1/300
dilution; Molecular Probes); 3) rat anti-mouse F4/80
(lgG2b, 1/1000 dilution; Caltag Laboratories, Northamp¬
ton, UK); 4) mouse-adsorbed biotinylated rabbit anti-rat
IgG (1/1000 dilution, Vector Laboratories); and 5) Alexa
Fluor-568-conjugated streptavidin (1/300 dilution, Molec-
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ular Probes). Primary antibodies were incubated over¬
night at 4°C, with remaining incubations being performed
at room temperature for 30 minutes. After each incuba¬
tion step tissue sections were washed three times in
Tris-buffered saline (pH 7.6) for 5 minutes. To assess the
specificity of the immunostaining, tissue sections were
incubated with nonimmune rabbit or rat IgG in place of
the primary anti-iNOS or anti-F4/80 antibodies and then
processed under identical conditions. Tissue sections
were mounted with anti-fade mounting medium (Vector
Laboratories), and double-immunofluorescent staining
was analyzed by inverted fluorescent microscopy.
Detection ofApoptosis and Proliferation
Apoptotic cells were detected by the terminal dUTP nick-
end labeling (TUNEL) assay as previously described.32
Briefly, 4-p.m formalin-fixed tissue sections were depar-
affinized and rehydrated in ethanol followed by an anti¬
gen retrieval step comprising of boiling in 0.01 mol/L
sodium citrate buffer for 2 minutes. Sections were then
incubated with proteinase K (6.2 pig/ml), followed by TdT
(300 enzyme U/ml; Amersham Pharmacia Biotech) and
Bio-14-dATP (0.94 nmol/L; Gibco BRL, Life Technologies,
Paisley, Scotland). Biotinylated ATP was detected using
the RTU Vectastain Elite ABC Reagent (Vector Laborato¬
ries) and slides were counterstained with methyl green
and eosin. As a positive control, slides were pretreated
with DNase I (20 Kunitz U/ml; Roche Molecular Biochemi-
cals, Lewes, UK). Cells were regarded as TUNEL-posi-
tive if they exhibited stained nuclei with an apoptotic
morphology. Tubular and interstitial cell apoptosis was
quantified in a blinded manner by counting the number of
TUNEL-positive tubular and interstitial cells in 20 to 25
sequentially selected nonoverlapping fields of renal cor¬
tex at X400 magnification. Data were expressed as the
mean number ± SEM per high-power field.
PAS-stained tissue sections were used to quantify
proximal and distal tubular cell proliferation because
proximal tubular cells exhibit a characteristic PAS-posi-
tive luminal brush border.33 Mitotic cells were readily
identifiable, and proximal and distal cell proliferation
were calculated in a blinded manner by counting the
number of mitotic proximal and distal tubular epithelial
cells in 20 to 25 sequentially selected nonoverlapping
fields of renal cortex at X400 magnification and ex¬
pressed as the mean number ± SEM per high-power
field.
StatisticalAnalysis
All results are presented as mean ± SEM. Statistical
analysis was performed using GraphPad Prism 3.02/ln-
stat 1.1 (GraphPad Software, San Diego, CA). The Stu¬
dent's t-test was used for comparisons involving two
groups, and statistical differences among multiple
groups of data were assessed by one-way analysis of
variance followed by a Newman-Keuls post hoc test.




Nonactivated macrophages did not induce significant
MDCK cell apoptosis in co-culture studies, thereby indi¬
cating that macrophages are not inherently cytotoxic
(Figure 1A; 1.49 ± 0.3% versus 0.96 ± 0.3% apoptosis,
nonactivated co-cultures versus control MDCK cells; P >
0.05). In addition, treatment of MDCK cells with LPS and
IFN-y had no effect on the level of MDCK cell apoptosis
(1.42 ± 0.3% versus 0.96 ± 0.3% apoptosis, cytokine-
activated MDCK cells versus nonactivated MDCK cells;
P > 0.05). However, MDCK cells in co-cultures activated
with LPS and IFN-y exhibited significantly increased lev¬
els of apoptosis after 24 hours (Figure 1A; 12.3 ± 4.1%
versus 1.49 ± 0.3% apoptosis; cytokine-activated co-
cultures versus nonactivated co-cultures; P < 0.01).
Apoptotic MDCK cells exhibited characteristic cyto¬
plasmic condensation (Figure 1B) and nuclear pykno-
sis (Figure 1C).
Macrophage-Derived NO Is an Important
Mediator ofMDCK CellApoptosis but Is Not
Implicated in the Inhibition ofMDCK Cell
Proliferation
Previous data indicate that macrophage-derived NO is
involved in the cytotoxicity of cytokine-activated macro¬
phages toward tumor cells34 and glomerular mesangial
cells.18 We therefore performed co-cultures with macro¬
phages derived from either iNOS wild-type or iNOS
knockout mice. Co-cultures of activated iNOS wild-type
macrophages and MDCK cells exhibited a 3.5-fold
higher level of MDCK cell apoptosis compared to co-
cultures of MDCK cells with activated iNOS knockout
macrophages (Figure 2A; 4.6 ± 0.9% versus 1.14 ±
0.4% apoptosis; activated co-cultures with iNOS wild-
type macrophages versus activated co-cultures with
iNOS knockout macrophages; P < 0.001). In addition,
cytokine-activated iNOS knockout macrophages did not
induce apoptosis above the background level evident in
cytokine-treated target cells alone, thereby suggesting a
key role for macrophage-derived NO in the induction of
MDCK death (1.14 ± 0.4% versus 0.69 ± 0.04% apopto¬
sis; activated co-cultures with iNOS knockout macro¬
phages versus nonactivated co-cultures with iNOS
knockout macrophages; P > 0.05). Furthermore, the cy¬
totoxic effect of activated iNOS wild-type macrophages
was completely abrogated by the inclusion of the non¬
competitive NOS inhibitor /V-nitro-L-arginine methyl ester
(L-NAME, 200 /u,mol/L) thereby reinforcing the impor¬
tance of NO as a death effector in cytokine-activated
co-cultures (Figure 2A; 0.92 ± 0.1% versus 4.6 ± 0.9%
apoptosis; activated co-culture with L-NAME versus ac¬
tivated co-culture; P < 0.001). Importantly, inclusion of
the control isomer A/-nitro-D-arginine methyl ester (D-
NAME, 200 |imol/L) did not prevent the cytotoxic action
of cytokine-activated iNOS wild-type macrophages (Fig-
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Figure 1. Cytokine-activated macrophages induce MDCK cell apoptosis. A:
MDCK cells were cultured alone or in the presence of mature murine bone
marrow-derived macrophages in the presence or absence of LPS and IFN-y.
After a 24-hour incubation the level ofMDCK cell apoptosis is determined by
in situ fixation of cultures with formaldehyde and fluorescence microscopy
after staining with Hoechst. Cytokine-activated macrophages induce signifi¬
cant MDCK cell death. *P< 0.001 versus nonactivated co-culture (data from
experiments with macrophages from four different mice). B: Low-power
view of cytokine-activated co-culture of macrophages (unlabeled) and Cell-
Tracker green-labeled MDCK cells after 24 hours. Apoptotic MDCK cells are
visible as bright cells exhibiting cytoplasmic condensation. C: The bright
rounded apoptotic MDCK cell exhibits nuclear pyknosis (green arrow); a
classical feature of apoptosis. The nucleus of an adjacent unlabeled macro¬
phage is also evident (red arrow). The merged image demonstrates the
proximity of the macrophage to the MDCK cell.
ure 2A; 4.4 ± 0.3% versus 4.6 ± 0.9% apoptosis; acti¬
vated co-cultures with D-NAME versus activated co-cul¬
tures; P > 0.05).
MDCK cell proliferation was significantly inhibited by
co-culture with macrophages, with the anti-proliferative
effect being independent of macrophage activation by
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Figure 2. Macrophage-derived NO is an important mediator of MDCK cell
apoptosis but is not involved in the inhibition of MDCK cell proliferation. A:
MDCK cells were cultured alone or in the presence of bone marrow-derived
macrophages derived from either iNOS wild-type (WT) or knockout (KO)
mice. Cultures were activated with LPS and IFN-y in the presence or absence
of the NOS inhibitor L-NAMF. (200 /xmol/L) or control D-NAMF, (200 jimol/
L). iNOS knockout macrophages are not cytotoxic under any conditions
whereas the cytotoxicity of iNOS wild-type macrophages is completely ab¬
rogated by pharmacological inhibition of NO production. *P < 0.05 versus
nonactivated iNOS wild-type macrophage co-cultures (data from experi¬
ments with macrophages from three different mice). B: MDCK cells were
cultured alone or in the presence of mature bone marrow-derived macro¬
phages derived from either iNOS wild-type or knockout mice. Cultures were
activated with LPS and IFN-y in the presence or absence of the NOS inhibitor
L-NAMF. Inhibition of MDCK cell proliferation by macrophages is indepen¬
dent of cytokine activation, macrophage genotype, or pharmacological inhi¬
bition of NO production. *P < 0.05 versus MDCK cells alone (data from
experiments with macrophages from three different mice).
erative effect was unaffected by the inclusion of the NOS
inhibitor L-NAME in the co-culture or the use of iNOS
wild-type and knockout macrophages (Figure 2B). This
indicates, in contrast to previous work using mesangial
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cells,18 that NO was not involved in the modulation of
MDCK cell proliferation. No difference was evident in total
cell number in these experiments (data not shown).
Macrophage-Derived NO Induces Apoptosis in
Murine PTE Cells
Although MDCK cells are a well-established tubular cell
line, they are of canine origin and may therefore not be
susceptible to other putative murine macrophage-de-
rived death effectors such as FasL and TNF-a. We there¬
fore determined whether cytokine-activated macro¬
phages exerted similar effects on murine PTE cells.
Treatment of PTE cells with LPS and IFN--y did not induce
significant apoptosis (Figure 3A). Cytokine activation of
co-cultures induced a significant threefold increase in
PTE cell apoptosis compared to nonactivated co-cultures
(Figure 3A; 5.28 ± 0.7% versus 1.08 ± 0.3% apoptosis;
activated co-cultures versus nonactivated co-cultures;
P < 0.001). In addition, inclusion of the NOS inhibitor
L-NAME reduced tubular cell death to baseline levels
(Figure 3A; 5.28 ± 0.7% versus 1.47 ± 0.3% apoptosis;
activated co-cultures versus activated co-cultures
treated with L-NAME; P < 0.001). Furthermore, although
iNOS wild-type macrophages were significantly cytotoxic
(Figure 3B; 3.26 ± 0.4% versus 0.72 ± 0.3% apoptosis;
activated co-cultures with iNOS wild-type macrophages
versus nonactivated co-cultures with iNOS wild-type
macrophages; P < 0.001), cytokine-activated iNOS
knockout macrophages did not induce significant apo¬
ptosis of PTE cells (Figure 3B; 0.57 ± 0.4% versus 0.33 ±
0.1% apoptosis; activated co-cultures with iNOS knock¬
out macrophages versus nonactivated co-cultures with
iNOS knockout macrophages; P > 0.05).
In contrast to MDCK cells, incubation of PTE cells with
macrophages in the presence or absence of LPS and
IFN-7 had no effect on the level of PTE cell proliferation
(data not shown). It should, however, be noted that PTE
cells exhibit a low level of proliferation compared to
MDCK cells. Although there was a trend to a reduced
total cell number in activated co-cultures, this did not
reach statistical significance (data not shown). We also
noted evidence of phagocytosis of apoptotic PTE cells by
macrophages in this primary cell co-culture system (Fig¬
ure 3C) unlike co-cultures of macrophages with MDCK
cells. The effect of phagocytosis would be predicted to
reduce the levels of free apoptotic cells evident, and this
may explain why a lower level of apoptotic PTE cells was
detected compared to MDCK cells. Interestingly, in ac¬
cordance with the increased level of PTE cell apoptosis in
activated co-cultures of iNOS wild-type macrophages
compared to iNOS knockout macrophages, we noted an
increased percentage of macrophages containing
phagocytosed apoptotic PTE cells (1.2 ± 0.79 macro-
phages/high-power field versus 0.3 ± 0.25 macro-
phages/high-power field: iNOS wild-type macrophages
versus iNOS knockout macrophages). In these studies
we did not find any significant difference between exper¬
iments involving the co-culture of C57BL/6 PTE cells with
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Figure 3. Cytokine-activated macrophages induce apoptosis in primary mu¬
rine tubular epithelial cells (PTEs). A: PTE cells were cultured in the presence
of mature murine bone marrow-derived macrophages. Selected cell cultures
were activated with LPS and IFN-y in the presence or absence of the NOS
inhibitor L-NAME (2(X) /xmol/L). *P< 0.05 versus activated co-cultures in the
presence or absence of L-NAME (data from experiments with cells from three
different mice). Bs PTE cells were cultured in the presence of mature bone
marrow-derived macrophages derived from either iNOS wild-type or knock¬
out mice. Selected cell cultures were activated with LPS and I FN-7. Cytokine
activation of iNOS wild-type macrophages induced PTE cell apoptosis
whereas activated iNOS knockout macrophages were noncytotoxic. *P <
0.05 versus nonactivated co-culture (data from experiments with cells from
five different mice). C: Photomicrographs from a co-culture of fluorescently
labeled macrophages (CellTracker orange) and PTE cells (CellTracker green)
demonstrating evidence of macrophage recognition and phagocytosis of
apoptotic tubular cells. The merged image demonstrates a condensed green
apoptotic tubular cell with a pyknotic nucleus that has been ingested by a
CellTracker orange-labeled macrophage.
C57BL/6 macrophages (0.58 ±0.1 apoptotic cells per
high-power field versus 0.42 ± 0.06 apoptotic cells per
high-power field; activated co-cultures with C57BL/6 PTE
cells and FVB/N macrophages versus activated co-cul¬
tures with C57BL/6 PTE cells and C57BL/6 macro¬
phages; P > 0.05).
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Figure 4. Obstructed kidneys exhibit tubulointerstitial infiltration with macrophages and iNOS-positive cells. Tissue sections were immunostained for the
macrophage marker F4/80 and/or iNOS. As Normal nonmanipulated kidneys exhibit occasional F4/80-positive resident macrophages (arrow). B: In contrast,
obstructed kidneys exhibit a prominent interstitial population of infiltrating F4/80-positive macrophages (arrow). C-E: Fluorescent photomicrographs showing
double-immunofluorescent staining of iNOS and F4/80 in day 7 obstructed kidney: iNOS-positive cells stained green (C), F4/80-positive interstitial macrophages
stained red (D), and merged image demonstrating co-localization (yellow) of iNOS and F4/80 indicating the presence of infiltrating macrophages expressing
iNOS (E).
Pharmacological Blockade of iNOS by L-NIL
Reduces Tubular Epithelial CellApoptosis in
Experimental Hydronephrosis
We then sought a role for iNOS-derived NO in the tubular
cell apoptosis evident during tubulointerstitial inflamma¬
tion in vivo. We used L-NIL, a specific irreversible iNOS
inhibitor, to pharmacologically inhibit the enzyme iNOS in
the model of experimental hydronephrosis, a model char¬
acterized by marked tubulointerstitial macrophage infil¬
tration and tubular epithelial cell death.22-35 We induced
experimental hydronephrosis in FVB/N mice and admin¬
istered L-NIL in the drinking water27-28 between day 5
and day 7, at which time the obstructed kidneys were
removed for histological analysis. Administration of the
inactive isomer D-NIL served as control. Normal kidneys
exhibited occasional scattered F4/80-positive resident
macrophages whereas obstructed kidneys developed a
prominent macrophage infiltrate in the tubulointerstitium
(Figure 4, A and B; 0.32 ± 0.04% versus 3.9 ± 0.9%
F4/80-positive surface area; normal kidney versus day 7
obstructed kidney; P < 0.001). In addition, iNOS-positive
macrophages were evident within the tubulointerstitium
(Figure 4, C-E). Pharmacological inhibition of iNOS did
not have any significant effect on the level of macrophage
infiltration (3.2 ± 0.7% versus 3.9 ± 0.9% F4/80-positive
surface area; L-NIL versus control; P > 0.05). Tubular cell
apoptosis and proliferation was determined by TUNEL
and PAS staining, respectively (Figure 5). Administration
of L-NIL significantly reduced the level of tubular epithe¬
lial cell apoptosis compared to controls (Figure 6A). In
contrast, the administration of L-NIL did not affect the
level of tubular cell proliferation in obstructed kidneys
(Figure 6B).
Pharmacological Blockade of iNOS by L-NIL
Reduces Interstitial CellApoptosis and
Increases Tubulointerstitial Fibrosis in
Experimental Hydronephrosis
Interstitial cell apoptosis and proliferation were deter¬
mined by TUNEL and PAS staining, respectively (Figure
5). The administration of L-NIL also resulted in a signifi¬
cant reduction in the level of interstitial cell apoptosis
(Figure 7A) with no effect on interstitial cell proliferation
being evident (Figure 7B). Tubulointerstitial fibrosis was
assessed by immunohistochemical staining for collagen
III, which is deposited by fibroblasts and is a represen¬
tative collagen of the scarred and injured tubulointersti¬
tium.36 Careful morphometric analysis of collagen III im-
munostaining indicated that pharmacological blockade
of the enzyme iNOS resulted in increased collagen III
deposition (Figure 8). We stained sections for a-smooth
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Figure 5. Obstructed kidneys exhibit apoptosis and proliferation of tubu¬
lar epithelial and interstitial cells. Tissue sections underwent TUNEL
staining to detect apoptotic cells whereas cells undergoing mitosis were
identified on PAS-stained tissue sections. A: Low-power view of ob¬
structed kidneys demonstrating scattered TUNEL-positive apoptotic cells
(arrows). B: High-power view of a TUNEL-positive apoptotic tubular
epithelial cell (arrow). C: High-power view of a TUNEL-positive apopto¬
tic interstitial cell (arrow). D: High-power view of a tubular epithelial cell
undergoing mitosis (arrow). E: High-power view of an interstitial cell
undergoing mitosis (arrow). Original magnifications: X200 (A); X1000
(B-E).
muscle actin, which is expressed by tubulointerstitial
myofibroblasts.26 The area of the renal tubulointerstitium
occupied by a-smooth muscle actin staining was as¬
sessed morphometrically as an indirect measure of the
tubulointerstitial myofibroblast population. This analysis
indicated no significant difference in a-smooth muscle
actin staining after short-term blockade of iNOS (3.1 ±
0.4% versus 2.8 ± 0.6% a-smooth muscle actin staining;
L-NIL treatment versus control; P > 0.05).
Discussion
The main finding of this study is that, despite the fact that
inflammatory macrophages may produce myriad pro-
apoptotic mediators,18"20 NO is the key mediator of mac-
rophage-induced tubular epithelial cell apoptosis in vitro





































Figure 6. Pharmacological blockade of iNOS reduces tubular cell apoptosis
but does not affect tubular cell proliferation after ureteric obstruction. Mice
were administered L-NIL, an irreversible pharmacological inhibitor of the
enzyme iNOS, or the isomeric control D-NIL, and the obstructed kidneys
were removed at day 7. A: The level of tubular cell apoptosis in obstructed
kidneys is significantly reduced after the administration of L-NIL. *P < 0.05
versus control (eight mice per group). B: The level of tubular cell prolifer¬
ation in obstructed kidneys is unaffected after the administration of L-NIL
( n = seven to eight mice per group).
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Figure 7. Pharmacological blockade of iNOS reduces interstitial cell apopto-
sis but does not affect interstitial cell proliferation after ureteric obstruction.
Mice were administered L-NIL, an irreversible pharmacological inhibitor of
the enzyme iNOS, or the isomeric control D-NIL, and the obstructed kidneys
were removed at day 7. A: The level of interstitial cell apoptosis in obstructed
kidneys is significantly reduced after the administration of L-NIL. *P < 0.05
versus control (eight mice per group). B: The level of interstitial cell prolif¬
eration in obstructed kidneys is unaffected after the administration of L-NIL
(n = seven to eight mice per group).
inflammation. Our data indicates that nonactivated mac¬
rophages per se are not inherently cytotoxic whereas
cytokine-activated macrophages induce significant apo¬
ptosis of MDCK cells, a well-characterized renal tubular
cell line. Studies using both pharmacological inhibitors of
NO production and macrophages derived from either
iNOS knockout or wild-type mice indicate that macro-
12,19,39; and
our study,
phage cytotoxicity in vitro is markedly dependent on
iNOS-derived NO. Importantly, similar results were ob¬
tained in an entirely primary cell co-culture system using
murine primary renal tubular epithelial cells. These data
are in accordance with previous work indicating that NO
is an important mediator of macrophage cytotoxicity to¬
ward renal mesangial cells and tumor cells.18,34 Interest¬
ingly, we noted that the level of PTE cell apoptosis evi¬
dent in these studies was less than the level of MDCK cell
apoptosis. Although this may reflect a variety of factors
including the different species of origin and the prolifer¬
ation status of the cells, our data suggest that macro¬
phage phagocytosis of apoptotic PTE cells but not MDCK
cells may be at least partly responsible because apopto¬
tic cells may be rapidly recognized, ingested, and
degraded.37
Despite the fact that previous work has indicated the
involvement of NO in the macrophage induced apoptosis
of mesangial cells18 and vascular smooth muscle cells 38
other death effectors such as TNF-a
FasL35,38,40 have also been implicated. In
however, pharmacological inhibition of NO production or
the use of iNOS-deficient macrophages resulted in a
complete abrogation of tubular cell apoptosis compared
to control co-cultures, thereby suggesting that NO is the
dominant mediator of tubular epithelial cell death in¬
duced by cytokine-activated macrophages in vitro. This
suggests that the presence of significant additional in
vitro proapoptotic mechanisms is unlikely and that mac¬
rophage generation of NO is critically important. Previous
in vitro studies have suggested macrophage production
of a soluble proapoptotic factor capable of inducing tu¬
bular cell death,11,12,21 and this may reflect the use of
different cells and assays in these studies.
The effect of macrophages on the level of target cell
proliferation varied according to the nature of the target
cell. The proliferation of MDCK cells was reduced by
incubation with nonactivated or cytokine-activated mac¬
rophages. Bone marrow-derived macrophages secrete
significant levels of transforming growth factor-p and this
cytokine has been documented to inhibit MDCK cell pro¬
liferation.24,41 In contrast, bone marrow-derived macro¬
phages exerted no significant effects on PTE cell prolif¬
eration although this may reflect the lower level of
proliferation of these primary cells.
Because in vitro studies suggested a key role for
macrophage-derived NO, we examined the effects of
pharmacological inhibition of iNOS on tubular cell
death during renal inflammation in vivo. We used the
neutrophil- and lymphocyte-independent model of ex¬
perimental hydronephrosis that is characterized by
prominent macrophage infiltration and significant tubu¬
lar cell apoptosis.22,26 Importantly, the administration
of the specific iNOS inhibitor L-NIL did not result in any
confounding effects on the level of interstitial macro¬
phage infiltration. However, L-NIL treatment did signif¬
icantly reduce the level of tubular cell apoptosis com¬
pared to the control group but had no effect on tubular
cell proliferation, in accord with our in vitro experiments
using primary murine tubular epithelial cells.
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Figure 8. Pharmacological blockade of iNOS increases tubulointerstitial deposition of collagen III after
ureteric obstruction. Mice were administered L-NIL, an irreversible pharmacological inhibitor of the
enzyme iNOS, or the isomeric control D-NIL, and the obstructed kidneys were removed at day 7.
A: Photomicrographs of collagen III immunostaining at day 7 in control mice and mice treated with L-NIL.
B: The administration of L-NIL increases the tubulointerstitial deposition of collagen III assessed by
computer image analysis. *P < 0.05 versus control (n = seven to eight mice per group).
It should also be noted that additional mechanisms
have been suggested for macrophage-mediated tubular
cell apoptosis in vivo. A study of a murine model of Alport
syndrome suggested that macrophage production of ma¬
trix metalloproteinases may result in degradation of
tubular basement membrane and resultant tubular cell
apoptosis by anoikis.42,43 In addition, Misseri and col¬
leagues44 suggested a role for TNF-a in the induction
of tubular cell death in experimental hydronephrosis in
the rat. In this study, the obstructed kidneys exhibited
up-regulation of both TNF-a and FasL expression with
systemic administration of a pegylated form of soluble
TNF receptor type 1, significantly inhibiting tubular cell
apoptosis. Macrophage infiltration, however, was not
determined, and it is therefore unclear whether block¬
ing the action of TNF-a may have modulated macro¬
phage infiltration, a key factor in determining the level
of tubular cell apoptosis during tubulointerstitial infil¬
tration.14 However, because L-NIL administration re¬
sulted in a partial inhibition of tubular cell apoptosis,
additional proapoptotic mediators may be used by
infiltrating inflammatory macrophages to induce tubu¬
lar cell death during tubulointerstitial inflammation in
vivo.
Our study does, however, reinforce the critically impor¬
tant role of infiltrating macrophages during tubulointersti¬
tial inflammation. A body of evidence indicates that mac¬
rophages are implicated in the deleterious induction of
tubular cell apoptosis in vivo. For example, the induction
of renal inflammation in mice exhibiting defective tubulo¬
interstitial macrophage recruitment is characterized by
significantly reduced levels of tubular cell apoptosis.11""13
Also, we recently used the transgenic CD11b-DTR con¬
ditional ablation mouse45 to examine the role of macro¬
phages in progressive renal inflammation during nephro¬
toxic nephritis. The ablation of macrophages between
days 15 and 20 of nephrotoxic nephritis improves renal
function and significantly reduced the level of tubular cell
apoptosis14 thereby reinforcing a direct role for macro¬
phages in the induction of tubular cell death. Our data
indicate that the pharmacological blockade of the pro¬
duction of proapoptotic NO by iNOS can inhibit tubular
epithelial cell death without affecting the level of macro¬
phage infiltration and stresses the importance of macro¬
phage phenotype as well as macrophage numbers dur¬
ing renal inflammation. Our data resonate with the work of
Anders and colleagues46 who noted that blockade of the
chemokine CCL5/RANTES in glomerulonephritis suc¬
cessfully inhibited macrophage infiltration but resulted in
increased macrophage expression of iNOS and in¬
creased tissue injury as a result.
It is also of interest that L-NIL treatment significantly
reduced the level of interstitial cell apoptosis. Previous
work has established that the vast majority of TUNEL-
positive apoptotic cells detected within the tubulointersti-
tium of the kidney have actually been phagocytosed and
are located within viable nonapoptotic cells.47 We were
therefore unable to use double staining for a-smooth
muscle actin and TUNEL to determine whether the apo¬
ptotic tubulointerstitial cells were dying myofibroblasts.
Despite the reduction in interstitial cell apoptosis, we
found no significant difference in the tubulointerstitial
population of myofibroblasts assessed by morphometric
analysis of a-smooth muscle actin immunostaining. This
may be attributable to the fact that the period of pharma¬
cological blockade of iNOS was relatively short. Despite
the absence of a significant difference in tubulointerstitial
a-smooth muscle actin expression, we found that L-NIL
treatment significantly increased the tubulointerstitial
deposition of collagen III that is characteristically found in
renal injury and scarring. This suggests that iNOS-de-
rived NO may also be involved in limiting tubulointerstitial
renal scarring and it is therefore of interest that iNOS
knockout mice develop increased levels of tubulointersti¬
tial fibrosis after ureteric obstruction.48 Our data indicat¬
ing that pharmacological blockade of iNOS-derived NO
ameliorates the level of tubular cell apoptosis is not in
accordance with previous work because NO has been
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implicated as a protective factor in the induction of tubu¬
lar cell apoptosis by mechanical stretch in vitro and in vivo
in ureteric obstruction.49 The reasons for this are unclear,
although strain differences may be important because
this can significantly affect the amount of NO generated
by macrophages.50 Although beyond the scope of this
study, it would be interesting to perform ureteric obstruc¬
tion in irradiated iNOS wild-type mice reconstituted with
bone marrow derived from iNOS knockout mice because
this would localize the defective expression of iNOS to
the infiltrating leukocyte population. It should be noted,
however, that double immunolabeling revealed F4/80-
positive macrophages that were strongly iNOS-positive
within the tubulointerstitium of obstructed kidneys, indi¬
cating that infiltrating macrophages may express iNOS.
Lastly, it is apparent from this and other studies that a
significant level of macrophage-independent tubular cell
death occurs in this model and it is undoubtedly the case
that additional proapoptotic stimuli including mechanical
stretch, hypoxia, ischemia, and so forth, also play a major
role in the apoptosis of tubular epithelial cells.51-53 In
conclusion, our work indicates that iNOS-derived NO is
an important mediator of macrophage-induced tubular
epithelial cell apoptosis in vitro and plays an important
role in tubular epithelial cell apoptosis and tubulointersti-
tial fibrosis in vivo.
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